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Critically ill children require accurate haemodynamic assessment to evaluate the severity of 
illness or response to therapy. Clinical estimation of cardiac output is inaccurate. Hence, 
advanced haemodynamic monitoring devices may help guide physicians towards the most 
appropriate treatment strategy. However, none of the currently available monitors for children 
fulfil all the criteria of an ideal device. 
  
Methods  
We evaluated two novel minimally invasive haemodynamic monitoring devices in 100 critically ill 
children. The transpulmonary ultrasound dilution (TPUD) method is a validated indicator dilution 
based technique for measuring cardiac output in children. Pressure recording analytical method 
(PRAM) is an arterial pulse contour based method and is not yet validated in children. We 
compared PRAM with TPUD both in terms of agreement with absolute values of CO and also 
quantified the ability of PRAM to track changes in CO in response to therapy. We also 
evaluated the ability of TPUD to identify, and quantify, small anatomic shunts. Finally, a range of  
variables measured by TPUD and PRAM were assessed for their ability to predict response to 
fluid bolus administration. The contribution of baseline myocardial contractility towards that 
response was also evaluated. 
 
Results 
PRAM showed unacceptable level of error for estimation of absolute values of CO and was 
unable to accurately track changes in CO. TPUD could identify small anatomic shunts. All of the 
volumetric variables were unable to predict accurately for fluid responsiveness. Myocardial 




A revision of the current algorithm of PRAM is recommended for measurement of CO in 
children. The predictive ability of the studied variables was poor to moderate for determining 
response of stroke volume to fluid bolus administration. 
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What this thesis aims to add 
 
Advanced haemodynamic monitoring is an important adjunct in the management of critically ill 
children. Broadly speaking, this includes assessment of adequacy of the balance between 
oxygen delivery and consumption. A key component of oxygen delivery is cardiac output, which 
must also include consideration of the inter-related variables comprising cardiac output (preload, 
afterload, contractility and diastolic function). To date, bedside measurement of cardiac output in 
children has been hindered by invasiveness of devices; however the past decade has seen 
more widespread uptake due to the introduction of less invasive techniques. However, it is vital 
that new techniques are evaluated adequately. One of the commonest therapies for improving 
oxygen delivery is fluid bolus administration; however this is not without risk, as fluid overload is 
increasingly recognised as a risk factor for poor outcome. Thus, a tool to predict fluid 
responsiveness may obviate the need for unnecessary fluid administration.   
 
My thesis aims to explore aspects of the above in critically ill children, via evaluation of two 
novel tools for advanced haemodynamic monitoring. Specifically this will include: 
 
 (i) Validation of accuracy of cardiac output measurement using a semi-invasive, pulse-contour 
based device:  Pressure Recording Analytical Method (PRAM) 
 
(ii) A systematic evaluation of fluid responsiveness using variables measured by PRAM and 
also a dilution based technique (transpulmonary ultrasound dilution, TPUD). This will include 
quantification of the predictive ability (in terms of stroke volume change), of various static and 
dynamic variables from the two devices, followed by quantification of the effect of baseline 
contractility on prediction.  
 
(iii) Determination of the accuracy of TPUD for detection of anatomic shunts. This is because 
anatomic shunts may impact on clinical status; and may go undetected in settings where 
echocardiography is not readily available. 
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The thesis is presented in 2 parts. 
 
Part A: Consists of an overview of haemodynamic monitoring with reference to paediatric 
applications. 
 
Chapter 1 is an introduction to advanced haemodynamic monitoring, with emphasis on 
methods for measurement of  cardiac output.  
 
Chapter 2 is a summary of static and dynamic variables estimating preload and fluid 
responsiveness. 
 
Chapter 3  is a detailed description of TPUD and PRAM  technology    
 
Part B: Describes our evaluation of TPUD and PRAM in 100 critically ill children.   
 
Chapter 4 Methodology and study protocol 
 
Chapter 5 is a validation study of the accuracy of cardiac output measurement using PRAM 
with TPUD as the reference method (TPUD has been evaluated previously). This included both 
absolute accuracy and trending ability.  
 
Chapter 6 is a systematic evaluation of the predictive ability (in terms of stroke volume change), 
of various static (TEDVI, ACVI and CBVI) and dynamic (SVV, PPV and SPV) variables 
measured using the two devices. I also investigated the influence of baseline contractility on 
relative stroke volume changes following fluid bolus administration. 
 
Chapter 7 is an observational study assessing the accuracy of TPUD technology for detection 
and quantification of small anatomic shunts with Doppler echocardiography as the reference 
method. 
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Chapter 8 is the summary of the major findings from our study, including a discussion of the 
implications and relevant literature. Finally, I provide suggestions for future research in the field 
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Chapter 1 General principles of monitoring in intensive care 
and review of cardiac output monitoring 
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1.1 Introduction to CO monitoring  
 
A key facet of management of critically ill patients is provision of adequate tissue perfusion and 





Cardiac output is defined as the volume of blood ejected by heart in one minute. It is usually 
expressed in relation to body surface area. The normal value in paediatric age range is 3.5 – 
5.5 l/min/m2 .3 Clinical estimation of cardiac output is challenging, even amongst experienced 
clinicians. Tibby et al evaluated the ability of clinicians involved in the provision of paediatric 
intensive care for estimation of cardiac index in ventilated children, based upon physical 
examination, clinical and bedside laboratory data. They demonstrated a poor correlation both 
categorically (kappa statistic 0.09, weighted kappa 0.17) and numerically (r = 0.24, 95% conf. 
intv 0.06 to 0.41).4 
 
Hence, pathological states resulting in inadequate delivery of oxygen such as shock, require 
accurate estimation of cardiac output. This facilitates provision of targeted therapy towards set 
treatment goals during management of critically ill patients. The use of cardiac output monitoring 
in fluid refractory shock is further recommended by the International consensus conference of 
‘haemodynamic monitoring in shock and implications for management’.5 
 
A range of techniques is available for measuring CO. They can be classified as utilizing the Fick 
principle, indicator dilution, Doppler ultrasound, pulse contour analysis, impedance, and other 
miscellaneous methods.  
 
When considering the evaluation of these techniques, certain characteristics mentioned below 
should be considered to justify their use and cost effectiveness6: 
 
 
Oxygen delivery =Oxygen content  of  arterial  blood ×Cardiac output
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a) Tests should be accurate and responsive  
 
Monitoring tests should accurately reflect the true value of the entity measured and be 
responsive to capture the changes following various interventions or with spontaneous changes 
in a patient’s clinical condition. 
 
(b) Monitoring test should improve patient outcome measures by guiding therapy 
 
Monitoring is performed with an aim to check disease progression and measure the effect of 
various interventions to improve patient outcomes. This may hold true for most methods or tests 
but the use of pulmonary artery catheters (PAC) for CO monitoring did not improve mortality 
rates among patients. CO monitoring using Pulmonary artery catheters came into existence in 
1970’s. Most studies failed to show any improvement in the mortality rates with the use of these 
devices. A multi-centre study by Connors et al included approximately 6000 adult patients 
undergoing PAC monitoring7. They reported an increase in mortality, length of stay and cost in 
patients with PAC in situ as compared to the matched controls without PAC. Another RCT with 
approximately 1000 adult patients reported a complication rate of approximately 10%8.  These 
results are partly attributed to: 
 
(i) Lack of knowledge to optimally use PAC and interpretation of the obtained data.  Iberti et al 
demonstrated a mean test score of 65% in a questionnaire based survey to approximately 500 
physicians, assessing their knowledge and understanding of the use of the pulmonary artery 
catheter and interpretation of data derived from it 9. 
 
(ii) Absence of treatment algorithms and management protocols linked to CO monitoring may 
have also contributed to failure of these devices in improving patient outcomes. Gan et al  
followed a treatment algorithm based upon stroke volume and FTc estimation in mixed surgical 
adult patients using oesophageal Doppler monitoring devices for CO estimation. They reported 
benefits in reducing the duration of hospital stay and incidence of feed intolerance10. Sinclair et 
al reported similar results with their use of clinical algorithm related to trans oesophageal 
Doppler11. In view of the current evidence showing a reduction in incidence of central venous 
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line insertion, length of stay, readmissions or repeat surgery and an estimated cost saving of 
£1100/patient, National institute for health and care excellence UK, has recommended the use 
of esophageal Doppler in adult patients undergoing major or high risk surgery 12. 
 
(c) Clinical validity 
 
Most of the CO monitoring devices mentioned have been studied and validated in adults and 
extrapolation of data towards paediatric age group may not always be the correct approach. 
Only a few devices or techniques are validated for measurement of CO in paediatric practice. 
Pulmonary artery catheter and Transpulmonary thermodilution methods are long been regarded 
as benchmark methods in clinical practise. One of the devices used in our study is based upon 
indicator dilution method and is validated against PAC in paediatric patients.  
 
(d) Signal to noise ratio 
 
Signal is the meaningful change in biological value measured over a given time. Noise is the 
background short term measurement variability arising as a result of biological or technical 
reasons. An ideal monitoring test should have a large signal to noise ratio and should be able to 
differentiate meaningful change from usual biological or technical variability. This is important to 
reduce bias in the measurements.  There are various ways to reduce the background noise and 
hence improve the accuracy of CO assessment. Firstly, choosing devices with low coefficient of 
variation can reduce technical component of the noise. Both the monitoring devices in our study 
had coefficient of variation of less than 10%. Secondly, we took mean of multiple CO 
measurements both before and after the intervention to help reduce the background noise 13.     
 
 Shepard et al also described desirable properties of an ideal CO monitoring device. They 
included no morbidity (invasiveness), continuous use, rapid response time, operator 
independence reproducibility, accuracy and cost effectiveness.14 
 
Paediatric practice presents a range of unique challenges for CO monitoring, including: patient 
size, anatomical variants, anatomical shunts, etc. 
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This chapter provides an overview of different cardiac output (CO) monitoring devices available 
along with their limitations, sources of errors and applicability in paediatric practice wherever 
possible. 
 
The chapter also gives a representative summary of paediatric studies comparing different CO 
monitoring devices using bias and precision statistics (wherever data is available). As such, it is 
presented as a narrative, rather than systematic review.   
 
A narrative review of adult and animal studies for different CO monitoring devices is provided 
collectively at the end of the chapter to provide reader an insight into the relevant literature. This 
list is not a systematic review or exhaustive in nature. 
 
The appropriate statistical method for demonstrating agreement between the two methods 
(experimental and reference methods) for measuring CO is Bland Altman analysis.15 Bias is 
defined as the mean difference between the two methods. Limits of agreement are calculated 
as mean bias + 1.96 Standard deviation (SD) of the bias. Percentage error is calculated as (1.96 
SD of bias / mean CO of the reference method). An acceptable percentage error is typically 
defined using two considerations: (a) the precision of the reference method, and (b) that the 
new method should be at least as accurate as the reference. Using a standard statistical 
approach for combining variance, and taking pulmonary artery thermodilution as a reference, 
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1.2 Methods for estimation of cardiac output  
 
1.2.1 Fick method 
 
(i) Direct Fick Method 
 
CO estimation first described by Adolf Fick in 1870 has long been been considered a laboratory 
gold standard. It involves adding or removing an indicator and measuring the change in 
indicator concentration upstream and downstream of the point of indicator addition or removal 
(fig 1-1).17 The most commonly employed indicator is oxygen (consumption) [carbondi-oxide 
(production) may also be used]. CO is calculated by the following formula: 
 




CO: cardiac output 
VO2: oxygen consumption  
CaortaO2: oxygen content in arterial blood  
Cmixed venousO2: oxygen content of mixed venous blood  
 
 





Hb: haemoglobin (g/l) 
PaO2: partial pressure of oxygen in arterial blood (mmHg) 
 

























Figure 1-1 Fick principle. Cardiac output is calculated from estimation of oxygen consumption (pulmonary 
uptake) and difference between the oxygen content at an upstream and downstream point. Reproduced 
from: Halley G, Tibby S. Haemodynamic monitoring . In: Roger’s Text book of Paediatric Intensive Care, 
Lippincott Williams & Wilkins 2008.18 
 
 
Direct measurement of these variables constitutes the direct Fick method. The Fick method can 
be used to calculate both systemic cardiac output and pulmonary blood flow.  Normally, 
pulmonary blood flow is equal to systemic cardiac output. However, in diseased states or  in 
conditions with anatomic shunts, this equilibrium may not necessarily hold true and requires 
careful consideration of which flow is being measured and the  upstream and downstream 
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Figure 1-2 Calculation of pulmonary and systemic blood flow in the presence of anatomic shunts. Diagram 
on the left has ASD (left to right shunting). For systemic cardiac output, mixed venous estimation should be 
done upstream from the shunt such as from SVC . The right diagram shows a patent ductus arteriosus, 
again with left to right flow. The mixed venous estimation should be done from the pulmonary artery 
‘downstream’ to the shunt to allow estimation of total pulmonary blood flow. Ao = aorta; LA = left atrium; PA 
=  pulmonary artery; PV = pulmonary veins;; RA = right atrium; RV =right ventricle; LV = left ventricle; SVC =  
superior vena cava. Reproduced from: Halley G, Tibby S. Haemodynamic monitoring . In: Roger’s Text book 
of Paediatric Intensive Care, Lippincott Williams & Wilkins 2008.18. 
 
 
Fick is an accurate method for CO estimation but it has several technical challenges and 





Firstly, the Fick technique requires measurement of oxygen consumption or carbon dioxide 
production. Traditional methods such as Douglas bag and spirometry are impractical to use in 
PICU settings. Modern, portable metabolic monitors or mass spectroscopy has replaced these.  
 
Secondly, oxygen content measurement (see formula above) requires arterial and pulmonary 
artery catheters for  arterial and mixed venous blood sampling. 
 
 
Sources of error for Fick method 
 
The Fick method is prone to numerous sources of error; both in estimating oxygen consumption 
and arterial and mixed venous oxygen content calculation. 
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Errors in estimating oxygen consumption 
 
(i) Loss of expired gas: Leaks around the endotracheal tubes and pneumothorax with 
associated bronchopleural fistula allow expired air to escape the metabolic monitors resulting in 
inaccurate estimations. A cuffed endotracheal tube is recommended to minimise the errors due 
to leaks.20  
 
(ii) High fractional inspiratory oxygen: Most modern metabolic monitors employ the Haldane 
algorithm to estimate oxygen consumption.21 The difference between the inspiratory and 
expiratory oxygen concentration is small with high fractional inspiratory oxygen concentration 
requirements for example in conditions with severe lung disease. This leads to an error in the 
denominator part of the Haldane algorithm. .This error is more pronounced with FiO2 greater 
than 0.85.22 
 
(iii) Severe lung pathology may violate the law of mass balance (systemic oxygen consumption 
is in equilibrium with oxygen uptake by the lungs). Oxygen consumption of normal lungs is 
accounted for in the Fick equation. However, in severe pulmonary disease, lungs may consume 
oxygen directly from the inspired oxygen, rather than via the bronchial circulation. This leads to 
a difference in measured oxygen uptake (greater) and systemic oxygen consumption resulting 
in overestimation of cardiac output.23 
 
(iv) Estimation of mixed venous saturations is sometimes performed using central venous rather 
than pulmonary arterial blood. This assumes a constant and small difference between the two 
sites, which is not guaranteed in critically ill patients. The range of limits of agreement between 
the two is reported as ±15 to ± 25%. This error is variable rather than fixed and is influenced by 
multiple factors such as venous sampling site, shunts, redistribution of blood flow, depth of 
anaesthesia and myocardial oxygen consumption.24 
 
(v) Other steps prone to errors in this technique are the conversion of gas volumes to standard 
conditions and controlling partial pressure of water vapours to desired effect. 
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 (ii) Partial carbondi-oxide (CO2) rebreathing or Indirect Fick method 
 
An alternative to direct invasive vascular access is to estimate the Fick parameters indirectly 
from the inspired and expired gases using a partial CO2 rebreathing technique. This is known as 
indirect Fick method. It involves introduction of a fixed volume of dead space into the ventilator 
circuit. The patient rebreathes a proportion of the exhaled CO2 for a short duration while 
mechanically ventilated. Parameters are measured before and after the CO2 rebreathing period 






Qpcbf: pulmonary capillary blood flow 
ΔVCO2:  measurement of change in CO2 production before and after rebreathe 
ΔC mixed venous: change in CO2 content in mixed venous blood before and after rebreathe and 
is assumed to be zero 
ΔC pulmonary end capillary:  change in CO2 content in pulmonary end capillaries before and 
after rebreathing. This is estimated from alveolar CO2 content which in turn is estimated from 
end tidal CO2 via a correction factor 
 
Nunn’s iso-shunt diagrams are used to estimate intrapulmonary shunt flow and added to 
pulmonary capillary blood flow to give total pulmonary blood flow.25 
 
 
Sources of error for Indirect Fick method 
 
(i) Indirect Fick method assumes no restriction of diffusion of CO2 across the alveolar 
membrane. This may not be entirely true in patients with severe lung injury who have deranged 
alveolar gas exchange thus affecting the CO calculation.26  
 
Qpcbf = ΔVCO2
ΔCmixed  venous−ΔCpulmonary end  capillary
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(ii) The effects of unknown ventilation perfusion mismatch or shunts may result in 
underestimation of cardiac output.27 Measurement of arterial PaCO2 is necessary when the 
dead space is large (  > 0.65) in conditions such as pneumonia or acute 
respiratory distress syndrome; as estimation of PaCO2 from the end tidal CO2 will be inaccurate. 
This is more likely to be the case in clinical practise in PICU settings.28,29 
 
 (iii) The relationship between PaCO2 and end tidal CO2 is only true for the linear part of the CO2 
dissociation curve  (PaCO2 greater than 30 mm of Hg). Hyperventilation leading to a PaCO2 less 
than this value will make this an invalid assumption.30 
 
 
Summary of paediatric studies using Fick and Indirect Fick method 
 
Only a limited number of studies have evaluated these methods in a paediatric population. 
Table 1-1 below illustrates the summary of some of the studies using direct and indirect Fick 
method. These studies suggest that direct Fick method is in good agreement with pulmonary 
artery thermodilution method (PATD). However, indirect Fick lacked agreement when compared 
with PATD.  
 
















       (1996) 
Fick-O2 PATD 25 na+ na+ -0.05 0.32 21.3 na+ 
Levy 32 
(2004) 
CO2 R PATD 37 9.2 – 47.4 1.2-5.4 -0.27 1.49 53* 0.83 
Botte 33 
(2006) 
CO2 R TTE 21 15 – 60 1.8-9.9 -0.61 0.94 20 0.85 
Dead space volume
Tidal volume
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CO2R = Carbon dioxide rebreathe; LOA = limits of agreement; N = number of subjects; na+ = Not available; 
PATD = pulmonary artery thermodilution; PE = Percentage error; R = Reference method; TTE = trans 
thoracic echocardiography; Weight and CO are expressed as range.* Value not provided but  estimated from 
the data provided. 
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1.2.2 Indicator dilution methods  
 
Stewart, first used the indicator dilution method for measurement of blood volume flow in 1827 
.34 Hamilton subsequently utilised this principle to measure cardiac output.35   
 
A variety of dilution methods are available; all are based on the same principle, regardless of 
the indicator used (temperature, dye, charge, ultrasound velocity). Injecting a known amount of 
indicator into the venous blood stream and measuring the temporal change in blood-indicator 
concentration downstream allows for generation of a dilution curve, from which blood flow may 
be calculated. The dilution curve rises to a peak level and decays exponentially with the curve 
never returning to the baseline. This mono-exponential decay is a result of the ventricle ejecting 
only a fraction of its content with each systole, leaving a part of the indicator within the ventricle. 
Indicator free venous blood returning to the heart dilutes the indicator during diastole and again 
only a fraction of this is ejected out of the ventricle. This cycle continues until recirculation of the 
indicator happens. Extrapolating the decay curve from just before the point of recirculation 
enables calculation of the area under the curve. This is achieved by semi-logarithmic 
conversion, which converts the decay curve into a straight line that is extrapolated to the 
baseline. The characteristics and shape of the curve depend upon the site of measurement of 
the indicator concentration (pulmonary artery or transpulmonary dilution methods) (fig 1-3). 
 
  




Figure 1-3 Comparison of thermodilution curves generated with thermistor in the pulmonary artery and 
further downstream (transpulmonary). The transpulmonary thermodilution curve has a delayed 
appearance and a smaller peak. However, both the curves approximate a similar baseline. Adapted from: 
Reuter et al, Anesth Analg 2010;110:799 –811 36. 
 
 







the denominator refers to the integral of the indicator concentration with time. This is 
represented by area under the curve (AUC) for indicator concentration versus time measured 
between time of injection and infinity. Hence, there is an inverse relationship between CO and 
AUC. High flow situations produce narrow peaked curves where as low flow situations produce 
broad and large dilutional curves. 
  
CO = Amount  of  indicator  injected
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Sources of error for Indicator dilution methods 
 
Indicator dilution methods are accurate as long as there is a rapid and even indicator injection, 
complete mixing of the indicator and blood, no loss of indicator between injection and 
measurement, no anatomical shunt, minimal valve regurgitation, and steady state flow. Any 
deviation from these characteristics as explained below, will impact on the accuracy of the 
measurements. 
 
(i) Loss of indicator before injection 37 (in terms of both the volume or temperature of the 
injectate) , during the injection due to catheter dead space and conductive warming (the latter 
only in cases of thermal indicator) 38 or after the injection  as a result of conductive rewarming 
(with thermal indicator) 39 can lead to reduction   in the mean blood temperature fall. This leads 
to a reduction in area under the curve, hence, overestimation of cardiac output by a 
considerable measure. 
 
(ii) Pathological recirculation of the indicator in situations of anatomical shunts or low cardiac 
output state increases the AUC hence underestimates the cardiac output. The shunt allows the 
indicator to recirculate and get detected multiple times.40 
 
(iii) Tricuspid regurgitation leads to inaccurate estimation in either direction. Reverse movement 
of the indicator during ventricular contraction is one of the contributory factors.41 
 
(iv) Fluctuations in the baseline temperature due to changing clinical conditions like rewarming 
42, after cardiopulmonary bypass 43 and cyclical changes in CO during different phases of 
respiration  may also lead to inaccuracies in CO estimation. 
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Types of Indicator dilution methods 
 
 (i) Thermodilution methods 
 
The thermodilution method utilises cold saline as an indicator and measures changes in the 





V0 and T0: volume and temperature of the injectate respectively  
Tb: temperature of the whole blood prior to injectate  
: time averaged temperature change  
K: heat constant 36 
 
 Cardiac output will be inversely proportional to the mean blood temperature depression and the 
duration of the transit of the cooled blood. 
 
  
CO = V0(Tb −T0 )K
ΔTb dt∫
ΔTbdt∫
   
 35 
Thermodilution techniques are further subdivided into pulmonary artery thermodilution and 
transpulmonary thermodilution. 
 
Pulmonary artery thermodilution (PATD) 
 
a) Intermittent pulmonary artery thermodilution 
  
 This method involves an indicator of known volume and temperature injected via the proximal 
port of pulmonary artery catheter (PAC) into the right atrium. The original description was with 
the use of cold saline or dextrose.44 The indicator mixes with the blood, travels to the right 
ventricle and further into the pulmonary artery. The change in the blood temperature is detected 
by the thermistor at the catheter tip within the pulmonary artery, and produces a thermodilution 
curve enabling CO measurement.  The technique has been validated with various other 
standardized techniques, such as Fick principle45 or electromagnetic flow probes.46  The 
accuracy of this method is reasonable, provided readings are performed meticulously. The 
quoted precision error of triplicate readings of approximately 13% made this a clinical reference 
standard for a many years.47  
 
Although this method is often regarded as a benchmark method in clinical practice, it is not a 
gold standard and has technical challenges and other potential sources of inaccuracy in 
addition to the generic errors described previously. These include technical complications for 
placement of PAC such as tissue damage, arrhythmias, catheter malposition, haemothorax, 
pulmonary infarction, sepsis.48 In addition, variations in blood temperature within the pulmonary 
artery that is unrelated to indicator injection and fluctuations in cardiac output as a result of 
positive pressure ventilation mandates averaging of multiple measurements timed throughout 
the ventilator cycle.49,50  
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b) Continuous pulmonary artery thermodilution  
 
This method has the same principles as the bolus pulmonary artery thermodilution. However, 
instead of injecting cold saline intermittently, there is a heating filament attached to the PAC 15-
25 cm before its tip. Depending upon the make of the monitor, either a flat heating filament is 
activated for 1-4 s using a pseudorandom binary sequence to produce constant heat or a coiled 
filament emits heat for 20 seconds of a 40-seconds repetitive on-off cycle. This signal in either 
case is picked up by the thermistor at the end of the catheter producing a thermodilution curve 
after averaging.51,52 
 
Continuous pulmonary artery thermodilution has been shown to have good correlation with the 
intermittent bolus method in different clinical conditions.53,54 The main disadvantage of this 
method is the time lag of up to 5 minutes for averaging during period of haemodynamic 
instability.55 This could be classed as a continuous but not instantaneous system. Another 
disadvantage is its reported inaccuracy in patients recovering from hypothermia possibly due to 




Transpulmonary thermodilution (TPTD)  
 
This method is similar to pulmonary artery thermodilution but the temperature change is 
measured typically in a large systemic artery such as the femoral artery. This obviates the need 
for introduction of PAC. One of the advantages of TPTD over pulmonary artery thermodilution is 
it’s less susceptibility to changes in CO induced by mechanical ventilation. It is due to a 
relatively long time interval between injection and sensing site (as compared to PATD) during 
which 3-4 cardiac cycles occur. This averages out any cyclical SV changes related to 
mechanical ventilation. The thermal indicator is injected into the superior venacava, mixes with 
the surrounding blood, traverses through the right side of the heart, pulmonary circulation, left 
side of the heart and aorta and is detected at a downstream location (for example a major 
branch of femoral artery).57 This produces a thermodilution curve similar to intermittent bolus 
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pulmonary artery thermodilution method from which CO is calculated using Stewart–Hamilton 
equation. Figure 1-3 compares pulmonary and transpulmonary thermodilution curves after 
injection of cold injectate into the superior venacava. The PATD curve has a higher peak and 
arrives early after the injection with the thermistor in the PA as compared to TPTD, where 
temperature detection is further downstream in the aorta. However, both curves approximate 
similar baselines.  
 
Initially there were concerns regarding the loss of indicator between injection and measurement. 
In fact several authors have demonstrated that the loss of heat is small and relatively constant 
without affecting the accuracy of cardiac output measurement provided the injectate is cooled 
sufficiently (to less than 10 degree C).58,59 In addition this small loss of heat has been utilized to 
calculate extravascular lung water, which may be used as a marker of disease severity in 
certain states (e.g. acute respiratory distress syndrome).60,61 
 
TPTD does not involve PAC insertion thus avoids many of the associated risks . This makes it 
more attractive for use in small paediatric patients. In addition to measuring CO, this technique 
also provides variables such as intra-thoracic blood volume and global end diastolic volume – 
markers for estimation of preload based upon the concept of mean transit time and exponential 
downslope time of the primary thermodilution curve (see chapter 2).62-64 
 
One obvious disadvantage over intermittent bolus pulmonary artery thermodilution is its inability 
to provide or estimate PA pressures or true mixed venous saturations. TPTD is amenable to the 
same sources of error as intermittent bolus pulmonary artery thermodilution as they both use 
the same principles but is less prone to ventilator induced fluctuations in CO. 
 
TPTD has been compared with pulmonary artery thermodilution 65 and Fick method 66 in both 
paediatric and adult patient population.67 The majority of studies report an acceptable level of 
error between the two (see table 1-2).  
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 (ii) Transpulmonary ultrasound dilution method (CO StatusTM, Transonic,  
NY, USA) 
 
The transpulmonary ultrasound dilution technique (TPUD) is based upon the principles of 
indicator dilution method with normal saline as an indicator. It utilises an ultrasound beam 
passing through an extra-corporeal arterio-venous (AV) loop attached to a central venous and 
arterial catheter. A roller pump provides a constant blood flow rate 9-12 ml/min in the AV loop. 
Normal saline (0.5–1 ml/kg, maximum 30ml) at body temperature is used as an indicator, and 
injected via the venous limb. The velocity of the ultrasound beam directed through a column of 
isotonic saline at body temperature is 1533 m/sec, which is different from that of blood (ranging 
typically between 1570 – 1585 m/sec). Thus, saline injected into the venous limb will produce a 
transient change in ultrasound velocity in both the venous and arterial limbs, in proportion to the 
degree of dilution. This is expressed graphically on the monitor as an arterial dilution curve. The 
arterial dilution curve can be used to calculate cardiac output via the Stewart-Hamilton equation. 
A more detailed description of the technique is provided in chapter 3. The theory and in-vitro 
validation of this technique is reported in detail by Krivitsky et al.68  
 
 
(iii) Transpulmonary Lithium dilution method (TPLD) 
 
TPLD is an indicator dilution technique based upon the same principles as TPTD. However, 
instead of the cold saline, Lithium chloride (LiCl) is used as an indicator injection through a 
peripheral or central vein. LiCl mixes with the venous blood, traverses through the right ventricle 
and lungs and is ejected in the arterial system by the left ventricle. Sampling arterial blood 
through a Li ion selective electrode or a sensor situated in a flow through cell with the help of a 
mechanical pump generates the concentration time curve (fig 1-4). 
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Figure 1-4 Set up for Transpulmonary Lithium dilution method. Arterial blood passes through a Lithium ion 
selective electrode (in earlier versions of the technology) or a sensor situated in a flow through cell 




The electrode contains membrane selectively permeable to lithium. The change in voltage 
across the membrane is related to the change in plasma Lithium concentration with plasma 






LiCl: dose of LiCl injected   
Area: area under the lithium dilution curve and  
PCV: packed cell volume 
 
The technique does not require a PAC but is vulnerable to the same sources of error as the 
thermodilution method (discussed above).  
  
CO = LiCl ×60Area (1−PCV )
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Limitations of Lithium Chloride method 
 
 LiCl method has some unique limitations in addition to the generalised limitations associated 
with indicator dilution methods.  
 
(i) It can not be used on patients on Li therapy, as the increased background Lithium 
concentration will interfere with the CO estimation (overestimation).  
 
(ii) Non-depolarising muscle relaxants (Pancuronium, Vecuronium) may cause a drift in the 
electrode leading to inaccurate results.70   
 
(iii) Blood sampling is required for every measurement (as in other indicator dilution techniques) 
which may lead to iatrogenic anaemia in small paediatric patients. 
 
(iv) Lastly, rapid repeated measurements are hindered by the persistence of Li in the blood for a 
short duration of time. 
 
TPLD has been validated against TPTD 71, electro-flowmetry 72  with  good correlation in  human 
and animal models respectively (see table 1-2). Linton et al,  in their study involving twenty eight 
children between the age  5 days to 9 years , compared TPLD with TPTD. They reported near 
acceptable percentage error of 32% for agreement between the two methods. The authors did 
not report any complications hence, suggesting it to be safe and accurate in the paediatric 
population.73 
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iv) Dye dilution technique 
 
Indocyanine green (ICG) was the most commonly used dye in this method (however, it is not 
available commercially now). ICG is injected via a central vein and change in concentration over 
time is measured in a systemic artery utilising photometric technique.   
 
 
Limitations of Dye dilution method 
 
There are three main limitations of its use. 
  
(i) Firstly, a densitometer requiring calibration with a sample of patient’s blood with known dye 
concentration is used for concentration–time curve. This is a labour intense and time consuming 
process.  
 
(ii) Secondly, each measurement requires blood sampling.  Use of fibre optic sensors in pulse 
dye densitometry has overcome the first two limitations. Here, the arterial concentration is 
measured noninvasively by a finger tip light emitting sensor (wavelength 805 and 890 nm). The 
ratio of ICG concentration measured at these wavelengths is used to derive the ICG 
concentration time curve.74  
 
(iii) Thirdly, ICG is metabolised by liver, hence recirculation restricts the time between 
successive measurements, which is further exacerbated in significant liver failure patients. 
Various studies have compared this technique with other methods with conflicting results.75-77 
Hence, this method has not gained widespread popularity in clinical use. 
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Summary of paediatric studies using indicator dilution methods 
 
 
Table 1-2 below presents some of the studies using different indicator dilution methods in  
 
paediatric settings.  Among these, TPTD has shown very good agreement with the direct Fick 
and pulmonary artery thermodilution method. Percentage error between TPLD and TPTD was 
just above the acceptable value of 30% to demonstrate agreement between the two. TPUD also 
showed agreement with pulmonary artery thermodilution and very nearly with ultrasound flow 
probes with an error of 31%.   
 

















TPTD O2 Fick 18 4.3 – 88 0.4 – 6.2 0.06 0.38 10.7 0.99 
Tibby 66 
(1997) 
TPTD O2 Fick 24 2.5 – 60 0.24 – 8.7 0.03 0.49 19 0.99 
Mcluckie 65 
(1996) 
TPTD PATD 9 9.8 – 23.7 3 – 5.3 0.19 0.42 9.5 na 
Linton 73 
(2000) 
TPLD TPTD 17 2.6 – 34 0.4 – 6 -0.10 0.62 31.8 0.96 
* Crittendon 78 
(2012) 
TPUD PATD 28 9.4 – 73.8 1.85 - 4.49 -0.004 0.8 25.4 0.95 
*Lindberg 79 
(2014) 
TPUD UFP 21 3.2 – 11.8 0.52 - 1.54 -0.02 0.3 31 na 
LOA = limits of agreement; N = number of subjects; na = Not available; PATD = pulmonary artery 
thermodilution; PE = Percentage error; Ref. = Reference method; TPTD = Transpulmonary thermodilution; 
TPUD = Transpulmonary ultrasound dilution; UFP = Ultrasound flow probe; Weight and CO are expressed 
as range. * =Studies published after commencement of MD.  
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1.2.3 Ultrasound Techniques 
 
(i) Transoesophageal Doppler ultrasound (TOD) 
 
Franklin first applied the Doppler principle for measurement of blood flow in 1961.80  
The theory of Doppler states that the shift in the frequency of the reflected ultrasound wave is 





V: velocity of the blood (measured) 
Δ f : frequency shift between transmitted and reflected signal 
c: Ultrasound velocity in blood (1540m/s) 
θ: angle of incidence referred as the angle formed between the ultrasound beam and the target 
direction of flow and is assumed to be 45 degrees and 
= transmitting frequency 
 
Doppler ultrasound can be applied continuous or pulsed. It can be applied to any pulsatile 
vessel. However, CO measurement is typically performed in the aorta via transthoracic or trans-
oesophageal route. The latter has the potential to be used for continuous measurements.82  The 
velocity-time signal characteristically shows a triangular shape. This also allows derivation of 





V = Δf × c2 ft × cosθ
ft




The integral of velocity-time (area under the triangle) represents stroke distance. It is the 
distance that a column of blood will travel along the aorta in one cardiac cycle. 
 
Conversion of stroke distance to stroke volume requires multiplication by the cross-sectional 
area of the vessel through which flow is occurring.  
 
where 
SV: stroke volume 
VTI: velocity- time integral calculated using Doppler ultrasound or stroke distance 
D: diameter of the vessel through which flow is occurring  
 
‘D’ can either be measured directly using echocardiography 83, or calculated using nomograms 
based upon age, sex, weight and height 84. Echocardiography (either M mode or 2-dimensional) 
can be used at a variety of sites such as aortic valve annulus or root, ascending or descending 
aorta. Out of these, the measurement of the left ventricular outflow diameter at the valvular 
annulus using 2-D echocardiography during systole is considered most accurate.85,86 
 
Another variable is Corrected Flow Time (FTc). This is defined as the time from the beginning of 
the aortic pulse upstroke to its return to the baseline. This will be affected by the native heart 
rate, hence is corrected for a baseline heart rate of 60 beats per minute using Bazett’s equation: 
SV =VTI × πD
2
4
Figure 1-5 Velocity time spectral representation from measurements involving aorta. The hatched area under  
 the triangle represents stroke distance. Reproduced from: Tibby S. Haemodynamic monitoring.In: 
Paediatric Critical Care Medicine.London:Springer;2014. 3 










FTC: corrected flow time 
FT: flow time 
RR: interval between two consecutive R waves on ECG 
 
 
Several studies have compared this with other established markers of cardiac preload with good 
agreement.87,88 
 
Several oesophageal Doppler probes are available commercially: ODM II™(Abbott, 
Maidenhead, UK), CardioQ™(Deltex Medical Ltd, Chichester, Sussex, UK), and 
HemoSonic100™(Arrow, Reading, PA, USA). 
 
 
Sources of error for Doppler methods 
 
(i) Range ambiguity and aliasing: Continuous-wave Doppler employed in most stand-alone 
Doppler techniques consider all blood flow within the path of the beam (i.e., not only flow across 
the aortic valve), resulting in range ambiguity. Range ambiguity is defined as the inability of the 
imaging system to precisely localize the source (location) of the reflected signal in the heart. A 
Pulsed-wave (PW) Doppler ultrasonography has an advantage over continuous wave (CW) 
Doppler in that by measurement of the time interval between the “send” and “receive” signals 
the location of the source of the ultrasound signal can be accurately measured. This permits 
“gating” of the signal to a particular region of interest.  The disadvantage of PW Doppler is that 
the maximal velocity of blood flow which can be measured is not as high as CW Doppler. In 
order to achieve the highest possible ability to measure high flow, a low frequency transducer is 
necessary with a region of interest close to the transducer. If the maximum velocity (Nyquist 
limit) is exceeded the Doppler signal will “alias” making it impossible to measure maximal flow 
velocity and its direction.88 
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(ii) Flow measured in descending aorta excludes blood flow to the arch and its vessels. A 
correction factor of approximately 30% is applied for the blood flow in the cephalic aorta in 
nomograms for adult patients. However, this proportion is not fixed and may alter in different 
haemodynamic states. This correction factor is not included in paediatric nomogram. Tibby et al 
derived a nomogram using transoesophageal Doppler for estimating CO from patient height and 
mean distance (analogous to mean velocity per minute, which is practically same in ascending, 
transverse and descending aorta). Hence, no correction factor is required for the estimation of 
CO.89 
 
(iii) Cross sectional area of aorta is not fixed and varies depending upon the vascular tone, 
volume status and inotropy. Hence, this introduces errors especially when the area is estimated 
from nomograms rather than direct measurements.90  
 
(iv) Position of the probe is important and a crucial step in the estimation of CO making it 
vulnerable to operator dependent errors. The angle of insonation between the Doppler beam 
and direction of  blood flow should be less than 15° (unless angle correction is applied) in order 
to get the best approximations.91,92  
 
(v) The flow in the aorta may not always be laminar. Conditions such as anaemia, tachycardia 
and aortic valve disease will result in turbulent flow thus altering the velocity measurements 
leading to further errors.91 
 
 
Summary of paediatric studies using oesophageal Doppler methods 
 
Several authors have compared this technique with various other methods both in paediatric 
and adult patients. Chew et al, reviewed systematically the accuracy and repeatability of 
Doppler use in paediatric cardiac output estimation. They included studies comparing Doppler 
flow measurements with thermodilution, Fick or dye dilution methods in paediatric critical care 
settings. They demonstrated a pooled precision of 30%, bias generally less than 10% and 
repeatability between 1-22%. They made an important recommendation that Doppler CO 
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measurement is acceptably reproducible in paediatric population especially when used for 
tracking changes rather than the absolute values.93    
 
Table 1-3 summarises some of the comparison studies of oesophageal Doppler with other 
reference methods in paediatric patients. Tibby et al did not report percentage error as the study 
was designed for creation of a paediatric nomogram for estimation of CO using minute distance 
and patient height. The two other authors (Schubert and Knirsch) reported a high percentage 
error hence, poor agreement between oesophageal Doppler and transthoracic 
echocardiography or PATD. Both the authors did not investigate the tracking ability of changes 
in CO of oesophageal Doppler following interventions aimed to augment CO. 
 

















OD TPTD 100 3 - 70 0.32 - 9.19 na
+ na+ na+ 0.82 
Schubert 95 
(2008) 




OD PATD 40 3.4 – 59.4 1.2 -7.1 0.66 1.79 54.3 0.65 
OD = Transoesophageal Doppler; LOA = limits of agreement; N = number of subjects; na+ = Not available as 
the study objective was derivation of the normogram; PATD = pulmonary artery thermodilution; PE = 
Percentage error; Ref. = Reference method; TPTD = Transpulmonary thermodilution; TTE = Transthoracic 
echocardiography; Weight and CO are expressed as range; * =  calculated from the data /graph provided. 
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Transcutaneous Doppler ultrasound (USCOM TM ) 
 
This non invasive, continuous wave Doppler based technique involves probe placement in the 
suprasternal notch or parasternal region, targeting the aortic or pulmonary valve respectively 
(USCOMTM, Sydney, Australia). It utilises nomograms for the estimation of cross sectional area 
at the aortic and pulmonary valves. One of the advantages is the measurement of CO in the 
ascending aorta . Thus, no assumptions are made regarding the percentage of flow of total CO 
making its way to the descending aorta.  
 




Summary of paediatric studies using transcutaneous Doppler (USCOM TM) 
 
Several authors have evaluated transcutaneous Doppler in paediatric setting. Knirsch et al 
compared this method with pulmonary artery thermodilution . They demonstrated a percentage 
error of 36% and did not reliably measure absolute CO values. However, Phillips et al compared 
this against echo Doppler in 37 preterm neonates and showed good correlation between the 
two. A representative summary is tabulated below in table 1-4. Transcutaneous Doppler did not 
show good agreement with any of the  reference methods in the paediatric age group. In 
addition, Mohan et al reported a large coefficient of variation of approximately 16% implying 
poor repeatability.  
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TCD PATD 24 3.4 - 51 1.3 - 5.3 -0.13 1.34 36 na+ 
Mohan 98 
(2002) 





na+ na+ na+ 
Phillips 99 
(2006) 
TCD TTE 37 0.66 -  1.6 na 0 0.16 46* 0.91 
LOA = limits of agreement; N = number of subjects; na+ = Not available in the manuscript; PATD = 
pulmonary artery thermodilution; PE = Percentage error; Ref. = Reference method; TCD = Transcutaneous 
Doppler; TOD = Transoesophageal Doppler; TTE = Transthoracic echocardiography; Weight and CO are 




(iii) Transthoracic echocardiography  
 
Transthoracic echocardiography can be used in two ways for the estimation of stroke volume or 
CO. The first method involves volumetric measurements for estimating the volume of the left 
ventricle at the end of the diastole and systole. The difference between the two is the stroke 
volume.  
 
The second method involves a pulsed Doppler aortic blood flow estimation at the exact level of 
the aortic annulus from the apical five-chamber view (see fig 2-10 on page 123). The aortic 
velocity–time integral (VTIao) is derived as a mean of three to five consecutive measurements 
over a single respiratory cycle. LV stroke volume (ml) and cardiac output (l/min) are determined 
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VTIao: velocity time integral at the aortic annulus 
D: diameter of the aortic annulus either estimated from nomogram or measured using 
echocardiography 
 
 Recently, contrast echocardiography has shown promising results in the measurement of CO 
.100  
However, echocardiographic estimation of CO is not continuous and requires a skilled operator 
which may not be readily available. In addition, accurate estimation of LV volumes is 
challenging by routinely available 2D echocardiography even by most experienced operator. 
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1.2.4  Arterial pulse contour analysis  
 
The arterial pulse contour method estimates stroke volume (hence CO) from the analysis of 
arterial pulse pressure waveform on a beat-to-beat basis. This technique requires an arterial 
catheter, which is commonly placed in the majority of critically ill patients as part of routine 
haemodynamic monitoring. This continuous monitoring system allows rapid tracking of  
haemodynamic changes. 
 
Otto Frank in 1899, first introduced the concept of measuring blood flow changes using blood 
pressure waveforms. He described the circulation with his Windkessel (air chamber) model 
which forms the basis of many of the modern pulse contour analysis methods.103 
 
The Windkessel model represented the heart and the systemic arterial system with a closed 
hydraulic water filled circuit along with a water pump connected to a chamber partially filled with 
air.104 The water was pumped into the chamber by the pump (representing the heart) thus 
compressing the air in the chamber. This pushed water back out of the chamber into the circuit 
towards the pump. The compressibility of the air in the pocket represented the elasticity and 
extensibility of the major arterial system as the heart pumps blood into them. This was referred 
to as arterial compliance. The resistance encountered by the water in leaving the Windkessel 
equates to the resistance faced by the blood while flowing through the arterial system. This 
comprised peripheral resistance. This simplistic ‘2 element Windkessel model’ helped in 
calculating flow using Ohm’s law (fig 1-6).  
  




Figure 1-6  The concept of  the 2-element Windkessel model, comprising compliance/elastance and 
peripheral resistance. The large arteries act as the Windkessel (air chamber) as a result of their vascular 
properties. Reproduced from: Westerhof N,et al.J. Biomech. 1969:2, 121-143.105 
 
 
The model was further improved to a 3 and 4 element Windkessel model introducing impedance  
106 and arterial inertance 107 respectively. This improved the accuracy of algorithm for stroke 
volume estimation from the arterial pulse pressure curve. This algorithm was initially described 
by Wesseling et al 108 based upon the assumption that stroke volume is directly proportional to 
the area under the systolic portion of the arterial pressure waveform.  
 
 
Sources of error for pulse contour methods 
 
(i) These methods rely on the characteristics of arterial pressure waveform; hence, any factors 
that affect these characteristics may introduce inaccuracies in the CO estimation. This includes 
age, disease or inotrope related changes in the vessel wall characteristics. Arrhythmias change 
the characteristics of arterial waveform hence, are important and common sources of error 
leading to inaccurate results. 
 
(ii) The contour of the arterial pressure waveform changes significantly throughout the forward 
motion of the arterial pulse.109 Thus, insertion of arterial catheter at different places may affect 
the waveform leading to interference with CO estimation (fig1-7).110  
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Figure 1-7 Contour of arterial pressure waveform at different sites. The peak systolic and diastolic pressure 
readings vary according to the position of the catheter. However, the mean blood pressure is the same, as it 
is estimated from area under the curve, which remains same irrespective of the catheter position. 
 
 
(iii) Changes in the calibre of the vessels and bifurcations can lead to reflection of the pulse 
pressure wave creating further interference.111  
 
(iv)The pressure transducers routinely used in clinical practice may be under or over damped 
contributing to imperfect waveforms and inaccurate measurements.112  
 
(v) The aortic valve incompetence will compromise the accuracy of these methods due to 
diastolic run off.  
 
(vi) Changes in arterial load parameters especially arterial compliance and elastance as a result 
of either pathology or treatment (volume expansion or vasoactive therapy) can lead to 
inaccurate estimation of cardiac output.113 
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Different types of pulse contour methods 
 
 
Currently arterial pulse contour analysis methods are broadly divided into methods requiring 
calibration or uncalibrated methods as described below. 
 
(i) Calibrated methods 
 
a) Pulse contour cardiac output (PiCCO, Pulsion, Munich, Germany)  
 
This method determines stroke volume from the systolic portion of the arterial pressure 
waveform. It requires manual calibration to incorporate inter and intra individual changes in 
resistance and compliance as a result of changing clinical conditions.114 
 
The arterial pulse contour method is calibrated using an average of three to five transpulmonary 
thermodilution measurements of cardiac output. The recalibration interval depends upon the 
haemodynamic stability of the patient, with shorter recalibration intervals recommended in 
unstable patients.115,116 
 
Fakler et al in a paediatric cohort demonstrated a strong correlation between transpulmonary 
thermodilution and contour analysis cardiac indices (Pearson correlation coefficient r = 0.93; 
coefficient of determination r2 = 0.86). The mean bias between cardiac indices derived by 
thermodilution and those derived by pulse contour analysis over all data points was 0.05 (SD 
0.4) L /min /m2 (95% conf. intv. 0.01-0.10).117 
 
b) Pulse power analysis (LiDCOTM plus, UK) 
 
Pulse power analysis method counteracts some of the limitations mentioned above. It is based 
upon the law of conservation of mass and an assumption that pulse power is proportional to the 
stroke volume. The arterial pressure signal is corrected to a standardized waveform which 
derives net effective beat power factor after auto-correlation proportional to the nominal stroke 
volume. The nominal stroke volume is converted to actual stroke volume by an independent 
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indicator dilution measurement using Lithium chloride (explained earlier) taking into account the 
arterial tree compliance. Lithium chloride injection can be done by a peripheral cannula and 
measurements for construction of dilution curve can be obtained by a sensor connected to 
radial artery. Pulse power algorithm is less prone to errors due to damping, wave reflection and 
the shape of the arterial pressure waveform. A detailed description of this methodology is 
provided by Rhodes and Suderland.70  The recalibration interval recommended is 8 hours but 
more frequently in haemodynamic instability.118  
 
Hamilton et al in their study involving 20 post coronary artery bypass graft patients compared 
this method with PAC thermodilution. They confirmed a good correlation and agreement based 
upon Bland Altman analysis.119 
 
Jonas et al validated this method with Lithium dilution in their adult ICU patients. They showed a 
good agreement between the two with mean bias of 0.3 litres/min, with limits of agreement + 1.7 
litres/min and a percentage error of  twenty one.69 
 
Limitation of Pulse power analysis 
 
The limitations associated with its use are in actual fact due to Lithium bolus dilution (calibration 
technique) rather than the actual pulse power analysis. It cannot be used accurately in patients 
on therapeutic Lithium therapy, is affected by plasma sodium concentration and is interfered 
with the concurrent use of depolarising muscle relaxants due to a drift caused in the lithium 
sensor.  
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(ii) Uncalibrated methods 
 
a) Flo Trac/Vigileo system (Edwards Life Sciences, California, USA) 
 
The Flo Trac/Vigileo measures CO in a continuous fashion without the need for any invasive 
manual calibration. The upgraded, second generation device is calibrated automatically every 
minute by assessing changes in arterial compliance based upon demographic data and the 
shape of the arterial pressure waveform. The algorithm makes an assumption that the pulse 
pressure is directly proportional to the stroke volume and considers the skewness and kurtosis 
of the arterial waveform. The arterial compliance and vascular resistance are estimated form 
patient demography. The arterial pressure waveform itself is analysed and averaged over 
twenty seconds and a beat detection algorithm eliminates extra -systoles and other small 
artefacts. Flo Trac/Vigileo can be easily connected to the already existing arterial catheter via its 
transducer for displaying CO.120 
 
The studies involving first generation device had poor correlation and agreement with the 
reference standard methods.121,122 This led to the upgrading of the software leading to second 
and third generation devices. However, Desebbe et al in their study involving adult cardiac 
surgical patients demonstrated inaccuracy of even the third-generation FloTrac/Vigileo software 
to reliably detect changes in cardiac output  in cardiac surgery.123 
 
 
Limitations specific to FloTrac/Vigileo method 
 
(i) The algorithm may be of uncertain value in cases of rapid, extreme changes in 
haemodynamics, although it may still be useful as a trend monitor.124  
 
(ii) Some authors have also demonstrated inaccuracies in measurement of CO in cases of 
vasodilatation with hyperdynamic circulation like sepsis 125 or hepatic cirrhosis.126 
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b) Pressure recording analytical method (PRAM, MostCare, Vytech, Padova, Italy) 
 
PRAM is based upon the principle that volumetric changes in a blood vessel primarily occur in a 
radial direction influenced by the interaction between the left ventricular ejection force, arterial 
compliance, impedance and peripheral resistance to the flow . PRAM measures the area under 
the pressure curve of the arterial waveform for calculation of stroke volume. Though no external 
calibration is needed, it does require an internal calibration factor dependent upon the 
morphology of the waveform.127 PRAM is a relatively new method; hence, there are very few 
comparison and validation studies available in the literature. 
 
Calamandrei et al in their study involving 48 critically ill children compared PRAM with Doppler 
echocardiography for the measurement of CO. Cardiac output values obtained by Doppler 
echocardiography (2.7 +/- 1.6 litres/min, range 0.92-8.20) were significantly correlated with 
those estimated by PRAM (2.6 +/- 1.7 litres/min, range 0.89-7.48; r2 = .99, p < .01). The mean 
difference between the two estimates was 0.12  +/- 0.27 litres/min (95% confidence interval, -
0.54 to 0.77 litres/min.128  
 
However, PRAM requires further validation studies especially in paediatric patients in different 
clinical settings before it can be recommended for the measurement of CO reliably. 
 
c) LIDCO rapid 
 
This is based upon the same principle as LIDCO plus. However, it uses nomogram for 
estimation of calibration or patient specific correction factor for conversion of nominal stroke 
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Comparison between calibrated and uncalibrated methods 
 
Calibrated devices have not always shown benefits 129 but the majority of the available data 
points towards a better performance of the calibrated devices as compared to the uncalibrated 
monitors. 
 
 Hadian et al compared PiCCO, LiDCO plus and FloTrac with PAC thermodilution. They 
demonstrated larger bias and wider limits of agreement with FloTrac as compared to PiCCO 
and LiDCO.130 
Similarly Cecconi et al compared LiDCO plus and FloTrac /Vigileo with PAC in critically ill 
patients with similar results as above.131  
 
 
Summary of paediatric studies using pulse contour methods 
 
 
A representative summary of studies utilising different pulse contour methods in children is 
presented below in table 1-5. Most authors showed an acceptable value of error to consider 
pulse contour methods in good agreement with either indicator dilution or Doppler techniques. 
Percentage error could not be calculated for study by Falker et al due to unavailability of the 
data  (in the manuscript) however, the authors reported a good correlation between PiCCO and 
TPTD (r=0.93). Of note, Mahajan et al reported a percentage error of 54% while comparing 
pulse contour methods in children with congenital heart disease.132 This may be explained by 
two important reasons. Firstly, presence of intra-cardiac shunts and valvular disease in some of 
their patients, may have affected the CO measurements. Secondly, authors chose to take pulse 
contour readings just before TPTD measurements to avoid capturing autocalibrated pulse 
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PiCCO TPTD 24 10.6 - 35.6 1.86 -7.04 0.05 0.8 na+ 0.86 
Mahajan 132 
(2003) 
PiCCO TPTD 16 >10 1.4 - 9.7 
 





TPLD 20 13 - 77 1.9 - 5.9 
 






48 2 - 45 
0.89 – 7.48 
(non indexed) 
(l/min) 
0.12 0.6 20.3 0.98 
LOA = limits of agreement; N = number of subjects; na+ = Not available; PATD = pulmonary artery 
thermodilution; PE = Percentage error; PRAM = Pressure recording analytical method; Ref.= Reference 
method; TOD = Transoesophageal Doppler; TTE = Transthoracic echocardiography; Weight and CO are 
expressed as range. 
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1.2.8 Bioimpedance, Bioreactance and Electrical velocimetry  
 
(i) Bioimpedance  
 
Bioimpedance technology uses constant electric current stimulation for identification of 
variations in electrical impedance associated with physiological (blood flow) or pathological 
changes (pulmonary oedema). A biological cell consisting of intracellular fluid, cell membrane 
and extra cellular fluid acts as resistor-capacitor while the blood vessels behave as electrical 
conductors. Kirchow’s law states that the electric current passes through conduits of higher 
conductance. This will be across the blood vessels in a human body.  Therefore, there is a 
proportional increase in the aortic electrical conductance with each systole due to an increase in 




where    
L: thoracic segment length 
VET: ventricular ejection time 
dZ/dt max: maximum rate of impedance change and 
Zo: transthoracic baseline impedance 
 
Impedance (opposition to flow of alternating current) can be measured in the body by the help 
of a potentiometer. Placement of electrodes at the root of the neck and xiphisternum measures 
thoracic electrical bioimpedance (TEB). Whole body electrical bioimpedance (WBEB) is 
measured by placing the electrodes at the wrist and the contralateral ankle. Both TEB and 
WBEB can be used for measurement of CO. In TEB, there is transthoracic transmission of the 
electrical impedance variations due to the increase in blood flow through the pulmonary artery 
and aorta. In other words, the rate of change in TEB over time is proportional to the rate of 
change in aortic blood flow. In WBEB, the arterial blood to the peripherally placed electrodes 
transmits the impedance variation of the aorta. 
 
Stroke volume = VET × dZ / dtmax× L
3
4.25× Z0
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Since the original work of Mann 134 and Kedrov 135 there have been alterations in the original 
formula (mentioned above) for the derivation of stroke volume. The most recent modifications 
have been by Kubicek, Sramek and Bernstein.136-138 
 
Bioimpedance technology was compared with other methods for measuring CO including a 
meta-analysis in 1999. This compared bioimpedance with thermodilution and demonstrated  a 
correlation coefficient of 0.67-0.71 in critically ill and healthy patients respectively.  However, 
patients with cardiac pathology only demonstrated a correlation coefficient of 0.59. This is 
because of the high prevalence of pulmonary oedema, peripheral oedema or pleural effusion in 
this group of patients that will affect the measurement of impedance variations.139 
 
Various other studies have demonstrated inconsistent and variable results.140,141 Hence, its use 
has been recommended more towards trend analysis rather than diagnostic interpretation.  
 
 
(ii) Bioreactance (NICOM, Cheetah Medical Ltd, Maidenhead, Berkshire, UK)  
 
This is a modification of bioimpedance technology to overcome the sources of potential errors. 
Four dual sensors (each dual sensor consists of an outer and an inner sensor) are applied on 
the chest wall of the patient. The device generates a signal at a frequency of 75 kHz into the 
thorax via the outer portion of the sensors.  The signal is reflected from the base of the aorta 
back to the sensors, which is   then compared to the original signal. Based upon the shift form 
the original signal called ‘phase shift’, or  ‘time delay, stroke volume is calculated.  Bioreactance 
has been compared with Doppler 142 and thermodilution based techniques 143,144 with promising 
results.  
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 (iii) Electrical velocimetry  
 
This is a recent modification in the impedance algorithm. It is based upon the Bernstein–Osypka 
equation.145 The principle is based on the theory that the change in the alignment of red blood 
cells from an arbitrary orientation in diastole to a parallel alignment in systole induces an 
increase in electrical conductivity of blood. SV is calculated by measuring this change. Standard 
ECG surface electrodes are placed side-to-side in a vertical direction to the patients’ left middle 
and lower neck, and to the lower thorax at the left mid-axillary. Preliminary pediatric evaluation 
has proven to be promising when compared to Fick.146 




Sources of error for bioimpedance based techniques 
 
(i) The methods are extremely sensitive to electrode position and contact. Any perspiration or 
activity leading to loss of contact will interfere with accuracy of the monitor. 
 
(ii) Changes in tissue water content (alteration of bioimpedance) due to tissue oedema, pleural 
effusion and pulmonary oedema  leads to inaccurate results. 
 
 
Summary of paediatric studies using bioimpedance and electrical velocimetry 
 
Only a limited number of paediatric studies are reported in the literature about this method. They 
are summarised in table 1-6. Most demonstrated an unacceptable percentage error for 
agreement with the reference methods. The wide variation in limits of agreement is noticeable 
and may be due to variation in the reference methods or patient population (Pianosi et al: cystic 
fibrosis patients; Schubert et al: post cardiac surgical children; remaining two studies recruited 
children from cardiac catheter lab). Considering the wide variation in the results, larger well 
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designed studies are required to find the accuracy and precision of this particular monitoring 
device. 

















EBI CO2R 21 21-87 na
+ -0.09 1.84 na+ 0.81 
Norozi 146 
(2008) 









13 2.6 – 47 
2.3 
(SD1.4) 
0.87 3.26 91* 0.77 
Tomaske 149 
(2008) 
EV PATD 50 0.5 – 16.5 0.6 - 7.2 0.66 1.49 43.8 0.79 
CO2R = Indirect Fick; EBI = Electrical bioimpedance; EV = Electrical velocimetry; LOA = limits of agreement; 
N = number of subjects; na = Not available; PATD = pulmonary artery thermodilution; PE = Percentage 
error; Ref. = Reference method; TOD = Trans esophageal Doppler; TTE = Transthoracic echocardiography; 
Weight and CO are expressed as range; * = calculated from graph/data in the manuscript; + = data not 
available even in the manuscript. 
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1.2.9 Other methods for measuring cardiac output   
 
This section briefly describes other methods available for measurement of cardiac output. 
However, these techniques require further validation studies in adults and paediatric age groups 
in different clinical settings before gaining recommendation for routine clinical use. 
 
 
(i) Photoplethysmography and the Volume clamp method (Nexfin, BMEYE, 
Amsterdam,The Netherlands) 
 
Jan Penaz first developed the ‘volume clamp’ technique in 1967. This involved monitoring of the 
changes in arterial blood volume of  a finger by an infrared transmitter and receiver 
combination, which is connected to an inflatable finger bladder and driven by a feedback control 
mechanism. The finger cuff is inflated and deflated to maintain a constant level of infrared 
absorption (or blood volume). When the artery is ‘unstretched’, the volume clamp technique 
assumes that the pressure in the finger cuff is equal to the arterial pressure. Thus, by 
maintaining the artery in an ‘unstretched’ form, finger pressure can be measured continuously. 
This peripheral arterial pressure waveform can then be used to estimate stroke volume using 
the methods described in the pulse contour analysis  section. 
 
This device has shown good agreement with invasive blood pressure monitoring system in adult 
150,151 and paediatric settings.152 However, it failed to show inter-changeability with other 
methods of CO monitoring  in a limited number of reported studies.153,154  
 
 
(ii) Pulse wave  transit time (PWTT)  (esCCOTM, Tokyo, Japan) 
 
PWTT is defined as the time measured from the ECG R-wave peak to the rise point of SpO2 
pulse wave and consists of three time components. First is the pre-ejection period including the 
electromechanical delay at the start of systole and isometric contraction time with the R wave of 
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ECG serving as the starting point. Second is the time it takes for pulse wave to travel from the 
aorta through the elastic arteries to and lastly the time it takes for pulse wave to travel from the 
muscular artery to the further distal peripheral site of SpO2 measurement. 
 
The esCCO monitor incorporates both PWTT (based on the ECG and pulse oximeter 
waveforms) and mean arterial pressure into its estimate of stroke volume and assumes a 
negative correlation between the stroke volume and PWTT.155 Various studies have shown 
inconsistent results with the use of this device hence it has not found its use in widespread 
clinical settings.156,157  
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1.3 Animal and Adult experiments 
 
Data from the animal studies provide a valuable adjunct to the assessment of CO monitoring 
devices in children and infants. Animal experiments offer three major advantages. First, the 
comparator method is often closer to a true gold standard. Typically, this comprises an invasive 
method such as ultrasound flow probes, which are placed around the aorta or the pulmonary 
artery. Theses provide a precision of 1% -2%. Second, the methods can be evaluated under 
extreme haemodynamic states such as shock (during haemorrhage), resuscitation or with 
artificial shunts. These conditions may be difficult to replicate in human subjects. Finally, animal 
subjects demonstrate physiological similarity with paediatric patients in terms of weight and 
circulatory volume. Hence, the initial animal data may prove useful when planning clinical 
validating studies. 
 
Table 1-7 provides a narrative summary of key animal and human adult studies using different 
types of CO monitoring devices. Transpulmonary indicator dilution (thermal or ultrasound 
dilution) methods seemed to be accurate both in adults and animal studies when compared to 
reference methods such as ultrasound flow probes and pulmonary artery thermodilution.  
Indirect Fick has shown large errors in animal and adult experiments. Both these results are 
also reflected in paediatric studies (see Table 1-1 and 1-2).  
Peyton et al 158  performed a meta-analysis of accuracy and precision of minimally invasive CO 
monitoring methods in human adults. They demonstrated, using pulmonary artery 
thermodilution as a reference method, a pooled percentage error of 41.3%, 42.1%, 44.5% and 
42.9% with pulse contour, oesophageal Doppler, indirect Fick and electrical bioimpedance 
respectively. 
 
Extrapolation of results from adult studies cannot be applied directly to paediatric patients. This 
could partly be due to unique vascular properties and haemodynamics as part of normal growth 
and various pathological states. This is very well demonstrated by pulse contour methods. Most 
studies have shown a better performance in adults as compared to the paediatric population 
(also see Table 1-5). 
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In summary, out of the various CO monitoring devices, indicator dilution devices are considered 
accurate for measuring CO in clinical practice but are slow to response and are invasive in 
nature. Pulse contour methods respond faster to changing clinical condition, however, are not 
validated to accurately measure CO in children. Ultrasound Doppler based methods are fast 
and responsive and have reported to be fairly accurate in their trending ability to monitor 
changes in CO. 
 
However, good quality validation studies are still required for upcoming new and some of the 
established technologies specifically targeting paediatric practise. The challenge however 
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                                                                    Fick method 




UFP Lambs 7 2.9-6.40 0.2-1.4 .08 0.25 35 0.86 




PATD Humans 28 59+9 3.6+1.7 -0.52 0.95 46.3* na 
                                                           Indicator dilution methods 
Lemson et al 
(2008) 161 
TPTD UFP Lambs 11 4.2-12.5 0.4-3.1 0.2 0.24 14.7 0.95 
Ruperez et al 
(2004) 162 
TPTD PATD Pigs 16 9-16 0.9-5.6 0.28 0.63 30 0.86 
Piehl et al 
(2008) 163 
TPTD PATD Pigs 10 24-37 0.8-6 0.14 0.47 11.6 0.96 
De Boode et al 
(2010) 164 
TPUD UFP Pigs 9 3.5-7 0.46-1.9 0.04 0.26 26.9 na 









 6.56+1.57 0.27 1.34 21.6* 0.82 














Pulse contour methods 
Lopez-Herce et 
al (2006) 167 
APCCO 
(PiCCO) 
TPTD Pigs 51 9-16 0.52-4.22 .04 1.1 62.7 0.41 




PATD Pigs 10 24-37 0.8-6 0.11 0.45 11 0.97 













           
                                                       Oesophageal Doppler methods 




UFP Dogs 6 11-22 
0.9-5.6 
(range) 
-0.01 0.33 13 0.87 









na -0.56 0.64 24.6* 0.38 
                                                             Bioimpedance methods 
Osthaus et al 
(2007) 172 
EV TPTD Pigs 5 11.2-13.8 
0.29-4.5 
(range) 
-0.63 1.28 83 0.67 





122 NA 2.38 -0.0009 
   -0.6849 
    +0.6831 
   
28.6 0.79 
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APCCO = Arterial pressure based continuous cardiac output; CO2R = Carbon dioxide rebreathe; EV = 
Electrical velocimetry; LOA = limits of agreement; N = number of subjects; na+ = Not available; PATD = 
pulmonary artery thermodilution; PE = Percentage error; Ref = Reference method; TCCWD = 
Transcutaneous continuous wave Doppler; TPTD = Transpulmonary thermodilution; TOD = 
Transoesophageal Doppler; TTE = trans thoracic echocardiography; UFP = Ultrasound flow probes, WBEB 
= Whole body electrical bioimpedance; * = calculated from data 
 
 
1.4 Expert Commentary and Summary 
 
This chapter summarised commonly used CO monitoring devices used in different clinical 
settings. In addition to Shepard’s14 definition of an ideal CO monitor (see Table 1-8)  and 
characteristics such as clinical validity, large signal to noise ratio, practicality of using a certain 
monitor plays an important part in choosing a monitoring device174. This is especially true since 
none of the available devices fulfil all the properties of an ideal CO monitoring device. 
 Hence, the following practical points are to be considered when choosing a particular device: 
 
(i) Patient related factors such as age, presence or absence of invasive venous and arterial 
catheters, cardiac anatomy in terms of presence of shunts or valvular regurgitation and severity 
of haemodynamic instability. 
 
(ii) Monitoring device: Firstly, differentiating whether the clinician is interested primarily in 
measurement of absolute values or tracking changes in CO in response to interventions. In the 
first case a more invasive approach is required where as a continuous monitoring device may 
be suitable for tracking purposes.  Secondly, the degree of invasiveness which will be 
acceptable to the patient. Generally, less invasive monitoring devices are less accurate and less 
reproducible. Finally, the desirability for obtaining additional haemodynamic variables such as 
extra vascular lung water or arterial pressure variations.  
 
(iii) Clinician experience or preference with any particular device and the clinical environment 
(ward, emergency department or intensive care settings).175  
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In summary, invasive dilution techniques are more appropriate for haemodynamic monitoring in 
pathologies such as severe septic shock or post-operative period where the child already has 
invasive catheters (venous and arterial) in situ while undergoing intensive care treatment. This 
may guide physicians in targeting appropriate therapy. Minimally invasive continuous CO 
monitoring using pulse contour devices or transoesophageal Doppler could prove useful in 
children in peri-operative periods as shown in adults.  Non invasive methods such as 
transcutaneous Doppler technique, Echocardiography or bioimpedance based methods may be 
useful in the initial phases of treatment in critically ill children with limited venous or arterial 
access. 
 
Whatever method is used or chosen, treating physician should have a good understanding of 
the advantages and disadvantages of the monitoring device and have the knowledge to   
interpret the data to utilise these monitors effectively in improving patient outcomes. In addition, 
ongoing research is required for validating newer methods and refining existing algorithms 
towards paediatric population. This is somewhat hampered by a lack of commercial interest and 
ethical and practical difficulties in performing such studies in small children. 
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Response     






O2 Fick + (A,C) + I Slow No ++ 




(PAC) ++ I Slow Yes ++ 
TPTD ++ (A, C) ++ I Slow Yes ++ 
TPUD ++ (A, C) ++ I Slow Yes + 
TPLD +  (A ± C) ++ I Slow Yes + 
Dye Dilution +  (A, C) ++ I Slow Yes + 
Ultrasound methods 
TOD + + C Fast Yes + 
TCD - - I Fast Yes + 
Arterial pulse contour methods 
PiCCO 
(APCCO+TPTD) 












Flo Trac + (A) - Cont. Fast No + 
PRAM + (A) - Cont. Fast No - 
Bioimpedance 
EBI - - Cont. Fast No - 
EV - - Cont. Fast No - 
+ Represents the degree of invasiveness or accuracy (+ to +++ represents increasing invasiveness or 
accuracy). A = Arterial catheter; APCCO = Arterial pulse contour continuous cardiac output; C = Central 
venous catheter; Cont. = Continuous; CO2R = Carbon di oxide rebreathe; EBI = Electrical bioimpedance; EV 
= Electrical velocimetry; I = Intermittent ; PAC = Pulmonary artery catheter; PATD = Pulmonary artery 
thermodilution; PRAM = Pressure Recording Analytical Method; TCD = Transcutaneous Doppler; TOD = 
Transoesophageal Doppler; TTE = trans thoracic echocardiography; TPTD = Transpulmonary thrmodilutiom; 
TPUD = Transpulmonary ultrasound dilution; TPLD = Transpulmonary Lithium dilution. 
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Chapter 2 - Review of: 
 
(a) Static and dynamic markers of preload and fluid 
responsiveness commonly used in clinical practice  
 
(b)  Introduction to arterial dP/dtmax (maximum rate of rise of 










Haemodynamic instability secondary to intra-vascular volume depletion is extremely common in 
critically ill patients. Fluid resuscitation or volume expansion may allow restoration of ventricular 
filling, cardiac output and arterial pressure and is routinely used to improve haemodynamics in 
critically ill patients.1,2 This improves oxygen delivery at the tissue level, a vital and important 
step in the management of critically ill patients.  
 
An increase in stroke volume SV of ≥15% is regarded as a significant response to therapies 
aimed for augmentation of CO by most authors.3 However, multiple studies designed for 
evaluating fluid responsiveness in critically ill patients demonstrated a response rate of only 
about 50% in terms of a significant increase in stroke volume or cardiac output.4 
 
The response to fluid bolus administration predominantly depends upon two main factors (a) the 
position of the myocardium on the Frank-Starling curve with respect to cardiac preload and (b) 
ventricular contractility as described below. 
 
Preload relates to the amount of passive ventricular wall stress (or tension) at the end of 
diastole.5 Blood volume in the ventricles at the end of the diastole is the main determinant of 
cardiac preload.  The SV will change with preload change on the ascending or steep part of the 
curve (marked as green rectangle in fig 2-1) as compared to on the flat part of the curve 
(marked as red rectangle in fig 2-1). The first situation is preload dependence where there is a 
gain in SV after fluid bolus administration and the latter situation is known as preload 
independence where any further increase in preload does not lead to any significant increase in 
stroke volume.  
 
Ventricular contractility: the slope of the Frank-Starling curve is determined by ventricular 
function or contractility (fig 2-1). The curve becomes flatter (reduced slope) and shifts to the 
right with decreasing ventricular function. This is manifested as a reduction in the gain in stroke 
volume for the same amount of preload change (fig 2-1, see curves marked 1 and 5). 
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Recognition of both these factors is important, as volume loading at a stage of preload 
independence may be detrimental to the patient. It will lead to an increase in bi-ventricular 
diastolic pressure, which in turn has numerous negative consequences such as increase in 
ventricular wall tension, impedance of coronary flow, distortion of the ventricular septum with 
consequent alterations in the ventricular function, the production of peripheral oedema and 
compromised flow to the liver and kidneys.6 
 
Figure 2-1 Frank-Starling curve.The green zone represents the region  of  fluid responsiveness whereas the 
red rectangle represents the area of preload independence. Magnitude of stroke volume change depends 
upon the myocardial contractility for similar increase in the preload. Here, curve 1 has good contractility 
demonstrating  much greater increase in stroke volume (a’ to b’) as compared to the curve 5 with poor 
contractility  having a smaller change in stroke volume from a to b, for the same increase in the preload from 
A to B. 
 
 
This emphasises the requirement for an accurate assessment of patient haemodynamic status. 
However, various authors have demonstrated the inadequacy of clinical examination and 
routine monitoring for accurate assessment of haemodynamics.7,8 This reinforces the need to 
search for accurate predictive markers of fluid responsiveness in order to select patients likely to 
benefit from volume expansion and avoid ineffective and deleterious volume expansion in non-
responder patients where other treatment strategies should be employed.9 
 
These markers are subdivided into static and dynamic markers. The section below describes 
some of the commonly used markers (including those measured by PRAM and TPUD) for 
predicting fluid responsiveness in clinical practice. The chapter also highlights general and 
specific sources of error and limitations associated with these markers. A representative 
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summary of paediatric studies evaluating the utility of these markers in prediction of fluid 




2.3 Static markers  
 
Static markers are single measurements essentially based upon direct or indirect estimates of 
ventricular filling. Various authors have suggested estimation of either the ventricular area (left 
ventricular end diastolic area), blood volume (global end diastolic volume, intra-thoracic blood 
volume) or pressure based parameters (central venous pressure, pulmonary artery occlusion 
pressure) as representative of preload estimation.  Over the past few years, a large number of 
studies have explored the utility of these static markers for the prediction of response to fluid 
bolus administration. 
 
The potential advantages for measuring static markers are: 
(i) Independence from the cardiopulmonary interactions during mechanical ventilation,  
(ii) They can be measured in patients with arrhythmias and  
(iii) Finally, they do not require muscle relaxation for accurate measurements, in contrast to the 
dynamic markers.  
 
None of these however, as yet, have convincingly proved to be useful for this role in critically ill 
paediatric patients.   
 
Transpulmonary ultrasound (TPUD) provides three novel volume based static markers: total end 
diastolic volume index (TEDVI), central blood volume index (CBVI) and active circulating volume 
index (ACVI). There are no studies reported to date regarding the utility of these markers for the 
purpose of predicting fluid responsiveness. My study has investigated the role of these three 
markers for prediction of response to fluid bolus administration in critically ill children. 
 
This section provides a description of commonly measured static markers used in clinical 
practice including the three novel static markers measured by the TPUD technique. 
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Description of commonly used static markers 
 
(i) Central venous pressure (CVP) 
 
CVP is defined as the pressure of the blood in the thoracic vena cava near the right atrium. It is 
essentially equivalent to the pressure in the right atrium assuming no venacaval obstruction 
.10,11 The origins of the CVP monitoring can be traced back to Hughes and Magovern 12 in 1959, 
where they described a technique for monitoring right atrial pressure as a guide to blood volume 
replacement in post-thoracotomy patients. Wilson and Grow 13 further popularized its use.  
 
CVP depends upon the interaction between cardiac function and factors determining venous 
return to the heart. Body fluid volume, venous capacitance, venous compliance, heart rate, 
rhythm, structural defects of the heart, pericardial effusion or tamponade are some of the major 
factors.14 The range of normal value quoted in the literature is fairly wide with typical values, 
referred to the mid-axillary line as 2-10cm H20.15 
 
 
Studies evaluating the use of CVP for prediction of fluid responsiveness in adult patients 
 
CVP has been used frequently to guide fluid management in intensive care settings.16 Marik et 
al 17 in their systematic review of 24 studies (803 adult patients) demonstrated a very poor 
relationship between CVP and blood volume. In addition, they reported the inability of 
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Paediatric studies evaluating the use of CVP for prediction of fluid responsiveness 
 
Various authors have evaluated CVP for fluid responsiveness in paediatric population. The 
range of area under the ROC curve  (AUC) ranged from 0.47 21 to 0.69 22, thereby 















23(9.2) NR  
Mean (SD) 










12(4) R, NR 
Mean (SD) 




2.2 – 71.5  
(Range) 




3 – 60  
(Range) 
Mixed PICU 0.57 
AUC = Area under the ROC curve; N = Number of fluid boluses administered; NR = Non responders;  
OR = Operating room; PICU = Paediatric intensive care unit; R = Responders. 
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(ii)  Left ventricular end diastolic area (LVEDA) 
 
The LV end diastolic area measured by transoesophageal echocardiography (TOE) in the trans-
gastric, mid-papillary, short axis view has been used as a measure of preload in critically ill 
patients.26,27 LVEDA is commonly estimated using a modified Simpson’s rule, which assumes 
that the mitral and papillary muscle levels trisect the ventricle equally and the relative position 
and/or geometry of the involved planes is constant in systole and diastole. 
 
 
Sources of error or limitations 
 
(i) The estimation of LVEDA by TOE is an invasive procedure. Moreover, the trans-gastric views   
require a high level of expertise. This also makes it less suitable in practical situations during 
resuscitation of severely ill children. 
 
(ii) The variability in LV geometry can be either age-related or due to different pathological 
states such as congenital heart disease, regional wall abnormalities. This limits the application 
of modified Simpson’s rule for an accurate estimation of LVEDA.28 
 
(iii) The pressure volume loops of the LV and RV may shift due to changes in myocardial 
relaxation, stiffness and systolic performance. Thus, a given ventricular volume may equate to 
different intra ventricular pressure depending on the interplay of the above factors. Hence, the 
estimation may become inaccurate and erroneous. 
 
 
Adult studies evaluating the use of LVEDA for prediction of fluid responsiveness 
 
Feissel et al in their study involving nineteen septic shock patients in adult ITU demonstrated 
that baseline LVEDA did not correlate significantly with the volume expansion-induced changes 
in cardiac index (p= 0.17) and was of little value in predicting the effects of volume expansion on 
cardiac output.29 Other authors have also reported similar findings in adult patients.30,31  
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Paediatric studies evaluating the use of LVEDA for prediction of fluid responsiveness 
 
Reich et al initially showed promising results in monitoring cardiac filling changes in paediatric 
patients by measuring changes in LVEDA.32  However, LVEDA has shown to be a poor 
predictor of fluid responsiveness in both paediatric and adult settings in subsequent studies. de 
Souza Neto et al 33  studied the utility of LVEDA as a marker of fluid responsiveness in thirty 
mechanically ventilated children. The area under the receiver operating curve (AUC) was 0.59 
(0.35–0.81) for children between 0-6 years. The AUC was slightly better for children  between 6-
14 years 0.71 (0.39–0.93) but still unsuitable to discriminate between responders and non-
responders (see table 2-2).  
 




N Weight (kg) 
 
Setting AUC 





Neuro OR 0.59 









3 – 15 
(Range) 
Cardiac OR na 
AUC = Area under the ROC curve; MAD = Median absolute deviation; N = Number of fluid boluses 
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 (iii) Global end diastolic volume (GEDV) and Intra-thoracic blood volume 
(ITBV) 
 
Ventricular preload is determined by an interplay between end diastolic pressure, ventricular 
wall thickness and radius of the ventricular cavity. Blood volume at the end of the diastole is the 
predominant factor affecting preload and is clinically best estimated as the end diastolic 
ventricular volume (EDV).  
 
Global end diastolic volume (GEDV)  
 
GEDV is the volume of all the chambers of the heart at the end of the diastole. It is estimated by 
a ‘thermal’ indicator dilution technique and is the difference between the intra thoracic thermal 





GEDV: global end diastolic volume 
ITTV: intra thoracic thermal volume 
PTV: pulmonary thermal volume 
 
 
The estimation of ITTV and PTV is briefly described below. 
 
ITTV is estimated by a transpulmonary indicator (thermal) dilution technique (see Chapter 1, 
section 1.2.2, page 31). This requires an injection of a cold indicator (≤10°C) through a standard 
central venous catheter into the right atrium or superior venacava with simultaneous 
measurement of the temperature dilution curves in the abdominal aorta or femoral artery using 
a thermistor tipped arterial catheter. The thermal bolus distributes throughout the entire thoracic 
vascular and extravascular compartment (intra-thoracic thermal volume, ITTV). The resulting 
dilution curve exhibits mono-exponential decay. Extrapolation of the decay curve to the baseline 
GEDV = ITTV −PTV
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from just before the point of recirculation by semi-logarithmic conversion enables calculation of 
the area under the curve, hence CO (see Chapter 1, section 1.2.2). 
  
The volume of distribution for the thermal indicator is a function of CO and mean transit time 
(MTt). Mean transit time is the time taken for detection of 50% of the amount of injected 
indicator by the distal thermistor; in other words, the centre of mass of the dilution curve area if 
recirculation is ignored (fig 2-2). Down-slope time (DSt) refers to the rate of decline of the 
thermodilution curve which is estimated as the time taken for the semilogarithmic concentration 
curve to decrease by a factor of e-1 . This typically approximates a concentration drop from 85% 
to 45% of the peak of temperature change. The concept of using DSt for calculation of PTV was 





Figure 2-2 Calculation of GEDV. Top panel: ‘Y’ axis represents the concentration of the thermal indicator 
i.e ‘temperature of the blood’. ‘X’ axis is time. ‘ta’ is the time delay between the injection of the cold saline 
and the onset of temperature sensing at the distal site. Extrapolation of the downslope corresponds to a 
first-pass effect of temperature variation that would have been obtained in the absence of any 
recirculation. Lower panel is the natural log (Ln) transformation of the transpulmonary thermodilution 
curve in the upper panel DSt: down-slope time refers to the decline of the thermodilution curve which is 
estimated as the time included within 85% and 45% of the peak of temperature variation.Reproduced from: 









ITTV: intra thoracic thermal volume 
CO: cardiac output 
MTt: mean thermal transit time and is equal to the time taken for detection of 50% of the amount 
of injected indicator by the distal thermistor 
GEDV: global end diastolic volume 
PBV: pulmonary blood volume 
EVLW: extra vascular lung water 
 
 
Pulmonary thermal volume (PTV) is the sum of pulmonary blood volume and extra vascular lung 





PTV: pulmonary thermal volume 
PBV: pulmonary blood volume 
EVLW: extra vascular lung water  
CO: cardiac output 
DSt: down-slope time (DSt) refers to the rate of decline of the thermodilution curve, which is 
estimated as the time included within 85% and 45% of the peak of temperature variation (fig 2-
2) 
  
DSt corresponds to the volume of blood contained between proximal and distal thermal 
sensors, i.e., the sum of blood contained within the serial chambers: SVC, right atrium, right 
ventricle, pulmonary blood volume (PBV), left atrium, and left ventricle and aorta.  
 
  
ITTV =CO×MTt =GEDV +PBV +EVLW
PTV = PBV +EVLW =CO×DSt
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Figure 2-3 GEDV and ITBV estimation using an indicator dilution method. GEDV is the difference between 
Intra thoracic thermal volume and Pulmonary thermal volume. ITBV is measured using Indocyanine Green 
or can  be estimated from GEDV(see text). Reproduced from: Benington S et al. European Journal of 
Anaesthesiology 2009; 26(11): 893-905. 34 
 
 
Limitations for measurement of GEDV  
 
(i) Measurement of GEDV is by indicator dilution technique, hence, it has similar limitations and 
sources of error as a thermodilution or dye dilution technique such as indicator loss, 
recirculation and inaccuracies in patients with valvular regurgitation. These are explained in 
detail in chapter 1.  
 
(ii) GEDV is not an accurate assessment of actual cardiac volume. It also includes blood volume 
in the vessels from the site of injection to the sensor. This is variable rather than a fixed volume 
due to changes in the venous and arterial mechanics in different pathological states. 
 
(iii) Changes in the aortic elastance attributable to vasopressors (apart from dobutamine) may 
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Studies evaluating the use of GEDVI for preload estimation and/or prediction of fluid 
responsiveness in adults 
 
Godje and co-workers performed a study about relationship between changes in SV with 
different preload markers in patients with heart transplantation. They demonstrated GEDVI was 
significantly correlated with changes in SVI (r= 0.73, respectively) in contrast to CVP and 
pulmonary artery occlusion pressure (r = -0.23 and r = - 0.06, respectively).40 Sakka et al 
reported similar results in their study involving 57 adult ICU patients). GEDV was an accurate 
assessment of preload but was not able to predict fluid responsiveness.41  
 
 
Paediatric studies evaluating the use of GEDV for prediction of fluid responsiveness 
 
De la Oliva studied the utility of GEDVI for fluid responsiveness in 75 children subdivided into 
groups with normal cardiac function, cardiovascular dysfunction and dilated cardiomyopathy. 
Each of these patient groups were divided into subgroups with four different preload levels 
based upon GEDVI/GEDVIN ratio [‘normal’ GEDVI value (GEDVIN) = 488.8 x (Body surface 
area)0.388].The highest predicted responsiveness was observed in cardiac dysfunction patients 
with GEDVI  less than or equal to 0.67 times normal global end-diastolic volume index (AUC of 
0.89). The least AUC was observed in dilated cardiomyopathy patients with a GEDVI/GEDVIN 
ratio greater than 1.33 but less than or equal to 1.51 (AUC 0.52).42 
 
Renner et al also investigated the role of global end diastolic volume index (GEDVI) in 
paediatrics for prediction of fluid responsiveness. They demonstrated a failure of GEDV to 
accurately predict fluid responsiveness in neonates and infants with intra-cardiac left to right 
shunts during pre-surgical setting (AUC 0.59). However, prediction after correction of shunts 
(closure of ASD and VSD shunts) was better with an AUC of 0.77 possibly due to improved 
accuracy of GEDV estimation.22 
 
A summary of these studies is presented in table 2-3. 
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N Weight (kg) 
Mean (SD) 
Setting AUC 
De la Oliva 42 
(2015) 
66 na Mixed PICU 0.52-0.89* 
Renner 22 
(2012) 










AUC = Area under the ROC curve; ASD = Atrial septal defect; N = Number of fluid boluses 
 administered; na = not available; OR = Operating room; VSD = Ventricular septal defect. 
* includes patients with cardiomyopathy and cardiac dysfunction  with four different preload levels classified 
according to GEDVI/GEDVIN ratio. GEDVIN = 488.8 x (Body surface area)1.388. 
 
 
Intra thoracic blood volume (ITBV) 
 
 ITBV is defined as the volume measurement of the left and right side of the heart along with the 
pulmonary blood volume at the end of diastole 43 (fig 2-3). 
 
ITBV was initially estimated by a transpulmonary double indicator (thermal dye) dilution 
technique. An injection of cold Indocyanine Green (IcG) dye is injected into the right atrium or 
superior venacava. The temperature and IcG dilution curves are measured simultaneously in 
the abdominal aorta. The volume of distribution for each of the indicators (dye and cold) is a 
function of CO and mean transit time (MTt) (explained above).  
 
Although the ‘thermal bolus’ distributes throughout the entire fluid compartment (intra-thoracic 
thermal volume, ITTV), the volume of distribution of IcG (highly protein bound) is limited to the 
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where 
ITBV: intra-thoracic blood volume 
CO: cardiac output 
MTICG: mean transit time for indocyanine green and is equal to the time taken for detection of 




Limitations for measurement of ITBV  
 
(i) The limitations or sources of error for measurement of ITBV are similar for the measurement 
of GEDV. In addition to commercial unavailability of IcG, the method is expensive, time 
consuming and too cumbersome for bedside use.34  
 
To overcome some of these shortcomings, different methods became available for its estimation 
with good correlation: transpulmonary single indicator (thermal) dilution technique 36, 41, 44 and 
contrast magnetic resonant imaging.45 ITBV derived from single thermo dilution showed good 
agreement with the ITBV measured directly by double-indicator technique with a mean bias of 
7.6(ml/m2) and a standard deviation 57.4ml/m2 .46 
 
Sakka et al  derived the following equation by using structural regression analysis to estimate 




Of note, these were adult patients with minimum GEDV and ITBV values approximately 750ml 
and 800ml respectively on the structural regression analysis. This relationship may not hold true 
in children as the volumes are much smaller as compared to the adults. 
 
(ii) Estimation of ITBV is partially based upon cardiac output (ITBV= CO x MTtIcg) hence, 
mathematical coupling between the two may seem possible. However, various authors  
demonstrated that infusion of dobutamine increased the CO 43,47  while esmolol decreased the 
CO 48  without any influence on thermodilution measurements of ITBV. 
  
ITBV = (1.25×GEDV )− 28.4(ml);r = 0.96, p < .0001
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Studies evaluating the use of ITBV for preload estimation and/or prediction of fluid 
responsiveness in adults 
 
Both Godje et al and Sakka et al 40,41 demonstrated ITBVI to be significantly correlated with 
changes in SVI (r =0.65), as compared to  CVP and PAOP (r = -0.23 and r = - 0.06, 
respectively) and an accurate measure of cardiac preload. However, Muller et al in their study 
involving 35 patients with acute cardiovascular failure demonstrated ITBVI (Intra thoracic blood 
volume index) was unable to predict fluid responsiveness reliably (AUC 0.64).49  
 




(iv) Static markers measured by the ultrasound dilution method 
 
Transpulmonary ultrasound dilution technique is an indicator dilution technique using normal 
saline as an indicator. It estimates three volume based novel static markers: total end diastolic 
volume index (TEDVI), central blood volume index (CBVI) and active circulating volume index 
(ACVI).  
 
At the time of initiating this MD, there were no reported studies evaluating the usefulness of 
these indices for predicting fluid responsiveness in critically ill children. 
 
 
(a) Total end diastolic volume index (TEDVI)  
 
This is the total amount of blood in the chambers of the heart at the end of diastole (see fig 2-4). 
The manufacturer recommends TEDV to be normalized to body weight for children weighing 
less than 40 kg (normal range being 7-12 ml/kg) and normalized to body surface area for more 
than 40 kg (expected range is 250-350ml/m2).  
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Several authors have demonstrated inconsistencies in reported that cardiac volumes across 
childhood ages when scaled to body surface area (BSA) expressed in m2. They are more 
closely related to BSA1.38 rather than BSA alone.50-52 This is in contrast to a more constant 
range of cardiac index scaled consistently to BSA (m2). This is because changes in the heart 
rate (inverse relationship with BSA) and stroke volume (linear relationship with BSA) ‘cancel 
each other out’. Hence, volumetric data (for TEDVI) was allometrically scaled to body surface 
area using a power of 1.38 (i.e. (m2)1.38 = m2.6) in our research study. Therefore, TEDVI volumes 




            Figure 2-4 Static markers measured by TPUD.  
 
 Calculation of TEDVI assumes that the spread of the arterial indicator dilution curve from its 
initial venous shape results largely from indicator mixing in the heart chambers. TEDVI values 
may be unreliable in patients with left to right or right to left shunts. 
 
TEDVI has shown to be an accurate reflection of the blood volume status. Vigani et al in their 
juvenile animal model demonstrated TEDVI to accurately reflect blood volumes during 
haemorrhagic and resuscitative phases. It was not affected by noradrenaline infusion. TEDVI 
also correlated with volume induced changes in stroke volume which was unaffected by 
noradrenaline infusion.53  TEDVI can be considered as analogous to global end diastolic volume 
(measured by PiCCO), which has been assessed as a preload marker by various authors.54,42  
However, TEDVI is considered a more accurate reflection of cardiac chamber volumes as 
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compared to GEDVI, as the estimation of the latter includes the blood volume in the vessels 
between the site of injection and the sensor. 
 
 
(b) Central blood volume index (CBVI) 
 
This is defined as the total volume of blood in the heart, lungs and major vessels (fig 2-4). 
CBVI is estimated by measuring the volume of blood between the injection and the recording 
(arterial) site and normalized to body weight. The longer the indicator travels, the larger will be 
the value of CBVI. 
 
 [see fig 2-5] 
 
where  
MTTa: mean transit time of indicator traveling from the injection site (venous senor) to the 
arterial sensor  
MTTv: mean transit time of the venous injection recorded by the venous sensor 




Figure 2-5  Screen shot from TPUD monitor. ‘Y’ axis is the percent concentration of saline in blood. ’X’ axis 
represents time. The concentration of injected saline becomes stable with in 40-60 seconds from the time of 
injection (H) (with permission form Transonic, NY, USA). 
   
 
The normal range of TEDVI is between 18-22 ml/kg.  Eremenko et al demonstrated CBVI and 
TEDVI to be useful indicators of preload in adult patients admitted to the cardiac ITU.55  
 
CBV =CO× (MTTa−MTTv−MTTt)
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Crittendon et al in their study involving 22 children demonstrated CBVI and TEDVI could be 
used as novel preload markers. They showed good correlation between these two indexes with 
pulmonary artery wedge pressure and CVP.56  
 
 
(c) Active circulating volume index  
 
This is the volume of blood in which the indicator (normal saline) mixes within one minute after 
injection (see fig 2-4). This is indexed to body weight irrespective of the child’s weight. The 





Vinj: volume of injected isotonic saline (ml)  
H: new level of isotonic saline concentration in blood [ml (saline)/ml (blood)] at the end of the 




Sources of error or limitations of ultrasound dilution method 
 
(i) Being an indicator dilution technique, TPUD shares the same sources of error and limitations 
as other indicator dilution methods. Invasiveness, intermittent nature and slow response time 
are few of the examples. In addition, accuracy of these markers to estimate preload in children 
still needs validating, especially in the presence of anatomical shunts. 
 
(ii) TPUD is as much prone to indicator loss errors as any other indicator dilution techniques.  
Though the venous sensor accurately measures the volume of the indicator injected however, 
the loss may be due to multiple other reasons past the venous sensor for example dead space 
of the venous catheter or abnormal lung perfusion. 
 
 (iii) Each measurement involves injection of normal saline as an indicator. This may result in a 
significant cumulative amount affecting fluid balance specifically in small babies. 
ACV =Vinj ÷ (H ×Weight)
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A summary of studies involving these markers is presented in table 2-4. Note that none of these 
markers were evaluated for fluid responsiveness. 
 




































CI Children  (22) 
          0.58 
 0.62 
Δ ACVI = Change in active circulating volume index; CI = Cardiac index; CBVI and  Δ CBVI = Central blood 
volume index and corresponding change  post  intervention respectively ; SVI and ΔSVI = Stroke volume 
index and corresponding change post intervention respectively; TEDVI and ΔTEDVI = Total end diastolic 
volume index and change respectively post intervention. Interventions are CO augmentation therapy such as 
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2.2 Dynamic markers 
 
Dynamic markers are a result of cardiopulmonary interactions resulting in cyclical changes of 
the loading conditions of the right and left ventricle as a result of mechanical ventilation (see 
section 2.2.1) . The magnitude of such respiratory-induced changes in the left ventricle (LV) 
stroke volume (further accentuated during hypovolaemia) can be measured and used to predict 
fluid responsiveness.57 Pulse pressure variation (PPV), systolic pressure variation (SPV) and 
stroke volume variation (SVV) are some of the dynamic markers which are measured on a beat-
to-beat basis by pulse contour based technology. These markers are relatively well evaluated in 
adult practice, however paediatric utility was not established at the time of commencement of 
my thesis. We studied the utility of these markers measured by PRAM in a cohort of 100 
critically ill children. 
 
 
2.2.1 Effects of positive pressure ventilation on ventricular function 
 
Intermittent positive pressure ventilation induces cyclical changes in the loading conditions of 
both sides of the heart. Positive pressure ventilation leads to a reduction in right ventricular (RV) 
preload, due to a decrease in the venous return pressure gradient as a result of increased 
pleural pressure.58  
 
The effect of mechanical ventilation on RV afterload is variable and depends upon interplay 
between a variety of factors described below: 
 
(a) Effect of an increase in transpulmonary pressure: positive pressure ventilation increases 
trans alveolar pressure (alveolar – pleural pressure) affecting the blood vessels surrounding the 
alveoli.59 This contributes towards an increase in afterload. 
 
(b) State of the lung inflation: pulmonary vascular resistance (PVR) is lowest at functional 
residual capacity. Lung volumes higher or lower than the functional residual capacity will lead to 
an increase in PVR, hence the afterload. 
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 (c) Phase of inspiration: The resistance values are consistently different during deflation 
(higher) and inflation (lower) at equal transpulmonary pressures.60 
 
(d) Pulmonary artery flow: The flow resistance is lower at high pulmonary artery flow than at low 
flow state.60  
 
(e) Mode of ventilation: positive or negative pressure ventilation has different effects on PVR for 
maintenance of similar lung volumes by Petak et al demonstrated an increase in PVR during 
positive pressure ventilation as compared to negative pressure for similar changes in lung 
mechanics such as airway resistance and parenchymal elastance.61 Therefore, the net effect on 
RV afterload is variable and difficult to predict accurately in clinical settings. 
 
Despite the variability on RV afterload, inspiration during mechanical ventilation typically leads 
to a reduction in RV stroke volume, with reduction in preload being the major contributor for this 
reduction 62 (fig 2-6). 
 
Left ventricle is also subject to volumetric effects during the positive pressure inspiration. 
Mechanical insufflation may induce a squeezing of the blood out of the alveolar vessels and 
transiently increase the LV preload.63 There is also a decrease in LV afterload due to reduction 
in the wall tension as a result of decline in transmural pressure, facilitating LV ejection.64 These 
two mechanisms induce an increase in the LV stroke volume during the inspiratory period. The 
inspiratory decrease in the RV stroke volume leads to a decrease in the LV filling after a phase 
lag of two to three heart beats because of the long blood pulmonary transit time.65 This leads to 
a decrease in LV ejection volume during the expiratory phase (fig 2-6). 
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Figure 2-6 Arterial pressure variations during mechanical ventilation and subsequent apnoea. Note the 
fluctuations in the blood flow in pulmonary artery and aorta during inspiration and expiration. Qao = aortic 
blood flow; Qpa = pulmonary blood flow; Pao = arterial pressure in aorta; Paw = airway pressure. 
Reproduced from: Lemson J et al. Pediatrics. 2011 Sep;128(3):560-71.66 
 
 
These cyclical changes are greater when the ventricles operate on the ascending portion of the 
Frank-Starling curve.67 Thus, the magnitude of these changes in the LV stroke volume could be 
representative of an individual’s preload dependence.68 
 
 
2.2.2 Measurement of Dynamic markers 
 
Dynamic indices were initially calculated manually using graphical analysis of arterial pulse 
waveform over a single respiratory cycle using mathematical equations. However, recently new 
software has been developed and validated to calculate these indices automatically and 
continuously from the arterial pressure waveform.69,70 These algorithms were further improved 
in order to make it more robust during periods of abrupt haemodynamic changes.71  In addition, 
non-invasive estimation of PPV using respiratory variations in the pulse-oximeter 
plethysmographic waveform amplitude has recently been evaluated with promising results.72,73 
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The following section describes commonly used dynamic markers for prediction of fluid 
responsiveness in clinical practice. General sources of error or limitations applicable to these 
markers are described at the end of this section. Errors or limitations unique to a particular 
marker are mentioned along with that specific marker. 
 
 
2.2.3  Description of commonly used dynamic markers  
 
 
(i) Systolic pressure variation (SPV) 
 
The difference between the maximum and minimum systolic pressures divided by their average 





SAP max and SAP min are the maximum and minimum systolic arterial pressure over one 
respiratory cycle. 
  
SPV = SAPmax− SAPmin1
2 × (SAPmax+ SAPmin)









Figure 2-7 Systolic pressure variation. Note Δ Down  and Δ UP  in relation to the baseline pressure 
measured during apnoea. Reproduced from: Vieira CR, et al. Brazilian Journal of Anesthesiology, 2005; 
55: 1: 3 -18.75 
 
 
SPV (normally 8-10 mm of Hg) is composed of two different segments Δ Down  and Δ UP in 
normotensive anaesthetized mechanically ventilated patients with SAP at end expiration as a 
reference.74,76 
 
Δ Down (6-8 mm of Hg) is a decrease in the SAP during the expiratory phase reflecting the 
inspiratory decrease in preload to the right side of the heart being subsequently transmitted to 
the left ventricle several beats later.  
 
ΔUP (3-4 mm of Hg): It is an early inspiratory increase in the SAP as a result of augmentation of 
stroke volume mainly caused by the increased preload to the left ventricle. In case of congestive 
heart failure, Δ UP may also be significantly contributed by the decreased afterload to left 
ventricle as a result of increased intra-thoracic pressure.77,78 
 
Being purely related to preload ΔDown is considered  a better marker as contrast to ΔUP. It is 
also considered to be the major contributor towards SPV.79 
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Studies evaluating the use of SPV for fluid responsiveness in adult patients 
 
Travernier et al evaluated the ability of ΔDown to predict an increase in cardiac index after 
volume loading in 16 patients with sepsis. They demonstrated that Δ Down of 5 mm of Hg was a 
more accurate predictor of increase in cardiac index as compared to pulmonary artery occlusion 
pressure or left ventricular end diastolic area.80 
 
On the contrary, Buettner et al in their study involving eighty patients undergoing major 
abdominal surgery showed that intra-operative SPV guided treatment was associated with 
slightly greater fluid administration with no difference in organ perfusion and function.81  
 
 
Summary of paediatric studies evaluating the use of SPV for fluid responsiveness 
 
Various authors have reported the inability of SPV to predict fluid responsiveness in children. A 
synopsis of these studies is presented in table 2-5. The maximum predictive ability for SPV in 
children is reported by Tran et al in their study involving 44 children in cardiac operating theatre 
(AUC 0.74).24 
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2.2 – 71.5  
(Range) 
Cardiac OR 0.74 
AUC = Area under the ROC curve; IQR = Inter quarantile range; MAD = Median absolute deviation;  
N = Number of fluid boluses administered; NR = Non responders; OR = Operating room;  
R = Responders; SD = Standard deviation. 
  
 
(ii) Pulse pressure variation (PPV) 
 
Pulse pressure is defined as the difference between the systolic and the diastolic arterial 






PP max and PP min: maximum and minimum value of the pulse pressure respectively over one 
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Figure 2-8 Pulse pressure and Stroke volume variation. Note the increase and decrease  in pulse 
pressure and stroke volume during inspiration and expiration during positive pressure ventilation. 
Reproduced from: Bouchacourt et al. BMC Anesthesiology 2013;13(1):41.83 
 
 
Michard et al proposed the superiority of PPV for prediction of fluid responsiveness over SPV. 
They suggested that variations in the pulse pressure results not only from the changes in the 
aortic transmural pressure (mainly related to changes in LV stroke volume)  but also from the 
changes in the extra mural or pleural pressures.84 
 
 
Studies evaluating the use of PPV for fluid responsiveness in adult patients 
 
PPV has been shown to be able to predict fluid responsiveness in different clinical settings 
(predominantly adult) such as post-coronary artery bypass grafting, perioperative period in 
patients undergoing coronary artery bypass 85,86 or during major abdominal surgery.87 A recent 
systematic review by Yang et al (2014) included twenty-two studies with 807 mechanically 
ventilated patients with tidal volume more than 8ml/kg, without spontaneous breathing and 
cardiac arrhythmia. The pooled sensitivity was 0.88 (95% confidence interval (conf. intv.0.81to 
0.92) and pooled specificity was 0.89 (95% conf. intv.0.84 to 0.92). A summary receiver 
operating characteristic curve yielded an area under the curve of 0.94 (95% conf. intv.0.91 to 
0.95).88  
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Summary of paediatric studies evaluating the use of PPV for fluid responsiveness 
 
There are only a small number of paediatric studies reporting the utility of PPV for fluid 
responsiveness. Most were reported after the commencement of this thesis. The range of AUC 
reported is 0.52 - 0.71 suggesting PPV is unable to predict fluid responsiveness to a high 
degree. Of note, Renner et al is the only study involving children between the age group 0-2 
years who reported the AUC of 0.79 and 0.86 pre and post atrial and /or ventricular septal 
defect closure. Table 2-6 summarises some of these studies.  
 



















































General PICU 0.59 
AUC = Area under the ROC curve; MAD = Median absolute deviation; N = Number of fluid boluses 
administered; OR = Operating room; SD = Standard deviation. 
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(iii) Stroke volume variation (SVV) 
 
Stroke volume variation is a result of the distinct variations in the stroke volume of the left 
ventricle 89 as a result of cardiopulmonary interactions during mechanical ventilation. SVV can 
be calculated from either Doppler echocardiography90 or arterial pulse contour based methods.   
 
The maximum and minimum SV values are identified over one respiratory cycle and SVV 





SV max: maximum stroke volume and  
SV min: minimum stroke volume over one mechanical respiratory cycle (fig 2-8). 
 
Pulse contour methods use the same formula as above. The maximum and minimum stroke 
volumes are estimated over one respiratory cycle using an inbuilt algorithm (which differs 
according to the commercial monitoring device). The effects of the various factors such as 
arterial compliance, resistance, impedance is taken into consideration for calculation of the 
stroke volume. 
 
Biais et al demonstrated an acceptable bias and limits of agreement between SVV measured by 
pulse contour method and aortic Doppler echocardiography.91 
  
SVV = (SVmax− SVmin)1
2 × (SVmax+ SVmin)
×100
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Studies evaluating the use of SVV for fluid responsiveness in adult patients 
 
Recently Zhang et al (2011) published a systematic review and meta-analysis regarding the 
accuracy of SVV in predicting fluid responsiveness in adult subjects.92 A diagnostic odds ratio of 
18.4 for SVV to predict fluid responsiveness at a sensitivity of 0.81 and specificity of 0.80 was 
reported from 23 studies across all settings. The SVV was of diagnostic value for fluid 
responsiveness in operating room or intensive care unit patients monitored with the PiCCO or 
the FloTrac/Vigileo system, and in patients ventilated with tidal volume greater than 8 ml/kg. 
 
However, various authors have reported contradictory results where SVV was found not being 
able to predict fluid responsiveness accurately. Recently, Biais et al (2012) evaluated the utility 
of SVV  for predicting fluid responsiveness measured by PRAM. Their study included 35 adult 
patients admitted to a surgical ITU settings. A 12.6% stroke volume variations threshold 
discriminated between responders and non-responders with a sensitivity of 63% (95% conf. 
intv.38% to 84%) and a specificity of 69% (95% conf. intv.41% to 89%). The area under the 
receiver operating characteristic curves was 0.60 (95% confidence interval 0.43-0.76).93 
Similarly, De waal et al 94 and Kee et al 95 reported SVV measured by Flotrac/Vigileo TM failed to 
predict fluid responsiveness in post coronary artery bypass patients. .  
 
In addition, Garcia et al also reported inaccuracy of pulse contour methods for estimation of 
stroke volume as a result of changing arterial load (arterial compliance, elastance and vascular 
resistance) due to volume expansion or vasoactive therapy 96 (most patients on advanced 
haemodynamic monitoring will require such treatment). This will affect the accuracy of SVV 
estimation  and subsequently it’s predictive ability for fluid responsiveness. 
 
 
Studies evaluating the use of SVV for fluid responsiveness in children 
 
A limited number of studies are reported investigating the use of SVV for prediction of response 
to fluid bolus. Renner et al reported a cut off SVV value of >15% is only able to predict fluid 
responsiveness with a sensitivity of 60% and specificity of 90% in post-cardiac surgical patients. 
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The prediction improved after cardiac surgical treatment of closure of ASD and VSD shunts.  A 
summary of the findings is presented in table 2-7. 
 


























2.2 – 71.5  
(Range) 
Cardiac OR 0.74 
AUC = Area under the ROC curve; ASD = Atrial septal defect; N = Number of fluid boluses administered; 
OR = Operating room; SD = Standard deviation; VSD = Ventricular septal defect. 
 
 
(iv) Doppler measured dynamic markers 
 
(a) Changes in aortic blood flow peak velocity measured by trans-thoracic 
Doppler (ΔVpeakAo)  
 
Changes in the aortic blood flow peak velocity (ΔVpeakAo) can be measured using the Doppler 
technique (explained in chapter 1) with either transthoracic or transoesophageal approach. 
ΔVpeakAo is a result of cardiorespiratory interactions during mechanical ventilation (as for other 
dynamic markers). 
 
Pulsed Doppler aortic blood flow velocity estimation at the exact level of the annulus from the 
apical five-chamber view over one mechanical respiratory cycle provides an estimation of 
maximal and minimal values of aortic peak velocity (VpeakAo). (see fig 2-9). 
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Figure 2-9 Measurement of Vpeak Ao maximum and minimum over one respiratory cycle using trans 




Changes in the blood peak velocity over one respiratory cycle is calculated as follows 97 
 





ΔVpeakAo: change in the aortic blood flow peak velocity 
VpeakAo max and VpeakAo min are the maximum and minimum aortic blood flow velocity over 
one mechanical respiratory cycle.
 
 
Limitations unique to measurement of ΔVpeakAo 
 
Measurement of ΔVpeakAo requires the use of pulsed Doppler directed at the aortic valve 
annulus level. This requires appropriate probe position and special operator dependent skills, 
making it prone to operator related errors. Belloni et al demonstrated this particular error in their 
study involving 19 patients. They reported inability of ΔVpeakAo measured by 
transoesophageal Doppler to predict fluid responsiveness with possible explanation of high level 
of operator dependence for measurement of this parameter.98 Operator dependence is less 
during  transoesophageal Doppler measurement of ΔVpeakAo in the descending aorta. 
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Studies evaluating the use of ΔVAo for prediction of fluid responsiveness in children 
 
Various authors have evaluated its use for fluid prediction in children; most have reported 
encouraging results. 
 
Durand et al studied the effects of volume expansion in 26 mechanically ventilated children. 
Increase in stroke volume greater than 15% was regarded as a positive response to fluid bolus 
administration. They demonstrated ΔVpeakAo in responders was higher than that in non-
responders [19% (12.1–26.3) vs. 9% (7.3–11.8), p = 0.001]. ΔVpeakAo was able to predict fluid 
responsiveness with area under ROC curve of 0.85 (95% conf. intv.0.99–1.8), p = 0.001]. The 
best cut-off for ΔVpeakAo reported was 12%, with sensitivity, specificity and positive and 
negative predictive values of 81.2%, 85.7%, 93% and 66.6%, respectively. They also reported a 
positive linear correlation between baseline ΔVpeakAo and change in stroke volume following 
volume expansion (Rho = 0.68, p 0.0012). 82 
 
Choi et al also demonstrated similar results in their study involving fluid bolus administration in 
21 mechanically ventilated post ventricular septal defect repair children. They also showed 
baseline ΔVpeakAo to be higher in the responders than non- responders (23.1 ± 5.7% vs. 14.0 
± 7.7%; p =  0.006) . ΔVpeakAo was able to predict fluid responsiveness as shown by a receiver 
operating characteristic curve area of 0.83 (95% conf. intv. 0.61–1.00; p =  0.01) . However, 
they defined the cut off value of ΔVpeakAo  of 20% with a sensitivity of 91% and  specificity of 
90%.23 
 
A summary of the studies evaluating its use in children is presented in table 2-8. 
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Table 2-8 Summary of the studies evaluating the use of respiratory variation in blood peak flow velocity in 




N Weight (kg) 
 







TTE Neuro OR 0.80 



























12(4) R, NR 
Mean (SD) 






TTE General PICU 0.85 
AUC = Area under the ROC curve; ASD = Atrial septal defect; MAD = Median absolute deviation; N = 
Number of fluid boluses administered; NR = Non responders; OR = Operating room; R = Responders;  
SD = Standard deviation; TTE = Transthoracic echocardiography defect; TOE = Transoesophageal 
echocardiography. 
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 (b) Change in velocity time integral (ΔVTI) or stroke distance 
 
Doppler velocity time integral (VTI) of left ventricular outflow tract, also known as stroke 
distance, is measured using the transoesophageal or transthoracic approach with commercially 




Figure 2-10 Calculation of VTI from spectral representation of Doppler of the aortic blood flow. VTI equals 
the area of the hatched triangle. Reproduced from: Durand P et al. Intensive Care Med 2008;34:888–94.82 
 
 
The maximum and minimum VTI are recorded over one mechanical respiratory cycle. ΔVTI is 





ΔVTI: change in the Doppler VTI of the blood in left ventricular outflow tract 




ΔVTI(%) = (VT Imax −VT Im in)1
2 × (VT Imax +VT Im in)
×100
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Limitations or Sources of errors for measurement of ΔVTI  
 
These are similar to any other method utilising Doppler based estimations such as positioning 
and fixation of probe to ensure the angle of insonation between the Doppler beam and direction 
of blood flow is less than 15° (see chapter 1, page 46). This predisposes this technique 
particularly vulnerable to operator related errors. 
 
 
Paediatric study investigating the use of ΔVTI for prediction of fluid responsiveness 
 
Renner and colleagues have shown encouraging results in their study involving 27 pre cardiac 
surgical, anaesthetised and mechanically ventilated children. The AUC was 0.84 with an optimal 
threshold value ≥ 4% (sensitivity 84% and specificity 71%) (table 2-9). 
 




N Weight (kg) 
 






TOE Cardiac OR 0.84 
AUC = Area under the ROC curve; N = Number of fluid boluses administered; OR = Operating room;  
SD = Standard deviation; TOE = Transoesophageal echocardiography. 
 
 
 (v) Change in pulse oximetry plethysmography (ΔPOP) and pulse 
variability index (PVI) 
 
The comparison of absorbencies at different wavelengths  (660 nm and 940 nm) allows 
estimation of the relative concentrations of oxyhaemoglobin and haemoglobin (i.e. saturation) 
by pulse oximetry. This is a continuous monitoring system generating a plethysmographic 
waveform (see fig 2-11). 
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Figure 2-11 Plethysmography waveform representing maximum and minimum amplitudes over one 
respiratory cycle.Reproduced from: Addison P. Anesth Analg 2014;119:1293–1306.100 
 
 
ΔPOP is extracted from the same waveform as suggested by Cannesson et al.101 They defined 






AMPmax  and AMPmin: maximum and minimum amplitude of pulse waveform of 
plethysmography signal over a respiratory cycle respectively. 
 
ΔPOP is based upon similar principles as PPV and many authors have reported a good 
correlation between ΔPOP and PPV in adult patients.102,103  
 
Perfusion variability index PVI (Masimo Corp., Irvine, CA) is a proprietary algorithm for 
automated and continuous representation of the respiratory variations in the plethysmographic 
waveform amplitude, using perfusion index (PI) as a surrogate. Perfusion index is an 
assessment of the pulsatile strength at a specific monitoring site (such as hand, finger or foot). It 
is calculated with pulse oximetry by expressing the pulsatile signal (during arterial inflow) as a 
percentage of the non-pulsatile signal, both of which are derived from the amount of infrared 
(940 nm) light absorbed.104 
ΔPOP = AMPmax− AMPmin1
2 × (AMPmax+ AMPmin)
×100
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PVI is the maximum change in the perfusion index (PI) over a time interval incorporating at least 





PImax and PImin are the maximum and minimum perfusion index over one respiratory cycle. 
 
 
Limitations specific for the measurement of ΔPOP and PVI 
 
Since both ΔPOP and PVI are dynamic markers, they are subject to similar disadvantages or 
sources of error as other dynamic markers. In addition, the variability of results is compounded 
by the procedure for calculating ΔPOP differs across various studies in terms of averaging 
period and location of signal interrogation.100 
 
 
Adult studies evaluating the use of ΔPOP and PVI for prediction of fluid responsiveness  
 
Δ POP and PVI have been directly compared with each other and found to be comparable in 
performance for prediction of fluid responsiveness or correlation with PPV.105,106 In addition, 
systematic reviews of the literature undertaken by Antonsen and Kirkebøen 107 and Sandroni et 
al concluded that ΔPOP and PVI were equally effective in predicting fluid responsiveness in 
ventilated adult patients in sinus rhythm.108   
 
  
PVI = (P Imax −P Im in)P Imax ×100
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Paediatric studies evaluating the use of ΔPOP and PVI for prediction of fluid 
responsiveness  
 
 ΔPOP was unable to   predict fluid responsiveness in children in studies conducted by 
Chandler et al 109  de Souza Neto et al 33. Results for utility of PVI in children are variable with 
some authors reporting it to be useful 21, 99 while others did not find it accurate enough.33,109   
 
Byon et al demonstrated PVI was able to predict for fluid responsiveness in their study involving 
thirty-three mechanically ventilated children undergoing neurosurgery, a PVI value of 11% 
predicted fluid responsiveness with a sensitivity of 73.3% and a specificity of 86.7%. The area 
under the curve was 0.767 (95% conf. intv.0.597 – 0.936).21 
 
On the contrary, de Souza et al in their study involving thirty mechanically ventilated children 
reported an area under the curve for ΔPOP and PVI to be 0.51 and 0.63 respectively in 0-6 year 
old and 0.57 and 0.54 in 6-14 year olds.33 
 
A summary of paediatric studies is presented in table 2-10 on the next page. 
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N Weight (kg) 
 
Setting AUC 
ΔPOP      





Cardiac cath 0.56 
























Neuro OR 0.77 





Cardiac cath 0.54 
























AUC = Area under the ROC curve; MAD = Median absolute deviation; N = Number of fluid boluses 
administered; N = Non Responders; OR = Operating room;; ΔPOP = Change in pulse oximetry 
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2.2.4 General sources of error or limitations of dynamic markers 
 
Dynamic markers have certain limitations or sources of error, which should be taken into 
consideration while interpreting them in clinical practice.110 
 
(i) Arterial pressure measurement system: The arterial pressure curves are obtained from fluid 
filled catheter systems. Several factors, such as kinking or clot formation, and excessive tubing 
length can affect the quality of signal, thus affecting the accuracy of the measurements. 
 
(ii) Dysarrythmia: Arrythmias will affect the beat-to-beat variability of stroke volume hence 
interfering with estimation of these markers to a variable degree. This is particularly true for 
atrial fibrillation or extra systoles.  
 
Measurement by PRAM depends upon the identification of dicrotic notch on the arterial 
pressure waveform. This identification may be difficult in cases of arrythmias leading to 
inaccurate measurements. 
 
(iii) Dynamic markers have limited value in assessing fluid responsiveness in settings where the 
pleural pressure changes are small during the respiratory cycle. This may be seen during 
spontaneous breathing and open chest conditions 111,112 common after neonatal cardiac 
surgery. De Backer et al demonstrated PPV to be a reliable indicator for fluid responsiveness 
only when the tidal volume is greater than 8ml/kg.113  Similar observations have been  reported 
by various other authors.114-116  
 
iv) High ventilator rates or  high frequency oscillation:  Higher mechanical ventilatory rates (not 
uncommon in small children) decreases the ratio of heart rate to respiratory rate. The number of 
cardiac cycles per respiratory cycle may be too low to allow variations in stroke volume.117 
 
(v) Right ventricular failure: PPV and SVV may not be reliable indicators for preload 
dependence in case of right ventricular failure. This is because the major contribution is by an 
inspiratory increase in afterload as opposed to decrease in preload. In this context the lack of 
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response to fluid administration with high PPV or SVV should be indicative of right ventricular 
failure.118 
 
(vi) Influence of vasoconstrictors on the dynamic variables: Vasoconstrictors influence arterial 
load as a result of predominant effect on effect on arterial compliance, elastance and vascular 
resistance. This can lead to inaccurate estimation of stroke volume (hence affecting accuracy of 
estimation of SVV, SPV and PPV). 
 
Garcia et al studied the accuracy of eight different pulse contour algorithms during acute 
changes in arterial load induced by vasoactive (norepinephrine infusion) or volume expansion 
therapy. Three different aspects of arterial load were evaluated- total systemic vascular 
resistance, arterial compliance and arterial elastance while comparing CO estimation between 
oesophageal Doppler and different (eight) pulse contour algorithms. The range of percentage 
error for cardiac output measurements was reported between 27%(best performing algorithm) to 
49.8% (worst performing algorithm) during vasoconstrictor therapy . Further, the mean bias, 
limits of agreement and percentage error were significantly higher in the vasoconstrictor group 
as compared to volume expansion group. This was a result of more pronounced and statistically 
significant changes in arterial load (especially arterial compliance and elastance) in the 
vasoconstrictor group as compared to fluid administration.96  
 
Nouira et al demonstrated a significant decrease in PPV and SPV following norepinephrine 
infusion during haemorrhage in animal study 119. Renner and colleagues also reported similar 
findings in their study with the use of norepinephrine in their porcine haemorrhagic model 120. 
However, Hadian et al demonstrated (n=15 cardiac patients) that PPV (and SVV) decreased 
after volume loading and increased after initiation of vasodilators but there was no effect on 
PPV (or SVV) after increase of inotropes or vasoconstrictors. In summary, additional larger trials 
are required to clarify the effect of vasoconstrictors in hypovolaemic patients on dynamic 
variables.121 
 
(vii) Influence of intra-abdominal hypertension (IAH) on dynamic variables: Raised abdominal 
pressures can lead to impaired venous return as a result of IVC obstruction. This may have a 
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direct effect on the measurement of dynamic indices. Duperett et al reported increase in SPV, 
PPV and IVC flow associated with increasing intra-abdominal pressures especially in the 
presence of hypovolaemia.122 This may be partly attributed to the associated changes in the 
pleural pressures. Renner et al also demonstrated  failure of SVV to predict preload 
dependence during IAH in their porcine model. However, PPV remained sensitive and specific 
during IAH to predict fluid responsiveness. Interestingly, the threshold value for PPV almost 
doubled to do so.123 
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2.4 Other tests for prediction of SV response to fluid bolus administration  
 
(i) Passive leg raising (PLR) induced changes in cardiac output 
 
Passive leg raising manoeuvre transfers blood from the venous compartment of legs and 
abdomen to the intra-thoracic compartment. This leads to an increase in preload of the right and 
subsequently left ventricle.124,125 The haemodynamic changes induced are not sustained (due to 
compensatory mechanisms of the body) and are reversible once the legs are returned to supine 
position.126 The effect of PLR on cardiac output in responders occurs within thirty seconds to 
one minute.126 
 
The advantages of performing PLR are:  
 
(i) Relatively simple procedure to perform,  
(ii) The effects are quick and reversible and  
(iii) PLR does not lead to additional volume overload in non-responders. 
(iv) PLR is shown to be accurate in self-ventilated patients and in the settings of arrhythmias.  
The last two characteristics differentiate PLR from other dynamic markers of fluid 
responsiveness. 
 
The  limitations of PLR testing are: 
 
 (i) PLR testing is not feasible where patient mobility is limited or not allowed such as severe 
trauma or head injury patients.127  
 (ii) PLR represents an inconsistent quasi fluid challenge in children, as the proportionate blood 
volume in the legs alters across paediatric age and weight range. This leads to difficulties in 
standardisation and interpretation of the test. This is most likely related to somatic growth and 
changes in body segment proportions with increasing age during childhood. 
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Adult studies evaluating the use of PLR for the prediction of fluid responsiveness 
 
Cavallaro and colleagues performed a systematic review on the diagnostic accuracy of PLR for 
prediction of fluid responsiveness in adult patients. A total of 353 patients from nine studies 
were included into the study. The pooled sensitivity and specificity of PLR induced change in 
CO for predicting fluid responsiveness were 89.4% (conf. intv.84.1-93.4%) and 91.4% (conf. 
intv.85.9-95.2%) respectively. The pooled area under the receiver operating characteristics 
curve (AUC) was 0.95 (0.92-0.97). The threshold for prediction of fluid responsiveness varied 
between 8 and 15%. The pooled correlation coefficient between the baseline value of PLR 
induced changes in CO and corresponding increase in CO after volume expansion was 0.81 
(0.75-0.86). The pooled difference in mean PLR induced change in CO values between 
responders and non-responders was 17.7% (13.6-21.8%, p < .0001). No significant differences 
were identified (a) between ventilated and spontaneously breathing patients (b) between 
patients in sinus rhythm versus and arrhythmias.128 
 
 
Paediatric study evaluating the use of PLR for the prediction of fluid responsiveness 
 
The only paediatric study evaluating PLR for prediction of fluid responsiveness is by Lukito V et 
al. They studied the role of PLR in predicting fluid responsiveness in forty children admitted to 
intensive care unit. They reported  a significant relation between changes in cardiac index to 
predict fluid responsiveness (p = .012, r(2) = .22, 95% confidence interval 1.529 to 31.37). A 
cardiac index increase by ≥10% induced by passive leg raising predicted preload-dependent 
status with sensitivity of 55% and specificity of 85% (area under the curve 0.71 ± 0.084, 95% 
Conf. intv. 0.546-0.874). The authors concluded that the concomitant measurements in cardiac 
index changes after the passive leg raising manoeuvre can be helpful in predicting fluid 
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(ii) Change in Inferior vena cava diameter (ΔIVC dia) 
 
The inferior vena cava (IVC) is an intra-abdominal compliant blood vessel returning blood from 
the lower parts of the body to the heart. It accounts for approximately 75% of venous return to 
the right side of the heart in adults, but less in children.130  It acts as a reservoir of blood and is 
subjected to abdominal pressure. The calibre of IVC is altered by phases of respiration 131, 
blood volume 132 and right heart function.133  
 
Takata et al suggested that the IVC diameter depends on the extra-mural IVC pressure i.e right 
atrial pressure and the abdominal pressure.134 During spontaneous ventilation, cyclic changes in 
pleural pressure transmitted to the right atrium produces inspiratory decrease in IVC diameter  
leading to cyclical changes in venous return.135 This cyclical change in vena cava diameter is 
most significant during hypovolaemia and is attenuated when the vessel is dilated. Kircher et al  
demonstrated that the inspiratory decrease in the IVC diameter was well correlated with the 
right atrial pressure during spontaneous breathing.136  
 
On the contrary, IVC diameter increases to a maximum at inspiration during positive pressure 
ventilation. Positive pressure inspiration leads to an increase in the pleural pressure which in 
turn rises the intravascular pressure of the right atrium. This will decrease the venous return 
gradient leading to dilatation of the IVC.137 This inspiratory dilatation is even greater during high 
compliance states such as hypovolaemia.138  
 
The IVC diameter is visualised by a sub-coastal view in a longitudinal section with the use of 
trans thoracic echocardiography. The diameter is measured in M-mode coupled to the two 
dimensional mode either just upstream of the origin of supra hepatic veins 137  or just below 
(3cm) the junction of IVC to right atrium.139 Both inspiratory and expiratory diameters are 
measured over a single respiratory cycle. 
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Limitations specific to the measurement of ΔIVC dia 
 
Measurement of ΔIVC dia requires the use of specific skills related to echocardiography making 
it prone to errors. 
 
 
Paediatric studies evaluating the use of ΔIVC dia for the prediction of fluid 
responsiveness 
  
Choi et al investigated the effect of fluid bolus administration (10ml/kg) in 21 post ventricular 
septal defect repair children in their intensive care unit. They demonstrated Δ IVC dia was 
higher in the responders (increase in SV >15%) as compared to the non-responders 
(26.5 ± 16.2% vs. 9.2 ± 9.1%; p = 0.008). The AUC was 0.85 (95% Conf. intv., 0.69-1.00; 
p = 0.01).23 
 
However, on the contrary, Byon et al did not find Δ IVC dia to be a useful marker for prediction 
for fluid responsiveness. They studied thirty-three mechanically ventilated children undergoing 
neurosurgery. There was no difference in Δ IVC dia between responders and non-responders 
21. 
A summary of these studies evaluating its use in children is presented in table 2-11.  
 
Table 2-11 Summary of the two studies evaluating the role of Δ IVC diameter for predicting fluid 




N Weight (kg) 
Mean (SD) 





  23(9.2) NR 
 
TTE Neuro OR 0.37 
Choi 23 
(2010) 
21 12(4) R, NR 
 
TTE Cardiac PICU 0.85 
AUC = Area under the ROC curve;; N = Number of fluid boluses administered; NR = Non responders;  
OR = Operating room; R = Responders; SD = Standard deviation; TTE = Transthoracic echocardiography; 
TOE =Transoesophageal echocardiography. 
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(iii) End expiratory occlusion test 
Inspiration with positive pressure mechanical ventilation reduces right ventricular preload. 
Pause in the mechanical insufflation at end expiration for 10-15 seconds suppresses this 
reduction in preload and may lead to increase in the cardiac preload to an extent to be used for 
prediction of fluid responsiveness for subsequent volume expansion.140 Two major advantages 
of this test are (i) can be used in patients with arrhythmias and (ii) patients do not need to be 
paralysed. 
Various authors have reported conflicting results about the use of this test in adult patient group 
.141,142  There are no paediatric studies reported in the literature evaluating the use of this test 
for prediction of fluid responsiveness.  
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2.5 Arterial dP/dtmax as a marker of left ventricular contractility 
 
Dynamic or static markers, irrespective of their ability to predict response to fluid bolus 
administration, are unable to provide any meaningful information regarding underlying 
myocardial contractility - a major determinant in cardiac output.  
 
The contribution of myocardial contractility towards the response for fluid bolus administration is 
increasingly been recognized. The slope between the change in preload and stroke volume on 
the Frank-Starling curve is partly dependent upon the contractile state of myocardium (see fig 2-
1). Disease processes like septic shock has a far greater effect on ventricular contractility than 
was previously recognised 143. Hence, an accurate estimation of left ventricular contractility is 
important in order to improve the prediction of response to fluid bolus administration.  
 
The gold standard for estimation of left ventricular contractility is the end systolic pressure 
volume relationship. The slope of this relationship is referred to as end systolic elastance. 
providing an index of left ventricular contractility.144,145 However, estimation of end systolic 
elastance is an invasive procedure involving left ventricular catheterization. This is a fairly high-
risk procedure in the critically ill paediatric population due to the small, variable size and 
associated haemodynamic compromise. A non-invasive or minimally invasive technique for 
estimation of the left ventricular contractility will be more appropriate and practically useful. A 
number of novel non-invasive 146 or invasive markers have been studied such as peak first and 
second time derivative of ventricular pressure, peak isovolaemic power, peak aortic blood 
acceleration, peak fibre velocity, mean aortic blood flow, time-tension index. Most of them failed 
to provide any valid or relevant estimation of the left ventricular contractility.147  
 
Peak first derivative of left ventricle pressure (LV dP/dtmax) provides a reliable estimate of the 
myocardial contractility.148,149 However, its estimation will require invasive catheterization in the 
left ventricle with all the perils as discussed above.  
Most of the critically ill patients exhibiting cardiovascular instability have arterial lines in situ. 
Arterial dP/dtmax is related to LV dP/dtmax, and can be estimated from the pressure waveform 
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Figure 2-12 Estimation of dP/dt max from arterial waveform. This is the maximum ascending slope of the 
arterial pressure waveform.  
                                
 
De Hert et al compared dP/dtmax estimated from a femoral artery pressure tracing to left 
ventricular (LV) dP/dtmax during various alterations in myocardial loading and contractile 
function in seventy adult patients scheduled for coronary artery bypass surgery. They 
demonstrated LV and femoral dP/dtmax were significantly correlated (r = 0.82, p < 0.001), but 
femoral dP/dtmax systematically underestimated LV dP/dtmax (bias = -361 +/- 96 mmHg/s)]. A 
very close linear relationship (r = 0.93) and a good agreement (bias = -5 +/- 17 mmHg/s) were 
found between the changes in femoral dP/dtmax and LV dP/dtmax. This relationship persisted 
during different interventions (leg raising, calcium administration, and dobutamine infusion).150  
 
Similarly Scolletta and colleagues compared LV dP/dtmax measured from echocardiography to 
peripheral arterial dP/dtmax measured by PRAM in seventy critically ill adult patients. They 
reported a strong linear correlation between the two (r=0.93, p<.001). The mean bias between 
the two was 23.7 mmHg/s (95 % CI -23.6 to 71.0) with limits of agreement of -372 to +383 
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mmHg/s (lower 95 % CI -454 to -290; upper 95 % CI 338 to 502) and a relative percentage error 
of 28% .151 
 
On the other hand, Sharman et al in their study in adult males concluded radial pressure 
waveform dP/dt max to be a poor reflection of left ventricular systolic function measured by high 
fidelity catheter system and echocardiography. They demonstrated a poor, but statistically 
significant, correlation between the LV dP/dtmax measured using catheter and estimated via 
radial artery dP/dtmax (R2=0.006; P < 0.05) during rest and exercise.Similar weak  to non-
significant association was demonstrated between radial dP/dtmax and all echocardiographic 




Paediatric studies investigating the role of peripherally estimated dP/dtmax for 
estimation of left ventricular contractility 
 
Unlike adult studies, it has been suggested that children demonstrate a stronger relationship 
between LV and arterial dP/dtmax. Masutani et al evaluated the role of Aortic dP/dtmax for 
estimation of LV contractility in 75 children (30 control; 45 disease). They demonstrated a high 
correlation between the measured LV dP/dtmax and the estimated LV dP/dtmax (from aortic LV 
dP/dtmax) in both control group and in children with cardiac diseases under variable contractility 
states (dobutamine infusion) and heart rate (atrial pacing) [r=0.89, p<.0001]. They concluded 
that LV dP/dtmax  is closely correlated and can be reasonably estimated from aortic dP/dtmax . 
This was based upon their results that the relationship between aortic dP/dtmax and  vascular 
mechanical and loading properties (such as impedance and mean arterial pressure) was 
maintained irrespective of the underlying cardiac condition or cardiovascular state.153  
 
Kawasaki et al studied 31 children with cardiovascular diseases for estimation of LV dP/dtmax 
from the maximum rate of  pressure rise in peripheral arteries (brachial and radial arteries). 
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Their group also demonstrated that the estimated LV dP/dtmax correlated well with the 
measured LV dP/dtmax (r=0.91, p<.0001). This high correlation between the two persisted even 
after changes in contractility were made using dobutamine infusion in randomly selected patient 
subgroup.154 
 
A gap regarding the utility and validity of this marker in paediatric population is well recognised. 
Our study investigated the role of dP/dtmax (measured by PRAM) as a marker of myocardial 
contractility in determining the response to fluid bolus administration in a cohort of critically ill 





This chapter summarized (a) the common dynamic and static markers used in clinical practice 
for discrimination between responders and non-responders to fluid bolus administration (b) the 
role of dP/dt max for estimation of ventricular contractility.  
 
Review of the literature pointed towards dynamic markers outperforming static markers. Change 
in aortic blood flow peak velocity and passive leg raising induced changes in cardiac output 
showed consistent results in their accuracy. However, the role of these markers is only well 
studied in adult patient group and further studies investigating their role in children in different 
clinical settings are still required. 
 
In addition to the preload and afterload, response to fluid bolus administration is also governed 
by state of myocardial contractility. An accurate assessment of this factor is equally important to 
prevent fluid overload in critically ill patients. 
 
Finally, it must be remembered that fluid responsiveness in itself does not mean that the patient 
requires fluid resuscitation. Most of the healthy persons are fluid responsive but do not require 
fluid bolus administration. The decision regarding fluid requirement or augmentation of CO 
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should be based on the overall clinical and biochemical picture in addition to these markers of 
fluid responsiveness. 
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Chapter 3 Description of Transpulmonary Ultrasound Dilution 
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3.1 Transpulmonary ultrasound dilution technique (CO StatusTM, NY, USA) 
 
Transpulmonary ultrasound dilution (TPUD) is an indicator dilution based technique utilising 
normal saline as the indicator. It incorporates an extra-corporeal arterio-venous (AV) loop and 
two reusable ultrasound sensors - one attached to each end of the AV loop  (fig 3-1). The AV 
loop is primed with heparin saline and the two ends are connected to the pre-existing arterial 
and central venous catheters. A roller pump provides a constant flow of blood at a rate of 6-12 
ml/min in the AV loop during the measurement. Isotonic saline (0.5 - 1 ml/kg, maximum 30ml) is 
used as an indicator. The speed of the injection will depend upon the size of the venous 
catheter and the volume of saline injected. The venous sensor directly measures the injection 




Figure 3-1 TPUD set up with AV loop (with permission form Transonic, NY, USA). 
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The velocity of an ultrasound beam directed through a column of isotonic saline at body 
temperature is 1533 m/sec. This is different from that through the blood (ranging between 1570 
– 1585 m/sec). Thus, saline injected into the venous limb will produce a transient change in the 
ultrasound velocity in both the venous and arterial limbs, in proportion to the degree of dilution. 
Figure 3-2 shows a screen shot from TPUD monitor after a normal saline injection. The venous 
curve (marked as ‘a’ in fig 3-2) is generated as a result of the saline injection by the venous 
sensor. It only represents the shape (or quality) of the injection and is not normalised to 
percentage dilution on the ‘y’ axis. The arterial dilution curve (marked ‘b’ in fig.3-2) is generated 
by the arterial sensor as a result of a transient change in the ultrasound blood velocity following 
the saline injection. It is expressed graphically on the monitor with the ‘y’ axis representing 
percentage of saline concentration in the arterial blood and the ‘x’ axis being time. It is worth 
noting that the venous curve will be much bigger in size than the arterial curve if similar scaling 




Figure 3-2 Display from TPUD monitor. Dilution curve of a normal four chamber heart. The ‘Y’ axis, C%, 
represents the percentage concentration of saline in the arterial blood; the ‘X’ axis is time (seconds). The  
dilution curve marked ‘a’ is generated from the ultrasound sensor on the venous limb at time of injection, 
while the dilution curve ‘b’ represents saline dilution of arterial blood. The latter is used to calculate cardiac 
output. Reproduced with permission form Transonic, NY, USA 
 
 
The quality of both the curves is inspected to ensure accuracy of the technique. Figure 3-3 
demonstrates examples of abnormal graphs that are rejected and measurements are repeated 
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till an accurate reading is obtained. The graph on the left (marked with blue arrow) shows an 
abnormal venous injection and the one on the right (marked with red arrow) shows an abnormal 
dilution curve.  
 
Figure 3-3 Abnormal venous injection and arterial dilution curves. The blue arrow points towards humped 
(abnormal) venous injection curve. Normally, it should be a smooth narrow curve. Red arrows point towards 
an abnormal downslope part of the indicator dilution curve probably due to abnormal signal noise. 
Reproduced with permission form Transonic, NY, USA. 
 
 
The software calculates the haemodynamic variables and displayed on the monitor. A set 
comprising of two or three measurements is taken to counteract the variations of CO in different 
respiratory phases and the readings averaged. The AV loop is flushed with the heparinized 
saline and is left in situ for the next set of measurements. In addition to measuring CO, TPUD 
also gives a qualitative and quantitative estimation of anatomical shunts and three novel 
markers of preload estimation as described below. 
 
 
3.1.1  Measurement of cardiac output 
 
TPUD generates an arterial dilution curve based upon changes in the ultrasound velocity in the 
blood after a saline injection as explained above. Cardiac output is calculated using the Stewart-
Hamilton equation.1 
 





Vinj : volume of injected saline quantified by the venous sensor 
(UVblood – UVsaline): difference between the ultrasound velocity of blood and saline measured 
by the venous sensor 
UVa: refers to the changes in the arterial blood ultrasound velocity measured by the arterial 
sensor 
 is the area under the dilution curve of the saline concentration of the injected saline 
in the arterial blood calculated from the changes in blood ultrasound velocity and the difference 
between the ultrasound velocity of blood and saline (measured by the venous sensor). This 
assumes a linear relationship between the changes in blood ultrasound velocity and saline 
dilution. 
 
The theory and in-vitro validation of this technique is reported in detail by Krivitsky et al.2  
 
TPUD has been validated for measurement of CO in paediatric animal model 3 and children with 
reference to other standard methods such as thermodilution 4, Fick method 5  and flow probes.6  
 
Crittendon 3rd et al compared TPUD with pulmonary artery thermodilution in twenty-eight 
patients with a median age and weight of 8 years and 31 kg respectively. The mean 
thermodilution cardiac index was 3.02 l/min/m2 (IQR 2.14 - 4.54l/min/ m2) against the mean 
cardiac index measured by TPUD of 3.05 l/min/m2 (IQR 2.81-3.45l/min/m2). Bland-Altman 
analysis revealed good clinical agreement with a mean bias of -0.004 l/min with a precision of 
0.8 l/min/m2 at 2 SD. The percentage error of 25.4% was within the clinically acceptable limits of 









Volume of  indicator  injected
Area under  the dilution curve
Ca(t) (dt)∫
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3.1.2   Qualitative and quantitative estimation of anatomical shunts 
 
The characteristics of the indicator dilution curves generated by TPUD may be used for 
qualitative and quantitative estimation of anatomical shunts. Dilution curves representing right to 
left shunts (see fig. 3-4) exhibit a short appearance time (arrow ‘a’ on figure 3-4) and an 
abnormal upslope (arrow b) or an extra hump (arrow c). This is due to a part of the indicator 
bypassing the lungs through the shunt and reaching the arterial sensor earlier followed by the 
rest of the indicator.7 In the case of left to right shunts, (see fig 3-5) dilution curves have a 
normal appearance time but there is more asymmetry of the downslope versus upslope than in 
the normal curves due to recirculation of the indicator (marked as arrow ‘d’). Bi-directional 
shunts demonstrated characteristic properties of both types of shunt i.e. short appearance times 




Figure 3-4 Dilution curve of right to left shunt after atrioventricular septal defect repair.Characteristic 
features include: (a) short appearance time (here an extra hump on the arterial curve begins before venous 
curve has finished), (b) an abnormal upslope, in this case resulting in a double peak, where (c) represents 
the normal peak resulting from indicator in the non-shunted blood. Reproduced with permission form 









Figure 3-5  Dilution curve in left to right shunt after ventricular septal defect repair. Here there is a normal 
appearance time for the arterial curve, but asymmetry of the downslope (indicated as ‘a’).. Reproduced with 




In addition to the qualitative shunt detection, the software also provides a quantitative estimate 
of the ratio between the pulmonary to systemic blood flow (Qp/Qs). This is derived via 
algorithms based upon the observed changes in the shape of the dilution curve due to the 
presence of anatomical shunts.8,9  It compares the predicted area under a normal dilution curve 
with the area of the observed dilution curve. In right to left shunts the observed area of the 
‘hump’ represents part of the indicator that bypasses lungs. Thus, the ratio of the rest of the 
area (from indicator that passed the lungs) to total area (including the ‘hump’) that was recorded 
in arterial gives a Qp/Qs ratio less than one. In the case of left to right shunt, the observed area 
under the curve is larger than the area of the predicted normal dilution curve due to the 
presence of saline recirculation, resulting in an abnormally extended downslope. Thus the ratio 
of observed area under dilution curve to predicted area gives Qp/Qs ratio greater than one.  
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3.1.3 Markers of preload 
 
In addition to measuring CO and detection of anatomical shunts, TPUD also measures three 
novel static markers of preload (fig 2-4 in previous chapter) 2 : 
 
 
(i) Total end diastolic volume index (TEDVI) 
 
 It is the sum of the end-diastolic volumes of the atria and ventricles (fig 3-6). The calculation is 
based upon the assumption that the major spread of the arterial vs venous curve is due to the 
indicator traveling through the heart chambers. It is indexed to body weight and the expected 
range is between 6-10ml/kg. (For our research, the volumetric data was allometrically scaled to 
body surface area using a power of 1.38 (i.e. (m2)1.38 = m2.6) (see chapter 2); hence volumes are 
expressed as ml/m2.6 .10,11 






CO: cardiac output  
HR: heart rate and  
CHc: (CHart2  - CHven2 )1/2 
CHart  and CHven are chords (width of the curve at one-half the maximum height of the curve) 








TEDV =CO× (1.62HR + 0.77×CHc)




Figure 3-6 Changes in the blood saline concentration after indicator injection. ‘Y’ axis is the percent 
concentration of saline in the blood .’X’ axis is the time. The concentration of injected saline becomes stable 
within 40-60 seconds from the time of injection (H). MTTa is the time during which the indicator travels form 
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 (ii) Central blood volume index (CBVI) 
 
 This is the volume of blood between the injection site (central vein) and the recording site 
(artery). Blood in the heart, lungs, and large vessels contributes to the majority of CBV. It is  
indexed to body weight with an normal value  between 18-22 ml/kg (fig 2-4, 3-6). 




where   
CO: cardiac output  
MTTa: time during which the indicator travels from the venous sensor (injection site) to the 
arterial sensor 
MTTv: mean transit time of the venous injection recorded by the venous sensor and 
MTTt: mean transit time during which the indicator travels in the arterial loop before reaching the 
sensor. It is calculated as MTTt =  where Va is the known priming volume of the tubing 
segment and Qa is the known blood flow in the AV loop. 
 
 
 (iii) Active circulating volume index (ACVI) 
 
 This is defined as the volume of the blood in which the indicator mixes in one minute from the 
time of injection. ACVI is also indexed to body weight and the typical values are between 40- 60 
ml/kg. ACV is calculated from the following formula: 
 
 
     
where   
Vinj: volume of the injected saline in millilitres and  
H: new level of isotonic saline concentration in blood at the end of the first minute after the 
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3.1.4 Main limitations of TPUD method 
 
There are three major limitations for TPUD as described below: 
 
1) The presence of intra or extra cardiac shunts may cause abnormalities of the dilution curve. 
9,12 This may affect the accuracy of the CO measurement. However, this will be apparent on 
inspection of the dilution curve and the software also produces a related message on the 
monitor screen to notify the user. 
 
2) TPUD is as prone to similar indicator loss errors as any other indicator dilution techniques.  
Though the venous sensor accurately measures the volume of the indicator injected, however, 
the loss may be due to multiple other reasons past the venous sensor for example dead space 
of the venous catheter or abnormal lung perfusion. This leads to loss of indicator resulting in 
overestimation of CO. Measurements involving central blood volume may also be inaccurate for 
the same reasons.  
 
3) Although the amount of isotonic saline used as an indicator is small (0.5-1 ml/kg, max 30 ml) 
however, repeated measurements may lead to considerable volume injection and volume 
overload. This is especially relevant in small post cardiac surgical neonatal patients where 
cardiac function  may be sensitive to excessive preload. 
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3.2 Pressure recorded analytical method (MostcareTM, Vytech Health, 
Padova, Italy) 
 
Pressure recording analytical method (PRAM) is a minimally invasive, continuous monitoring 
(beat to beat) system based upon pulse contour analysis. Measurement involves connecting the 
pre-existing arterial line to the PRAM monitor via a standard disposable pressure transducer 
and a dual output electronic module. One output is fed into the standard bedside monitor, while 
the other one is connected to the PRAM monitor. The arterial pressure tracing is checked 
beforehand to exclude artefacts and ECG is monitored to confirm sinus rhythm.  
 
 
3.2.1 Background and Description of PRAM technique for measuring 
cardiac output 
 
Pulse contour methods convert pulse pressure to SV from the area under the pulse systolic 
portion of the pressure wave (i.e., from the start of the upstroke [aortic valve opening] to the 
dicrotic notch [point of aortic valve closure]) represented by ‘P’ in fig 3-7. This was based upon 
the classic ‘2 element Windkessel model’ (see fig 1-6 on page 52) described initially by Otto 
Frank in1899 13 and further refined by Westerhof 14   and Stergiopulous 15   to a 3 and 4 element 
model introducing impedance and arterial inertance respectively. This improved the accuracy of 
the algorithm for stroke volume estimation form the arterial pulse pressure curve.  
  





Figure 3-7 Arterial pressure waveform. ‘P’ is the pulsatile and ‘C’ is the continuous phase during systole. 
Reproduced from: Romano SM and Pistolesi M. Crit Care Med 2002; 30:1834-1841.16 
 
 
PRAM is a pulse contour based method based upon the physics theory of perturbations, which 
states that each physical system under the effects of a stress tends to react to reacquire its own 
condition of stability (i.e. the situation of minimal energy required). PRAM also makes an 
assumption that volume changes in any vessel occur mainly because of the radial expansion in 
response to variations in pressure.17 The interaction between these pressure and volume 
changes of arterial system is influenced by four main physical variables. Firstly, the force of the 
blood ejection generated by the left ventricle, second is the arterial impedance counteracting the 
pulsatile blood inflow, third is the arterial compliance and lastly, the peripheral vascular 
resistance generating backward reflections of the pressure wave depending on the heart rate 
and physical characteristics like diameter and stiffness of the arterial vessels downstream.16 All 
these variables are dynamic, interdependent and require simultaneous evaluation for the 
estimation of CO. The relationship between all these factors is taken into account by a factor ‘Z’.  
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Estimation of ‘Z’ either by predicted data from unrelated in vitro measurements or by calibration 
with an independent measurement of SV will enable measurement of stroke volume, hence CO.  
 
 PRAM differs from the rest of the pulse contour analysis methods in the following ways:  
 
Firstly, it takes into account both the pulsatile and continuous contributions (P+C) of the physical 
forces underlying the relationship between pressure curve morphology and blood flow while 
estimating CO (fig 3-7).  
 
Secondly, ‘Z’ is measured directly from the morphology of arterial pressure waveform without 
the use of predicted data or external calibrations against a reference method. 
 
 ‘Z’ is calculated by PRAM as equal to   
where  
 (mmHg/sec): the analytical description of the pressure wave profile as changes of pressure 
(P) with time (t) along each cardiac cycle 
K: dimensional factor inversely related to the instantaneous acceleration of the vessel cross-
sectional area.  
 
‘K’ is calculated from the ratio between the expected (under physiologic conditions) and 
measured mean blood pressure. The denominator is variable and can change with each cardiac 
cycle. As a result, ‘K’ may vary with every cardiac cycle. The reference constant value at the 
numerator determines the magnitude of deviation from the normality of the mean arterial 
pressure. Two different values of the expected mean blood pressure are considered for 
estimation of ‘K’ depending upon the catheter position [central (100 mm hg) or distal artery (90 
mm Hg)].18 The value of ‘K’ will be affected by the presence of physical factors affecting the 
pressure wave transmission  for example low stroke output from the left ventricle or backward 
wave reflections from the peripheral vasculature. This incorporates the deviation from 
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A (mmHg x seconds): the whole area under the systolic portion of the pressure curve 
represented by ‘P+C’ (fig 3-7).  
 
Estimation of P/t from the pressure wave assumes a dynamic equilibrium among various factors 
at the point of peak systolic pressure and the pressure at the dicrotic notch leading to arterial 





Psys, Pdia, Pdic and Pinst are peak systolic pressure, diastolic pressure, pressure at the dicrotic 
notch and pressure at any given instant of time respectively. 
 tsys is the systolic time, t1 is the total time of the cardiac cycle, and ( t1-tdic ) is the diastolic 
time. tinst is the time at any given instant. 
 
represents the impulse generated by the left ventricular output in the vessel  where 
the pressure is recorded, 
 
is the pressure over time at the dicrotic notch mainly affected by the arterial properties 
like compliance, impedance and resistance .  
 
Variations in the downslope between Psys and Pdic as a result of backward reflections of the 
pressure wave from the periphery affects the characteristics and appearance of dicrotic notch 










(t1 − tdic )
−
Pinst




(t1 − tdic )
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on the pulse wave. accounts for the changes in the morphology of the pressure curve 
as a result of these back reflections. Pinst is the pressure value occurring at the time (tinst) of the 
relative maximum value of the second derivative of the pressure curve between Psys and Pdic . 
 
In addition, PRAM differs from other pulse contour methods in the frequency of sampling of data 
from the arterial tree. PRAM samples data at 1000Hz 19 as opposed to 100 Hz by other 
methods. This high frequency is considered useful for improving the accuracy of calculation of 
‘Z(t)’ and stroke volume. The details of PRAM methodology is described in detail by Romano 
and Pistolesi.16 
 
Calamandrei et al compared PRAM with Doppler echocardiography for measurement of CO in 
forty eight mechanically ventilated children. They reported significant correlation between the 
two methods (r2=0.99, p<.01). The mean bias reported was 0.12+ 0.27 l/min.20  
 
Similar results were reported by Romano and Pistolesi in their study involving twenty two adult 
patients comparing PRAM with Fick’s and thermodilution method.16  
 
 
3.2.2 Dynamic markers of fluid responsiveness measured by PRAM  
 
In addition to measuring SV, PRAM also measures three dynamic markers of fluid 
responsiveness - systolic pressure variation (SPV), pulse pressure variation (PPV) and stroke 
volume variation (SVV). Dynamic markers are measured on a beat-to -beat basis and are based 
upon the cyclical changes of the loading conditions of both the ventricles as a result of positive 
pressure ventilation. The magnitude of these respiratory changes can be used as a guide to 
predict fluid responsiveness.21 A detailed description with literature review regarding the utility 
and limitations of these markers in predicting fluid responsiveness is described in Chapter 2.  
  
Pinst
(t1 − tinst )
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3.2.3 Measurement of arterial dP/dt max  
 
Arterial dP/dtmax can be estimated from the pressure waveform obtained via peripheral arterial 
catheters. This is the maximum ascending slope of the arterial pressure waveform (fig 2-12 in 
chapter 2). This has been shown to correlate well with invasively measured intra-ventricular 
dP/dtmax in children 22  and act as a surrogate marker for estimating left ventricular contractility. 
 
 PRAM is able to provide an estimation of the arterial dP/dtmax continuously from the  arterial 
pressure waveform. The only study estimating  dP/dtmax by PRAM appears valid (despite being 
inaccurate for SVI) when compared to dP/dtmax derived from echocardiogram in adults.23 A 
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3.2.4 Limitations of PRAM 
 
PRAM is prone to similar sources of error(s) as other pulse contour methods. 
 
Quality of the recorded arterial pressure waveform: Since the estimation of SV is dependent 
upon characteristics of arterial pressure waveform, any factors affecting the quality of this 
recording will directly affect the accuracy of CO estimation. These may be either patient related 
or technical problems.  
 
Arrhythmias, valvular or vascular disease process for example aortic regurgitation, aortic 
dissection or peripheral arterial stenosis can lead to inappropriate signal acquisition affecting the 
accuracy.  
 
Technical factors commonly seen in intensive care settings or operating rooms are generally 
due to an inadequate response of the elastic fluid filled catheter and the pressure transducer 
system. This leads to under or over damped trace resulting in incorrect estimation of arterial 
impedance and stroke volume. Majority of these factors can be overcome by a careful 
evaluation of the arterial pressure waveform by the attending physician. 
 
The accuracy of measured dynamic markers in the prediction of fluid responsiveness is further 
compromised in situations with small pleural pressure changes during the respiratory cycle for 
example spontaneous breathing patients, open chest conditions 24,25 or ventilation with small 
tidal volumes.26 In addition, the influence of vasoconstrictors 27 and abdominal hypertension 28  
on the utility of these markers is still debated.  
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Chapter 4  Research Methodology 





4.1.1 Validation study for PRAM   
 
The hypotheses were: 
 
 (i) PRAM  is as accurate as  TPUD for measuring CO in children. 
  
(ii) PRAM is able to  accurately track changes in CO after routine therapeutic interventions with 
the use of polar plots. 
 
 
4.1.2 Predicting fluid responsiveness from static and dynamic markers 
measured  by  TPUD  and  PRAM  respectively  and  study  the effect of 
baseline contractility on stroke volume in response to fluid bolus 
administration 
 
The hypotheses were:  
 
(i) Novel static and dynamic markers measured by TPUD and PRAM respectively are able to 
predict for fluid responsiveness in critically ill children in PICU setting.   
 
(ii) Baseline myocardial contractility has a significant influence on the stroke volume response 
after fluid bolus administration. 
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4.1.3 Accuracy of TPUD method for identifying small anatomic shunts 
 
We hypothesise that TPUD technique is accurate for identifying small anatomical shunts when 
compared with standard echocardiography. 
 
 
4.2 Study design and population 
 
 The study was a prospective, non-randomised, single centre study conducted within a 20 bed, 
multi-disciplinary paediatric intensive care unit, at Evelina London Children’s Hospital, London, 
United Kingdom.  
 
 
Research application and ethics approval 
 
The research idea was first presented to a local research group for peer review. Once 
approved, a formal application was made to the hospital research and development board on an 
online portal (Integrated research application system) with minor modifications based upon 
comments from peer review group. This was accompanied with a detailed study protocol, parent 
and child (elective admission only) information leaflets (see appendix), consent form (see 
appendix) and an application for research ethics approval.   The regional ethics committee 
(South East London REC2, 10/H0802/62) approved the study after a short interview process.  
 
 
Database for data capture 
 
An electronic database was created on Microsoft access to capture the clinical data. The data 
was first recorded on paper printouts of the database at the bedside. This was due to two 
reasons (a) unavailability of computers at each bed space and (b) laptops will occupy more 
space in addition to the two existing monitoring devices (TPUD and PRAM) at the bed side and 
   
 182 
may limit accessibility to the patient. The data was entered into the electronic database within 
24 hours of conclusion of the case. Another research fellow checked all the data entries to 
minimise errors during transcription. Data from TPUD and PRAM was downloaded in an ‘Excel’ 
file through a data transfer module or a data card respectively. All data was kept on hospital 
computers and was password protected. 
 
 
Case recruitment and consent 
 
Patients fulfilling or likely to fulfil the inclusion criteria were identified during their stay in PICU or 
from the cardiac wards through daily operating lists. Parents were approached by a member of 
the research team (comprising of two research fellows and a nurse) for obtaining written 
informed consent for the study. All the members of the team were GCP (good clinical practice) 
trained. The timing of the consent depends upon the nature of the admission to the intensive 
care unit. For elective admissions (for example cardiac surgical patients), parents were 
approached during pre- operative assessment, which is typically between 24-72 hours before 
the day of the surgery in majority of the cases in our institute. Consent was obtained as soon as 
possible after the admission to intensive care unit in emergency cases once the patient qualifies 
as per the inclusion criteria (mentioned below). Data was collected within the first 24 hours 
following admission to the intensive care unit. 
 
 
Inclusion and exclusion criteria 
 
Inclusion criteria were (i) weight >2kg, (ii) age <16 years and  (iii) pre-existing arterial and 
central venous lines.  
 
Children with (i) significant valvular regurgitation, (ii) large anatomical shunts, (iii) extreme 
haemodynamic instability, or (iv) arrhythmias (v) residual left sided obstructive lesions (e.g. 
aortic stenosis, coarctation) were excluded from the study. Severe valvular regurgitation and 
large anatomical shunts were excluded by trans thoracic echocardiography. Extreme 
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hemodynamic instability was defined as either of the following occurring in the 30 minute period 
before advanced hemodynamic variables were measured: (a) ongoing fluctuations in the 
bedside hemodynamic variables of heart rate and/or blood pressure and/or central venous 
pressure greater than approximately 20% of baseline, or (b) requirement for an increase in 
inotropic or vasopressor support, greater than an increment of 5 mcg/kg/min for dopamine or 
0.05 mcg/kg min for adrenaline or noradrenaline. All children had continuous ECG monitoring 





A total of one hundred, mechanically ventilated children (64 males) were enrolled into the study 
between September 2010 to May 2012. The median (IQR) age and weight were 18 (6-48) 
months and 10 (5.6 - 15) kg, respectively.The majority of patients enrolled were post cardiac 
surgery with different aetiologies. The patient diagnostic characteristics are shown table 4-1. 
 
The number of participants for the validation of PRAM  (48 children ) and determination of 
accuracy of TPUD for detection of small anatomical shunt (73 patients) were subset of the total 
study population of 100 children recruited to assess the predictive ability of static and dynamic 
markers for fluid responsiveness. Children were enrolled consecutively (after consenting) as 
there was no randomisation. 
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Table 4-1 Patient diagnostic characteristics (all patients). 
    
Diagnosis Number of Patients 











VSD: Ventricular septal defect; TCPC: Total cavopulmonary connection; 
TOF: Tetralogy of Fallot; AVSD: Atrioventricular septal defect; 
TAPVD: Total anomalous pulmonary venous drainage; 
CoA: Coarctation of aorta. 
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4.3 Study protocol 
 
The following section provides a brief overview of the study protocols for the three research 
aims listed before. A more detailed description of the protocol including statistical methods for 
each of the studied aims is described in individual corresponding chapters 5-7.  
 
Study protocol for: 
(i) Validation study for PRAM and  
(ii) Assessment of the predictive ability of the static and dynamic markers 
measured by TPUD and PRAM respectively, for fluid responsiveness 
 
Paired haemodynamic measurements using TPUD and PRAM were made as soon as possible 
after the patient was admitted to the PICU. Baseline demography and physiological data were 
also collected. 
 
The paired measurements were made before (up to 15minutes) and after (up to 30 minutes) 
therapeutic interventions aimed towards augmentation of cardiac output (for example 10ml/kg of 
0.9% Saline or Hartmann’s solution over 20 minutes, initiation or augmentation of dose of 
inotrope). The attending physician made the decision regarding the timing and choice of 
intervention on the basis of the available clinical information. They were blinded to the advanced 
haemodynamic measurement data.  
 
An average of at least two consecutive TPUD measurements were taken. A third measurement 
was only obtained if the shape of the injection or dilution curves was unsatisfactory (fig 3-3,) or if 
the variation between the two measurements was greater than 20%. In addition to CO and CI, 
data was also recorded for the three novel preload markers TEDVI, CBVI and ACVI measured 
by TPUD. 
 
PRAM measurements could not be obtained exactly at the same time as the TPUD 
measurements required interruption of the arterial line. Thus, an average of the continuous 
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PRAM measurements (CO, CI, PPV, SPV, SVI and dP/dtmax) was obtained for 3 minutes 
before and after the time corresponding to the TPUD measurements for comparison.  
The study protocol(s) is shown in fig 4-1. 
 
The set of paired measurements was repeated approximately 5-20 minutes after initiation of CO 
augmenting interventions (fluid bolus administration or initiation or increase of inotropic therapy). 
A positive response was described as an increase in stroke volume index ≥15% after the fluid 
bolus or change in inotrope therapy. 
 
Repeated sets of paired measurements on these patients enabled (i) comparison of  the cardiac 
output and index measured simultaneously by TPUD and PRAM and (ii) assessment of  the 
ability of PRAM to track changes in CO in response to these interventions. A maximum of five 
combined sets (pre and post intervention) were taken on each patient during the course of their 
admission.  
 
There was a time lag of approximately 8-10 minutes from the decision to administration of CO 
augmentation therapy due to the TPUD and PRAM measurements. Hence, measurements were 
only performed for episodes where the attending physician considered this time lag to be safe, 
taking the clinical condition of the child into consideration. However, on few occasions, child’s 
clinical condition warranted immediate treatment and hence measurements were not performed. 
We did not collect the data to quantify such events. 
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Figure 4-1 Study protocol for (a) validation of PRAM and (b) assessment of the predictive ability of the static 
and dynamic markers for fluid responsiveness. 
 
 
 (ii) Study protocol for assessment of accuracy of TPUD for diagnosis of 
anatomic shunt 
 
TPUD measurements were performed simultaneously with 2D echocardiography in 73 children. 
TPUD diagnosed and classified shunts as either right to left or left to right or bidirectional 
depending upon the characteristic changes in the dilution curve as explained in chapter 7.  
 
In addition to the qualitative analysis, TPUD software also provided a quantitative estimate of 
the ratio between the pulmonary to systemic blood flow (Qp/Qs) as described in chapter 3. 
Briefly, this is derived via algorithms based upon the observed changes in the shape of the 
dilution curve due to the presence of anatomical shunts.1-3 Comparing the predicted area under 
a normal dilution curve with the area of the observed dilution curve derives Qp/Qs.  
 
Procedure for validating shunt detection 
 
Echocardiography was considered as the reference method for shunt detection in our study. An 
experienced operator performed a single, detailed 2D echocardiographic scan when clinically 
indicated. Conventional echocardiographic methods were employed to detect residual shunts 
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including cross-sectional echocardiography coupled with pulsed wave, continuous wave and 
colour flow Doppler assessment of any residual shunts. These techniques allowed 
determination of direction of the shunt (right to left, left to right or bidirectional) but they cannot 
reliably quantify Qp/Qs in this setting. The operator described the  shunt size as: 
“tiny” if there was only a narrow jet of flow on colour flow Doppler which was not visualized on 
cross-sectional imaging alone,  
“small” if the shunt jet appeared wider than 2mm and if a residual shunt could be visualized 
without colour flow Doppler. 
 “moderate to large”, where a shunt was not pressure restrictive and which appeared 
hemodynamically significant by volume loading of cardiac chambers.  
 
In case of poor image quality due to absence of good acoustic windows in some of our patients 
(immediate post cardiac surgery) two experienced observers, blind to the TPUD results, agreed 
the final echocardiographic findings.  
 
All TPUD measurements taken for different reasons within one hour on either side of the 
echocardiogram were considered as eligible for shunt detection (fig 4-2). A minimum of one set 
of TPUD measurements (on either side of an hour of echocardiogram) was required as part of 
the study protocol.  
Additional sets of TPUD measurements were also performed when therapeutic manoeuvres 
were made for clinical indications within the stated time window (for example, administration of a 
fluid bolus or addition of a vasoactive agent).  
Each set of TPUD measurements required generation of good quality dilution curve. In case the 
quality of the curve is compromised due to any reason (see fig 3-3 on page 160), indicator 
injection was repeated until at least two analysable curves were produced. Ultrasound dilution 
was considered to have identified a shunt only if two or more measurements within a set 
suggested presence of the shunt. In all cases, operators performing both echocardiography and 
TPUD were blinded to the results from the other technique. 
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   Figure 4-2 Study protocol for detection of anatomical shunt by TPUD. 
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4.4 Research publications and presentations 
 
Various aspects of the work have been presented at various national and international platforms 
enabling sharing of our findings and research ideas with the scientific community with similar 
interests. The details of the presentations and publications arising as a result of this research 
study are listed below: 
 
Publications 
(i) Saxena R, Steeley S, Durward A, Murdoch I and Tibby S Predicting fluid responsiveness in 
100 critically ill children: the effect of baseline contractility.  
(Intensive Care Med 2015 Dec;41(12):2161-9. doi: 10.1007/s00134-015-4075-8) 
 
(ii) Saxena R, Durward A, Murdoch I and Tibby S. Accuracy of transpulmonary    ultrasound 
dilution (co-status™) for identifying anatomic shunts.  
 (J Clin Monit Comput. 2015 Jun; 29(3):407-414 .DOI: 10.1007/s10877-014-9618-y. PMID: 
25240251) 
 
(iii) Saxena R, Durward A, Murdoch I and Tibby S. Comparison between Transpulmonary 
ultrasound dilution and Pressure recording analytical method for measuring Cardiac output in 
children.   





 (i) Saxena R , Durward A, Murdoch I and Tibby S. Prediction of stroke volume response    
 to  fluid bolus in 100 children. Poster presentation at 33rd International Symposium    
 on Intensive Care and Emergency Medicine, Brussels, March 2013. 
(Abstract: Crit Care 2013, Volume 17 (Suppl 2): S78) 
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(ii) Saxena R, Durward A, Murdoch I and Tibby S Accuracy of transpulmonary ultrasound 
dilution (CO-Status™) for identifying anatomic shunts. Short oral presentation at 
European Society of Paediatric and Neonatal Intensive Care Meeting, Hannover, Germany, 3 
Nov 2011. 
(Abstract: Intensive Care Med 2011, Volume 37 Supplement 2: S345)  
 
(iii) Saxena R, Durward A, Murdoch I and Tibby S. A comparison between novel static   and 
dynamic markers of fluid responsiveness - preliminary data from 47 children – Oral presentation 
at European Society of Paediatric and Neonatal Intensive Care Meeting, Hannover, Germany, 3 
Nov 2011. 
(Abstract: Intensive Care Med 2011, Volume 37 Supplement 2: S344) 
 
(iv) Saxena R, Durward A, Murdoch I and Tibby S. Comparison between Transpulmonary 
ultrasound dilution and Pressure recording analytical method for measuring cardiac 
output in children. Oral presentation at the European Paediatric  Cardiac Intensive Care 
Society Meeting, Cambridge, UK, September 2011. 
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Chapter 5 Pressure Recording Analytical Method for 
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Pressure Recording Analytic Method is a novel, arterial pulse contour based method for 
measuring cardiac output (CO). Validation studies of PRAM in children are few, and have not 
assessed both absolute accuracy and ability to track changes in CO across a broad case mix. 
We aimed to compare CO as measured by PRAM with that using a transpulmonary dilution 




Forty eight, mechanically ventilated children with a median (interquartile) weight of 10.7 (5.5 - 
15) kilograms with arterial and central venous catheters in situ were studied. Cardiac output 
(CO) was measured simultaneously using PRAM and the comparator method, transpulmonary 
ultrasound dilution (TPUD). Measurements were repeated before and after therapeutic 




 In total, 210 paired measurements were compared. The mean (SD) CO was 1.9 + 1.2 L/min 
with TPUD as compared to 1.92 + 0.5 L min-1 using PRAM. The mean bias was 0.02 L/min with 
wide limits of agreement: + 2.21 L min-1, giving a percentage error of 116%. The concordance 
between PRAM and TPUD for measuring changes in CO was also poor, with only 37% of 




 There is an unacceptably poor agreement between TPUD and PRAM. We do not recommend 
the use of PRAM for measuring CO in critically ill children with the current algorithm. 
  




Cardiovascular organ failure is common in critically ill children.1 2 Compared to adults, children 
manifest both a higher incidence of cardiovascular dysfunction, and greater variability in 
haemodynamic status during resuscitation; furthermore, these changes can occur rapidly.3 Early 
detection of cardiovascular insufficiency in high-risk patients may reduce morbidity and 
mortality, by guiding the timely application of appropriate therapy.4 5 However, an accurate 
assessment of cardiovascular status requires advanced haemodynamic monitoring, including 
measurement of cardiac output (CO).6 7 This is reinforced by the finding that CO cannot be 
estimated clinically, and deleterious changes in CO can precede changes in other 
haemodynamic variables.8 9 
 
Although a variety of techniques for CO measurement are available in paediatric patients, there 
is growing interest in continuous methodologies based upon arterial pulse wave analysis. These 
have the obvious advantage of utilising a pre-existing arterial line; in addition, not all require 
external calibration.10 However, concerns have been raised about the accuracy of these 
methods, particularly during periods of haemodynamic instability.11 12 
 
Pressure recording analytic method (PRAM) is a relatively novel arterial pulse wave method of 
CO measurement.13 In contrast to other pulse contour techniques, PRAM is based primarily 
upon detailed morphological analysis of the pressure waveform, including identification of 
pulsatile and non-pulsatile systolic pressure-time areas together with an estimation of vascular 
impedance. There are several adult and animal validation studies of PRAM; however there is 
paucity of literature regarding its use in paediatrics.14 15 
 
With this in mind, we aimed to validate PRAM in a heterogeneous group of critically ill paediatric 
patients, by comparison with a transpulmonary dilution method for CO measurement. The latter 
have recently been described as approaching a gold standard for bedside paediatric 
measurement.16 Our aims were twofold: first to compare absolute values for the two techniques 
via Bland Altman analysis, and second to evaluate whether PRAM could track changes in CO 
after routine therapeutic manoeuvres, via use of Polar plots. 17 





This prospective, single centre, observational study conducted within a 20 bed multi-disciplinary 
paediatric intensive care unit. The study was approved by the regional ethics committee (South 
East London REC2, 10/H0802/62) and written informed consent was obtained from all parents 
or legal guardians. 
 
Forty eight, mechanically ventilated children (32 males) were enrolled during September 2010 
to October 2011, of whom 78% were also receiving inotropic support. The median (IQR) age 
and weight were 17.0 (4.5 – 47.3) months and 10.7 (5.5 - 15) kg, respectively. The majority of 
patients were admitted following cardiac surgery (table 5-1), and data were collected within the 
first 24 hours following admission. Inclusion criteria included presence of arterial and central 
venous lines. Children with significant valvular regurgitation, extreme haemodynamic instability, 
large anatomical shunts, arrhythmias and residual left sided obstructive lesions (e.g. aortic 
stenosis, coarctation) were excluded from the study.  
 
Table 5-1 Patient diagnostic characteristics for validation of PRAM 
 
Diagnosis Number of Patients (%) 
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VSD: Ventricular septal defect; TCPC: Total cavopulmonary connection; AVSD: Atrioventricular septal 
defect; TOF: Tetralogy of Fallot; TAPVD: Total anomalous pulmonary venous drainage. 
 
 
5.3.1 Transpulmonary Ultrasound dilution technique 
 
Transpulmonary ultrasound dilution (TPUD) (CO-StatusTM–Transonic systems, Ithaca, NY, 
USA) is an indicator dilution method. It utilises an extra-corporeal arterio-venous loop and two 
reusable ultrasound sensors: one on each side of the loop. A roller pump provides a constant 
blood flow rate in the AV loop. Normal saline (0.5 - 1ml/kg, max 20ml) at body temperature is 
used as an indicator. The transit times of the ultrasound beam crossing the extracorporeal tube 
change when saline is injected, in proportion to the amount of dilution of blood by the saline (the 
typical ultrasound velocities through 0.9% saline and blood are 1533 and 1580 m/sec, 
respectively), which are used to calculate CO via the Stewart-Hamilton equation.18 This is an 
accurate and validated technique for measurement of CO in children and paediatric animal 
models.19-21 The theory and in vitro validation of this technique is reported in detail by Krivitsky 
and co-workers.22  
 
 
5.3.2 Pressure recorded analytical method 
 
PRAM (Mostcare®- Vytech Health®, Padova, Italy) is a minimally invasive continuous (beat to 
beat) monitoring system utilising a form of pulse contour analysis. Measurement involves 
connecting the pre-existing arterial line to the PRAM monitor via standard disposable pressure 
transducer (Edwards life sciences, Irvine, CA, USA) and a dual output electronic module 
(Agilent, Technologies, Germany). One output is fed into the standard bedside monitor, while 
the other is connected to the PRAM monitor. All the arterial pressure tracings were checked 
beforehand to exclude artefact. The ECG was monitored to confirm sinus rhythm. A detailed 
description of the PRAM technology is found elsewhere.23 
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5.3.3 Study Protocol 
 
Measurements were made as soon as possible after patients were admitted to the PICU (all 
within 24 hours of admission). Baseline demographic and physiological data were collected at 
the time of CO measurement. The study protocol is shown in figure 4-1. 
 
Paired TPUD and PRAM measurements were made as follows: Two consecutive TPUD 
measurements were made, and the dilution curves inspected. If the shape of the injection or 
dilution curves were unsatisfactory (see figure 3-3), or if the variation between the two 
measurements was greater than 20%, a third measurement was obtained. The readings were 
than averaged. This process typically took 3-5 minutes. PRAM measurements could not be 
obtained exactly at the same time, as the TPUD measurements required interruption of the 
arterial line. Thus, we averaged the continuous CO from PRAM for 3 minutes before and after 
the time corresponding to the TPUD measurements. Thus, a complete set of comparative 
measurements took approximately 10 minutes. Heart rate was monitored continuously and non 
invasive blood pressure measurement performed every minute to ensure haemodynamic 
stability during this 10 minute period. 
 
We performed repeated comparisons (as above) when patients received therapies likely to 
augment CO, such as fluid bolus administration or initiation of vasoactive medications. By taking 
repeated measurements on patients, we were also able to assess the ability of PRAM to track 
changes in CO. 
 
5.3.4 Statistical Methods 
 
Values for CO are reported as mean + SD. Repeatability of each technique is reported via the 
coefficient of variation (standard deviation / mean, expressed as a percentage). Agreement 
between the two methods for measuring absolute values of CO was quantified using Bland 
Altman analysis.24 Bias was defined as the mean difference between the two methods (PRAM 
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minus TPUD). Limits of agreement were calculated as mean bias + 1.96 SD of the bias, 
adjusted for multiple measurements per patient.24 Percentage error was calculated as (1.96 SD 
of bias / mean of reference method). We stipulated that the acceptable limits of agreement 
should be up to + 26%. This was derived using animal data from de Boode and colleagues, who 
demonstrated a combined precision error for TPUD and surgically placed flow probes of 
13.9%.21 Assuming a precision of approximately 5% for flow probes yields a likely precision for 
TPUD of 13% (√[13.92 – 52]).25 If we stipulate that PRAM should be at least as accurate as 
TPUD, we thus expect an upper limit for the combined limits of agreement of + 26%. 
 
Agreement between the two methods for tracking changes in CO (ΔCO) was quantified using 
polar plots.16 This methodology is illustrated briefly in figure 5-1, and in more detail elsewhere.17 
26 After exclusion of data points representing small changes in CO (i.e. vectors less than 10% of 
the mean Δ CO, equating to changes of less than 0.2 L min-1 in our study), we quantified 
tracking in two ways. First, acceptable calibration was defined as an angular mean bias of less 
than ± 5o 17. Second, we reported the percentage of data points lying within radial limits of ± 30o 
from the polar axis. This area should contain approximately 95% of the data points if the test 
method is able to track changes in CO accurately. 
 
Statistical analyses were performed using Stata v11 (StataCorp Texas), Microsoft Office Excel 
2007 and polar plots were created using Sigmaplot 8.02 for Windows (Systat Software, Inc, San 
Jose, CA). 
  




Figure 5-1 Explanation of Polar plots.(A) A hypothetical change in cardiac output (CO), as measured by two 
methods. If both methods concur exactly, the vector representing the change will lie on the line of identity. In 
example 1, the test method is over-reading the increase in CO compared to the reference method by 1 L 
min-1. The vector representing this relationship will have an angle θ1 that has a positive deviation from the 
line of identity. This is represented on the polar plot (B), whereby the angle θ1 is represented relative to the 
zero degree axis, and the size of the vector is relative to the hypotenuse of the change in CO from the two 
methods. For a decrease in CO, as seen in example 2, where the test method also overestimates the 
negative change in CO (θ2), the corresponding polar plot vector will be relative to the 180 degree axis (B). 
Good concurrence is represented by 95% of the points lying within an absolute deviation of + 30 degrees 
from the polar axis (0 to 180 degrees, blue dashed lines). It is also customary to exclude small changes in 
CO, identified as those lying within the circular zone of exclusion. Typically this boundary represents 
changes in CO that are less than 10% of the mean change (blue shaded circle). Here example 1 shows 





A total of 210 paired measurements using TPUD and PRAM, were compared in 48 children. Six 
children had two comparisons, 3 had three comparisons, 21 children had four and 18 patients 
had five or more comparisons. No child had more than eight comparisons. Repeated 
measurements on the same patient were made for the following reasons: fluid bolus (84%), 
administration of a vasoactive agent (8%) and extubation (8%). 
 
The mean CO with TPUD was 1.9 ± 1.2 L min-1 as compared to 1.9 ± 0.5 L min-1 using PRAM. 
For cardiac index, the values were 3.8 + 1.3 and 4.2 + 1.8 L min-1 m-2 for TPUD and PRAM, 
respectively. The mean (SD) coefficient of variation for TPUD was 5.7 ± 6%. To quantify 
haemodynamic stability across each measurement epoch, we also calculated the coefficient of 
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variation for PRAM (by comparing the mean readings of each 30 second epoch, including both 
pre- and post-TPUD readings: this gave a mean (SD) coefficient of variation of 9.1 ± 6.2%.  
 
Bland Altman analysis (figure 5-2) gave the mean bias of 0.02 L min-1, with wide limits of 
agreement of ± 2.21 L min-1 and a percentage error of 116%. The Bland Altman plot suggested 
presence of a systematic error, with PRAM over reading at lower CO and under reading at high 
CO (figure 4, r = 0.69).  
 
Since CO is a measure of total flow, which is influenced by patient size we repeated the 
analysis after normalisation to body surface area (i.e. cardiac index) to see if the error was 
influenced by high or low flow states. Here the mean bias was 0.95 L min-1 m-2 with very wide 
limits of agreement of ± 5.78 L min-1 m-2, and an overall percentage error of 143% (figure 5-3). 
This suggested a different type of systematic error, heteroscedasticity, which persisted even 
after log transformation (data not shown). 
 
The polar plots demonstrated a poor ability of PRAM to track changes in CO (figure 5-4). On 
average, PRAM followed the change in CO (mean angular deviation from polar axis of -5.4 
degrees), however only 36.6% of measurements fell within the polar limits of ± 30 degree. 
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Figure 5-3 Bland Altman analysis for cardiac index as measured by transpulmonary ultrasound dilution and 
PRAM. 
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Figure 5-4 Polar plot demonstrating agreement between transpulmonary ultrasound dilution and PRAM for 
tracking changes in cardiac output. The small, bold circle indicates the zone of exclusion, whereby changes 
in cardiac output are too small to assess accurately. Hence data points lying within this circle are 
disregarded. Elsewhere, good agreement in tracking change in cardiac output is measured by the proportion 





Our results demonstrate poor agreement between PRAM and TPUD, both in terms of 
measuring absolute CO (percentage error 116%) and tracking changes in CO (36.6% of 
measurements falling within polar limits). Our findings are at odds with the other two paediatric 
studies using PRAM. Calamandrei and colleagues compared PRAM with Doppler 
echocardiography in 48 children in a general PICU setting.14 They reported a mean bias of 0.12 
L min-1, with limits of agreement of ± 0.65 L min-1, giving a percentage error of 25%. Ricci and 
co-workers compared PRAM with pulmonary artery thermodilution in 25 cardiovascularly stable 
patients undergoing diagnostic cardiac catheterisation. Here the mean bias and limits of 
agreement were 0.2 ± 0.94 L min-1, with a calculated percentage error of 45%.15 
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There are a number of potential reasons for the discrepancy between our results and these 





 We used ultrasound dilution as the reference method, which although a novel technique, has 
been shown to be accurate in small patients. In a piglet model using pulmonary artery flow 
probes as the reference method (a true gold standard), de Boode showed that the percentage 
error for TPUD was 27% (mean CO 0.96 L/min).21 Similar accuracy (percentage error 24%) was 
shown in another swine model, using pulmonary artery thermodilution as the reference.27 In 28 
children undergoing cardiac catheterisation Crittendon compared TPUD with pulmonary artery 
thermodilution, again yielding a similar percentage error of 25.4%.19 We have no reason to 
suspect that TPUD is any less accurate in our study; this is further supported by our low 
coefficient of variation (5.7%). 
 
Case Mix and cardiovascular profiles 
 
 Our patient population contained potentially important differences to both prior paediatric 
studies. Ours was comprised primarily of children post cardiac bypass, a group not represented 
in either previous study.14 15 Our median patient age was approximately half that of Ricci (2 
versus 4 years). Despite having a similar age to that of Calamandrei, our median CO was 
approximately 30% lower (1.9 versus 2.7 L min-1), suggesting a low flow state, as is typically 
seen post cardiac surgery. We have no information on vasoactive agent usage between the 
three studies, but these are likely to be very different given the differing case mix. 
 
Our results do agree with recent adult studies. Paarmann and others compared PRAM with 
pulmonary artery thermodilution in 23 adult patients on the first post –operative day after cardiac 
surgery.28 They reported an error of 87% with wide limits of agreement of + 4.53 L min-1. Biais 
and colleagues, in a study involving 35 adult patients, compared PRAM with transthoracic 
echocardiography at baseline and after volume expansion.29 They showed a bias of -0.1 L min-1 
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and limits of agreement of 1.9 to -2.1 L min-1 with percentage error of 34% at the baseline. 
Similar to our results they also demonstrated PRAM to be unable to accurately track changes in 
CO (concordance rate of 60%). 
 
Our study has several possible limitations. Firstly, PRAM CO was not measured precisely at the 
same time as TPUD. Instead, PRAM readings were averaged 3 min before and after the time 
corresponding to the TPUD measurement. This was because the arterial line connection to the 
PRAM was interrupted during measurement of CO using TPUD. However, we believe that this 
is unlikely to have compromised our results due to unexpected haemodynamic instability, as the 
entire measurement period was brief (typically less than 10 minutes), PRAM readings were 
averaged pre- and post-TPUD and the average coefficient of variation for PRAM from each 
measurement period was 9.1± 6.2 %, which infers haemodynamic stability. The coefficient of 
variation for TPUD was 5.7 ± 6% which is in agreement with another study.30  
 
Secondly, we did not measure the arterial line dampening coefficient while using PRAM. This 
represents a potentially important limitation, as both under- and over-dampening have recently 
been shown to adversely affect the ability of PRAM to estimate CO.31 However, we are currently 
undertaking a follow on study evaluating factors that may affect accuracy of the PRAM 
algorithm, which includes measurement of the dampening coefficient. 
 
A final point to consider is that there may be inherent limitations with the use of continuous 
pulse contour methods unique to the paediatric population. These methods typically estimate 
stroke volume from the arterial pressure waveform taking into consideration vascular properties 
such as impedance, compliance and peripheral vascular resistance. However paediatric studies 
have shown that these vascular properties may be age dependent, and can change rapidly 
during the course of illness. 3 32 - 33 Furthermore measuring small values in tiny children may 








In conclusion, we found an unacceptable lack of agreement between TPUD and PRAM for 
measurement of paediatric CO in critically ill patients. PRAM was also not able to track changes 
in CO accurately as compared to the TPUD method. Hence we do not recommend the use of 
PRAM for measuring CO in critically ill children with the current algorithm. 
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Chapter 6 Predicting fluid responsiveness in 100 critically ill 
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Fluid overload is a risk factor for poor outcome in intensive care; thus volume loading should be 
tailored towards patients who are likely to increase stroke volume. We aimed to evaluate the 
paediatric predictive ability (stroke volume increase >15% after fluid bolus) of novel and 
established volumetric and dynamic haemodynamic variables, and assess the influence of 





We assessed 142 volume loading episodes (10 ml/kg crystalloid) in 100 critically ill ventilated 
children, median (interquartile) weight 10 (5.6 – 15) kg. Eight advanced haemodynamic 
variables were assessed using two commercially available devices. Systemic ventricular 




Overall, predictive ability was poor, with volumetric variables performing better than dynamic 
(area under receiver operating characteristic curves ranged from 0.53 to 0.67). The best 
predictor was total end diastolic volume index; however this did not increase in a consistent way 
with volume loading, with change post volume being weakly related to baseline values (r = -
0.19, p = 0.02). A multivariable model quantified the importance of contractility on stroke volume 
response. Children with high baseline contractility, (> 75th centile), typically achieved a positive 
stroke volume response when end diastolic volume values changed by 10 to 15 ml/m2.6, 
whereas patients with low contractility (< 25th centile), typically required end diastolic volume 









Current paediatric predictors of volume response perform poorly; prediction may be improved if 
baseline contractility is taken into account. 
 
Take home message 
The majority of advanced haemodynamic variables (volumetric and dynamic) have poor to 
moderate predictive ability in children in terms of the stroke volume response to fluid boluses. 
Baseline contractility is an important factor influencing patients’ response to fluid volume 
loading. A patient with poor baseline contractility will need to increase their end diastolic volume 
by an increment that is 3 to 4 times greater that of a patient with good contractility to be able to 
increase stroke volume >15%. 
 
Tweet 
Advanced haemodynamic variables are poor predictors of fluid response in critically ill children. 
This improves when contractility is factored in 
 
Keywords 
cardiac output, fluid responsiveness, contractility, paediatric 




Fluid resuscitation may increase cardiac stroke volume in critically ill patients with sub-optimal 
preload [1]. However, this carries risk, as overzealous fluid administration can lead to fluid 
overload with deleterious consequences on patient outcome 2–4. Approximately 40-60% of 
patients will typically respond to fluid therapy, by increasing cardiac output >10-15% 5, 6. Thus, 
the ability to predict which patients will respond may obviate the need for unnecessary fluid 
administration. 
 
The past two decades have witnessed development of several haemodynamic variables aimed 
at predicting fluid responsiveness 5 – 10. Broadly speaking, these are classified as static and 
dynamic. Static variables are typically volumetric, and estimate either (i) maximal ventricular 
volumes, found at end diastole, or (ii) an aspect of intravascular volume; both are commonly 
derived using indicator dilution techniques 11. Dynamic variables rely on the principle that 
cyclical changes in preload occur during the ventilatory cycle, which translate into changes in 
stroke volume via the Frank-Starling mechanism: the greater the change, the higher the 
likelihood of volume response. 
 
Early enthusiasm for the predictive ability of these variables has been tempered by later studies, 
which show a poorer performance when applied in normal clinical practice 12 – 14. This is likely for 
a variety of reasons, including low tidal volume ventilation, spontaneous respirations, 
arrhythmias, and heart valve regurgitation 12 – 14. However, two other haemodynamic factors 
which can compromise predictive ability require consideration. First, standardized volumes (e.g. 
10 ml/kg) of administered fluid may not produce equivalent alterations in preload between 
patients. This is due to variability in: (a) baseline blood volume, (b) mechanics of the venous 
vasculature (capacitance, compliance and resistance), (c) transthoracic pressure gradients, and 
(d) myocardial diastolic function 15, 16. Second, patients with diminished contractility will manifest 
a flatter gradient of the Frank-Starling curve, yielding smaller changes in stroke volume for a 
given change in preload 17, 18. 
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Prediction of fluid responsiveness remains relatively under-explored in the paediatric intensive 
care unit (PICU), perhaps due to the challenges of cardiac output measurement. To date, most 
studies are small (typically <50 patients), and thus potentially both underpowered and prone to 
type 1 error 5. None, to our knowledge, have addressed the two haemodynamic factors alluded 
to above. Thus, we aimed to evaluate volume responsiveness in a large PICU cohort (n = 100), 
using an accurate, indicator dilution method for cardiac output measurement. Our aims were 
three fold: 
 
(i) to evaluate the predictive ability (stroke volume increase >15% after fluid 
administration) of a range of static and dynamic variables derived using two 
commercially available devices; 
(ii) to document typical changes in volumetric variables after a constant fluid bolus (10 
ml/kg), and investigate factors associated with change in preload (end diastolic volume); 
(iii) to investigate whether the baseline myocardial contractile status influences stroke 




This prospective, non-randomized study was conducted within a 20-bed multi-disciplinary PICU, 
after ethics committee approval and parental informed consent. Detailed methodology is 
available in the electronic supplement. Briefly, haemodynamic measurements were made within 
24 hours of admission, timed to coincide with fluid bolus administration. Fluid boluses (typically 
0.9% saline or Hartmann’s solution at 10ml/kg of crystalloid over 20 minutes), were 
administered at the attending clinicians’ discretion, who were blinded to the advanced 
haemodynamic measurements. Variables were measured less than 15 minutes before, and up 
to 30 minutes after fluid administration.  
 
Standard haemodynamic variables included heart rate, arterial and central venous pressures. 
Advanced haemodynamic variables (table 1) were measured using two commercially available 
devices. The first, CO-StatusTM (Transonic systems, Ithaca, NY), uses an indicator dilution 
method: transpulmonary ultrasound velocity.19  A central venous injection of 0.9% saline (0.5 - 
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1ml/kg, max 20ml) is given, and blood is pumped through the arterial limb of an extra-corporeal 
arterio-venous loop. The principle involves saline diluting the blood in proportion to total blood 
flow (cardiac output), resulting in a similar proportionate change in transit time, and hence 
velocity, of an ultrasound beam passed across the arterial loop. From this, an ultrasound dilution 
curve is produced, and cardiac output calculated via the Stewart-Hamilton equation. In addition, 
several static volumetric variables are calculated from the curve properties (table 1 and online 
supplement).20 
 
The second device, Mostcare® (Vytech®, Padova, Italy) is a continuous system utilizing arterial 
pulse contour analysis (Pressure Recording Analytical Method, PRAM).21 This technology 
calculates beat-to-beat stroke volume via a custom algorithm, as well as a range of dynamic 
variables (table 6-1). Variability measures (e.g. pulse pressure variability) were averaged over 
30 seconds. 
 
A positive fluid response was described as an increase in stroke volume index (SVI) >15% after 
fluid bolus. We chose arterial dp/dtMAX as a measure of systemic ventricular contractility 
myocardial contractility, as this has correlates closely with intraventricular dp/dtMAX.22 Arterial 
load was as expressed as effective arterial elastance, using the Segers formula.23 Cardiac 
volumetric data were allometrically scaled to body surface area using a power of 1.38 (i.e. 
(m2)1.38 = m2.6); hence volumes are expressed as ml/m2.6. 24, 25 
 
Inclusion criteria were: (i) weight >2kg, (ii) age <16 years, (iii) pre-existing arterial and central 
venous lines. Exclusion criteria were: (i) significant valvular regurgitation, (ii) large anatomical 
shunts, (iii) residual left sided obstructive lesions (e.g. aortic stenosis, coarctation), (iv) extreme 
haemodynamic instability, (v) arrhythmias. Exclusions (i) to (iii) were screened using 
transthoracic echocardiography. Patients with repaired single ventricle physiology (i.e. post 
Fontan operation) were included, as this should not compromise indicator dilution based cardiac 
output assessment. However, the effect on intravascular volume estimation (which relies on 
mean transit times) is unknown: thus a sensitivity analysis was anticipated (with and without 
Fontan patients). 
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Units Modality Definition 
Stroke Volume Index SVI ml / m2.6 TPUD Volume of blood ejected from the heart during  
a single cardiac cycle 
Cardiac Index CI L / min / 
m2.6 




SVRI Dyne-sec / 
cm5 / m2.6  
TPUD Mean arterial – central venous pressure x 80 / 
cardiac index  
Effective Arterial 
Elastance 
EAE mmHg / ml 
/ m2.6 
TPUD Composite measure of arterial load, based on a 
2-element Windkessel model that includes 
peripheral resistance and total arterial 
compliance 
     
Static Variables     
Total End Diastolic 
Volume Index 
TEDVI ml / m2.6 TPUD Sum of end-diastolic volumes of the atria and 
ventricles 
Central Blood Volume 
Index 
CBVI ml / kg TPUD Volume of blood between the injection (central 
vein) and recording (artery) sites, which includes 




ACVI ml / kg TPUD Volume of blood in which the indicator (saline) 
mixes in one minute from the time of injection 
Maximum rate of 
systolic arterial 
pressure rise 
dp/dtMAX mmHg / sec PRAM Maximum rate of systolic arterial pressure rise 
     
Dynamic Variables     
Systolic Pressure 
Variation 
SPV % PRAM Difference between the maximum and minimum 
systolic pressures divided by mean systolic 
pressure during one mechanical breath 
Pulse Pressure 
Variation 
PPV % PRAM Difference between the maximum and minimum 
pulse pressures divided by mean pulse pressure 
during one mechanical breath 
Stroke Volume 
Variation 
SVV % PRAM Difference between the maximum and minimum 
stroke volume divided by mean stroke volume 
during one mechanical breath 








Data are expressed as mean (+ SD), or median (IQR). Bivariate comparisons were via unpaired 
t-tests. Models evaluating factors predicting and explaining fluid response were constructed 
using multilevel logistic and linear regression respectively (adjusted for multiple measurements 
within patients). Model fit was quantified by the area under the receiver operating characteristic 
curve (AUC) for logistic models, and adjusted r2 for linear. Collinearity was quantified via the 





Study Population and Measurements 
 
One hundred mechanically ventilated children, median (IQR) age 18 (6 - 48) months, and 
weight 10 (5.6 – 15) kg were enrolled between September 2010 and May 2012. The majority 
were admitted following cardiac surgery (electronic supplement table E2). Two subsets of this 
population have been published elsewhere 26, 27, and abstract results containing the first 47 
patients are reported in a systematic review.5 
 
A total of 169 paired (pre- and post-fluid) measurements were taken; no patient had > 5 
measurement  pairs. On review of the raw data from the dilution curves and PRAM outputs, 27 
measurements were rejected due to poor signal quality or data capture issues, leaving 142 
measurements for final analysis. Of these, 116 (82%) were taken while patients were receiving 
inotropic agents (predominantly milrinone), and 19 (13%) were receiving vasopressors. All 
patients were mechanically ventilated in SIMV mode (see table E3, online supplement). Muscle 
relaxants were not routinely used; however sedation level was titrated to minimise spontaneous 
respirations, as evidenced by concordance of the set SIMV and measured patient respiration 
rates (table E3, online supplement). None received renal replacement therapy. The overall 
response rate (SVI increase >15%) was 45.1% (64/142).  
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Prediction of fluid responsiveness 
 
There were no significant differences in baseline, basic haemodynamic data between 
responders and non-responders (table 6-2). However responders demonstrated lower stroke 
volumes and cardiac indices and higher systemic vascular resistance and effective arterial 
elastance.  
 
Responders had significantly different values than non-responders for all baseline static 
haemodynamic variables, but for none of the dynamic variables (table 6-2). Of relevance to the 
dynamic variables, there were no differences between the two groups in terms of expiratory tidal 
volumes: 12.0 + 3.3 versus 11.8 + 3.8 ml/kg (p = 0.73) or respiratory rate 18.4 + 2.2 versus 18.6 
+ 2.2 (p = 0.69). 
 
Despite these statistical differences, overall prediction was poor, with static volumetric variables 
generally performing better than dynamic variables in terms of AUC (table 6-2). The highest 
predictive value was demonstrated for TEDVI (AUC 0.67), with optimal prediction occurring at 
TEDVI  of 240 ml/m2.6. This yielded: sensitivity of 45.3%, specificity of 85.9%, and a correct 
classification rate of 67.6%. Prediction improved significantly when dp/dtMAX was added as a 
second predictor to TEDVI (AUC increased from 0.67 to 0.71, p = 0.02). 
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(N = 64) 
Non-
response 
(N = 78) 
P AUC 
(95% CI) 
Basic      
Heart Rate (bpm) bpm 141 (23) 135 (22) 0.10 _ 
Central venous 
pressure 
mmHg 8.8 (3.7) 9.1 (3.5) 0.66 0.53 
 (0.43 to 0.63) 
Systolic Blood 
Pressure 
mmHg 93 (21) 87 (18) 0.07 _ 
Diastolic Blood 
pressure 
mmHg 51 (11) 49 (10) 0.27 _ 
Advanced: Routine      
Stroke Volume Index  ml / m2.6 28 (8) 34 (12) 0.001 _ 




cm5 / m2.6 
1267 (624) 1067 (456) 0.03 _ 
Effective Arterial 
Elastance 
mmHg / ml / 
m2.6 
2.59 (1.1) 2.08 (0.89) 0.002 _ 
Advanced: Static      
Total End Diastolic 
Volume Index 
ml / m2.6 259 (75) 306 (82) <0.001 0.67 
(0.58 to 0.76) 
Central Blood Volume 
Index 
ml / kg 16.1 (3.6) 17.7 (5.1) 0.04 0.59 
(0.49 to 0.68) 
Active Circulating 
Volume Index 
ml / kg 46.2 (11.8) 53.3 (15.5) 0.003 0.64 
(0.55 to 0.73) 
Maximum rate of 
systolic arterial 
pressure rise 
mmHg / sec 1116 (392) 958 (346) 0.01 0.61 
(0.52 to 0.70) 
Advanced: Dynamic      
Systolic Pressure 
Variation 
% 12.6 (8.6) 10.4 (6.8) 0.10 0.59 
(0.50 to 0.69) 
Pulse Pressure 
Variation 
% 23.3 (11.2) 21.8 (9.4) 0.38 0.54 
(0.44 to 0.64) 
Stroke Volume 
Variation 
% 22.9 (6.8) 23.3 (7.7) 0.79 0.53 
(0.43 to 0.62) 
Data are presented as mean (SD), and refer to paired measurement episodes (n = 142). AUC = area under 
receiver operating characteristic curve; bpm =  beats per minute. 
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Factors associated with change in preload (total end diastolic volume) 
 
Fluid bolus increased TEDVI, on average by 34.6 + 34.2 ml/m2.6 for responders, and 8.4 + 34.7 
ml/m2.6 for non-responders (p < 0.001). There were similar inter-group differences for other 
volumetric variables: delta CBVI (2.2 + 2.3 versus -0.11 + 2.4 ml/kg, p<0.001), delta ACVI (6.3 + 
5.4 versus 0.4 + 5.4 ml/kg, p<0.001). The correlation between delta TEDVI and delta CBVI was 
r = 0.71, p<0.001, which was higher than that for delta TEDVI and delta ACVI, r = 0.42, 
p<0.001. Delta TEDVI did not have a significant correlation with delta central venous pressure, r 
= 0.14, p = 0.10, nor delta heart rate, r = 0.08, p = 0.37. Also, there was no difference in heart 
rate change after volume between responders and non-responders (mean change -4.7 versus -
3.2 beats per minute, p = 0.24).  
 
There was a weak inverse relationship between delta TEDVI and baseline TEDVI (r = -0.19, p = 
0.02, figure 6-1), but none between delta TEDVI and baseline central venous pressure (r = -
0.03, p = 0.72), expiratory tidal volume (r = -0.01, p = 0.89), dp/dtMAX (r = 0.10, p = 0.24) or 
arterial load (r = -0.02, p = 0.83, see supplement figure E1,). 
 
 
Figure 6-1 Scatterplot showing baseline versus change in total end diastolic volume after fluid 
administration. Gray circles represent patients who did not respond to fluid bolus, red squares represent 
responders. TEDVI; total end diastolic volume index. 
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Factors influencing fluid responsiveness 
 
We investigated the joint influence of change in preload (delta TEDVI), baseline systemic 
ventricular contractility, and arterial load on the change in stroke volume (delta SVI) after fluid 
bolus using multivariable linear regression (table 6-3, figure 6-2). The model explained 45% of 
the variability in delta SVI after fluid bolus, with delta TEDVI being the dominant factor, 
exhibiting a partial R2 value approximately 5 times greater than that for contractility (dp/dtMAX). 
Of note, arterial load was not related to delta SVI.  
 
 
Table 6-3 Regression model quantifying the relationship between haemodynamic factors and change in 








95% CI P Partial 
R2 
VIF 
Change in Preload ∆TEDVI  per  
10 ml / m2.6 
0.84 (0.67 to 1.01) <0.001 0.40 1.02 
Baseline 
contractility 
dp / dtMAX per  
100 mmHg / sec 
0.31 (0.14 to 0.48) <0.001 0.08 1.01 
Arterial Load EAE per  
mmHg / ml / m2.6 
0.14 (-0.49 to 0.77) 0.66 0.001 1.01 
CI = confidence interval; VIF = variance inflation factor. 
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Figure 6-2 Scatter plot demonstrating the relationship between absolute change in stroke volume index and 
absolute change in total end diastolic volume index after fluid administration.TEDVI; total end diastolic 




Although delta TEDVI explained the majority of the variability in delta SVI, baseline contractility 
was nonetheless an important factor. This is shown in figure 3, which was constructed using the 
regression coefficients from table 6-3. Here the gray horizontal bar represents the cut off 
whereby a positive delta SVI response is defined as >15%. Children with high baseline 
contractility, defined as a dp/dtMAX > 75th centile (>1300 mmHg/sec), typically achieved a positive 
SVI response with delta TEDVI values of 10 to 15 ml/m2.6, whereas patients with low contractility 






Analyses were repeated (n=114) after excluding single ventricle patients (post Fontan 
procedure). This produced a significant improvement in predictive ability for dp/dtMAX, with 
AUROC increasing from 0.61 to 0.68 (see supplement table E4). For other variables, the 
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predictive ability changed only slightly, and not consistently. For example, the AUROC 
increased for TEDVI (from 0.67 to 0.69), but decreased for PPV (from 0.54 to 0.51). In terms of 
“Factors associated with change in preload” (see above), exclusion of Fontan patients did not 
produce major qualitative changes in the relationship between delta TEDVI and any variable. 
For “Factors influencing fluid responsiveness”, Fontan exclusion improved regression model fit 






Our first aim was to evaluate potential predictors of volume response using two novel, 
commercially available devices. Overall the predictive ability of most variables was poor, with 
static variables performing better than dynamic (see table 6-2). This is largely concordant with  
Gan's  systematic review (12 studies, 438 children), which demonstrated limited predictive 
ability across a broader range of static and dynamic variables using different measuring devices 
to those in our study.5 Our AUC values compared to Gan* are as follows: central venous 
pressure 0.53 versus 0.54, cardiac end-diastolic volumetric variables 0.67 versus 0.62, systolic 
pressure variability 0.59 versus 0.63, pulse pressure variability 0.54 versus 0.71, stroke volume 
variability 0.53 versus 0.69. The larger between-study AUC differences for the latter two 
variables have possible explanations. For pulse pressure variability, Gan’s higher AUC is 
influenced by one outlier study; when this is excluded the value falls to 0.61 5. For stroke volume 
variability, our lower AUC may be due to different methods of calculation. We used PRAM, 
which was not assessed by Gan; this technology may provide an inaccurate paediatric estimate 
of stoke volume 26, and predicts volume response poorly in adult studies, yielding an AUC of 
0.60.28 
 
It is interesting to note that the predictive ability for the dynamic, arterial waveform-derived 
variables is markedly lower in children compared to adults, where typical AUROC values range 
                                                       
* Calculated using pooled, weighted data from relevant studies within Gan 5 
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from 0.84 to 0.96 29, 30. This may be due to age-related differences in vascular mechanical 
properties, affecting arterial waveform behaviour. There are dramatic (at least two-fold) changes 
in both total arterial compliance and aortic characteristic impedance (normalized to body surface 
area) from birth to adulthood 31, 32, associated with changes in arterial vessel wall thickness and 
collagen fibre quantity/length 33. There are also inherent differences in vascular properties within 
paediatric pathologies. For example, in congenital cardiovascular disease, average arterial 
elastance may exhibit two-fold differences, dependent upon the anatomic cardiac lesion, being 
both higher and lower than that for normal children 34. 
 
However, these arterial mechanical factors would likely only explain a proportion of the 
differences between paediatric and adult studies. Thus, our second and third aims of our study 
involved investigating factors that may affect predictive ability. Unsurprisingly, the largest 
determinant of change in SVI with volume loading was change in preload, as measured by 
TEDVI. However, preload did not change in a consistent fashion after volume loading, with delta 
TEDVI being only weakly correlated with baseline TEDVI (figure 1). This relationship was three 
to four times weaker in our patients compared to adults with sepsis 35, and in an animal 
hemorrhagic model 36, yielding correlation coefficients of -0.19 (current study), versus -0.65 and 
-0.73, respectively. We do not know the reason for this, but speculate that it may be due to 
variable degrees of systemic inflammation and capillary leak, differences in diastolic function 37, 
38 and venous mechanics 39, 40 in paediatrics. Of note, very little is known about the mechanics 
of venous return in paediatric critical illness.41 
 
Our third finding emphasized the importance of considering systemic ventricular contractility 
when assessing predictive ability of end diastolic volume. Although highlighted by others, this 
has only been quantified in terms of change in AUC when contractility is dichotomized as “poor” 
versus “preserved”.42, 43 We have extended these findings, by considering contractility as a 
continuous variable (table 6-3, figure 6-3), allowing for a more precise quantification. This shows 
that a patient with poor baseline contractility needs an absolute increase in end diastolic volume 
approximately 3 to 4 times greater than a patient with good contractility (i.e. 35 to 40 ml/m2.6 
versus 10 to 15 ml/m2.6) to achieve SVI “responder” status (i.e. SVI increment >15%). This 
obviously requires higher volumes of fluid loading: Reuter showed, that critically ill adult patients 
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with reduced contractility require, on average 25 ml/kg of 6% hetastarch to reach the top of their 
Starling curves.18 The clinical implications of this are important for patients with reduced 
contractility, who will require increased volume administration if a stroke volume increase >15% 
is targeted, but are also at higher risk of inadequate fluid clearance and hence fluid overload.44 




Figure 6-3 Regression derived multivariable relationship between percentage change in stroke volume 
index and absolute change in total end diastolic volume index after fluid administration, taking into account 
baseline contractile state.. Isobars represent centiles of contractility (dp/dtMAX) for the study population. The 
gray horizontal bar represents the cut off when a positive delta Stroke Volume Index response is defined as 
>15%.Red solid triangles represent patients with good base line contractility whereas green solid triangles 
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1) SVI and the volumetric variables (TEDVI, ACVI and CBVI) were derived from aspects of the 
ultrasound dilution curve, raising the possibility of mathematical coupling. Reassuringly 
however, several clinical and animal studies have shown that coupling is unlikely with 
transpulmonary dilution curves, as volumetric variables remained constant when stroke volume 
was altered with beta agonists/blockers 35, 45, 46. 
 
2) We may not have evaluated stoke volume variability accurately, as PRAM has been found to 
be an inaccurate measure of SVI 26. This may explain the discrepancy between our findings and 
the good prediction (AUROC 0.85) for aortic peak velocity, a variable closely related to stroke 
volume variability 47. However there is no reason to believe a similar error is present with PPV or 
SPV, as these were calculated directly from the arterial line.  
 
3) Spontaneous ventilation can compromise the predictive value of dynamic variables. Although 
our patients were ventilated in SIMV mode, the concordance of the set SIMV and measured 
patient respiration rates (table E3), suggests that very little spontaneous respiration was 
occurring. Also, our AUROC for the dynamic variables were similar to other paediatric studies 
using CMV (see paragraph 1 of Discussion).  
 
4) We used only one indirect measure of contractility (dp/dtMAX), derived from the arterial, rather 
than the left ventricular waveform. However, this correlates closely with invasively measured 
intraventricular dp/dtMAX in children 22. Also, the PRAM estimate of dp/dtMAX appears valid 
(despite being inaccurate for SVI) when compared to echocardiographically-derived dp/dtMAX in 
adults 48. It also tracks changes in inotropic state accurately in adults 49. A limitation of this 
measure is its sensitivity to changes in preload 49. However, this potential collinearity did not 
appear to be significant in our study, given the low regression variance inflation factors (table 3). 
 
5) We did not assess the influence of venous mechanics on TEDVI response to volume loading. 
Bedside techniques for this are still relatively novel in adult practice 50, and pose distinct 
challenges in terms of paediatric application. 
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6) Clinical indications for fluid administration were not recorded. The likelihood of volume 
response may possibly differ, according to clinical indication or perhaps clinician seniority. 
Interestingly, a recent multicentre study has highlighted enormous variability with fluid 
challenges, in terms of indication, type, volume and assessment of response 51. 
 
We suggest that these limitations are unlikely to change the three fundamental findings of our 
study. First, haemodynamic variables predict response to volume poorly, when SVI response is 
dichotomized as </>15%. Second, that volume loading does not produce consistent changes in 
ventricular end diastolic volumes. Third, that baseline contractility plays an important role in 
influencing volume response. Paediatric studies investigating the role of venous mechanics in 
volume response are needed. We also suggest that more information would be gained from 
future studies if SVI response is expressed as a continuous variable. 
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Chapter 6 Predicting fluid responsiveness in 100 critically ill 
















This prospective, non-randomized study was conducted within a 20-bed multi-disciplinary PICU, 
after approval by the regional ethics committee. Informed consent was obtained from all 
participants’ parents. 
 
Inclusion criteria were: (i) weight >2kg, (ii) age <16 years and (iii) pre-existing arterial and 
central venous lines. Exclusion criteria were: (i) known significant valvular regurgitation, (ii) large 
anatomical shunts, (iii) residual left sided obstructive lesions (e.g. aortic stenosis, coarctation), 
(iv) extreme haemodynamic instability, and (v) arrhythmias. Exclusions (i) to (iii) were screened 
using transthoracic echocardiography. Extreme haemodynamic instability was defined as either 
of the following occurring in the 30 minute period before advanced haemodynamic variables 
were measured (see below): (a) ongoing fluctuations in the bedside haemodynamic variables of 
heart rate and/or blood pressure and/or central venous pressure greater than approximately 
20% of baseline, or (b) requirement for an increase in inotropic or vasopressor support, greater 
than an increment of 5 mcg/kg/min for dopamine or 0.05 mcg/kg min for adrenaline or 
noradrenaline.  
 
Standard hemodynamic variables included heart rate, arterial and central venous pressures. 
ECGs were checked to verify sinus rhythm. Arterial lines were age appropriate (the smallest 
was 22 gauge), and located in: femoral (n = 90), radial (n = 46), axilla (n = 4) and brachial (n = 
2) sites. Invasive arterial pressure measurements were transduced via a standard disposable 
pressure transducer (Edwards Life Sciences, Irvine, CA, USA) and a dual output electronic 
module (Agilent, Technologies, Germany). One output is fed into the standard bedside monitor 
(IntelliVue MP70, Philips Healthcare, The Netherlands); while the other is connected to an 
arterial pulse contour monitor (see PRAM, below). All the arterial pressure tracings were zeroed 
before each measurement, and checked to exclude artifact.  
 
Advanced hemodynamic variables (see main manuscript, table 1) were measured using two 
commercially available devices. The first, CO-StatusTM (Transonic systems, Ithaca, NY), uses 
an indicator dilution method: transpulmonary ultrasound dilution (TPUD)1. A central venous 
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injection of 0.9% saline (0.5 - 1ml/kg, max 20ml) is given, and blood is pumped through the 
arterial limb of an extra-corporeal arterio-venous loop. The principle involves saline diluting the 
blood in proportion to total blood flow (cardiac output), resulting in a similar proportionate 
change in transit time, and hence velocity, of an ultrasound beam passed across the arterial 
loop. From this, an ultrasound dilution curve is produced, and cardiac output calculated via the 
Stewart-Hamilton equation. In addition, several static volumetric variables are calculated from 
the curve properties (main manuscript, table 1).2 
 
The second device, Mostcare® (Vytech®, Padova, Italy) is a continuous system utilizing arterial 
pulse contour analysis (Pressure Recording Analytical Method, PRAM).3 This technology 
calculates beat-to-beat stroke volume via a custom algorithm, as well as a range of dynamic 
variables (main manuscript, table 1). Variability measures (e.g. pulse pressure variability) were 
averaged over 30 seconds. 
 
Advanced hemodynamic measurements were made as soon as possible after patients were 
admitted to the PICU, timed to coincide with fluid bolus administration (all within 24 hours of 
admission). Baseline demographic and physiological data were collected at the same time. Fluid 
boluses (typically 0.9% saline or Hartmann’s solution at 10ml/kg over 20 minutes), were 
administered at the attending clinicians’ discretion, who were blinded to the advanced 
hemodynamic measurements. Variables were measured less than 15 minutes before, and up to 
30 minutes after fluid administration. The sequence of advanced hemodynamic measurements 
is shown in figure 4-1,. 
 
  
Paired TPUD and PRAM measurements were made as follows: Two consecutive TPUD 
measurements were made, and the dilution curves inspected. If the shape of the injection or 
dilution curves were unsatisfactory, or if the variation between the two measurements was 
greater than 20%, a third measurement was obtained. The readings were than averaged. This 
process typically took 3-5 minutes. PRAM measurements could not be obtained exactly at the 
same time, as the TPUD measurements required interruption of the arterial line. Thus, we 
averaged the continuous variables (systolic and pulse pressure variation, stroke volume 
variation and dp/dtMAX) from PRAM for 3 minutes before and after the time corresponding to the 
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UD measurements. Thus, a complete set of comparative measurements took approximately 10 
minutes. Heart rate was monitored continuously and non invasive blood pressure measurement 
performed every minute to ensure hemodynamic stability during this 10 minute period. We 
performed repeated comparisons (as above) after fluid bolus administration. 
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The coefficients of variation for the dilution curve-based measures are given in table  E1  
 









SVI ml / m2.6 pre volume 5.3 (5.1)% 
   post volume 4.7 (4.0)% 
Total End Diastolic 
Volume Index 
TEDVI ml / m2.6 pre volume 5.3 (5.9)% 
   post volume 4.6 (4.4)% 
Central Blood 
Volume Index 
CBVI ml / kg pre volume 4.6 (4.9)% 
   post volume 4.4 (4.1)% 
Active Circulating 
Volume Index 
ACVI ml / kg pre volume 7.5 (6.9)% 
   post volume 7.8 (6.7)% 
     
 
 
A positive fluid response was described as an increase in stroke volume index (SVI) >15% after 
fluid bolus. We chose arterial dp/dtMAX as a measure of myocardial contractility, as this has 
correlates closely with intraventricular dp/dtMAX .4 Arterial load was as expressed as effective 
arterial elastance, using the formula of Segers.5 Cardiac volumetric data were allometrically 
scaled to body surface area using a power of 1.38 (i.e. (m2)1.38 = m2.6); hence volumes are 
expressed as ml/m2.6 .6, 7 
  
   
 239 




Post Cardiac Surgery* 90 
    - Ventricular septal defect repair                                             (n = 17)  
    - Total cavopulmonary connection                                          (n = 17)  
    - Tetralogy of Fallot                                                                 (n = 10)  
    - Atrioventricular septal defect                                                (n = 9)  
    - Total anomalous pulmonary venous drainage                     (n = 7)  
    -Aortic coarctation / hypoplastic aortic arch                           (n = 5)  
    - Other cardiac anomaly                                                        (n = 25)  
Sepsis 8 
Respiratory Illness 2 
Total     100 
* For cardiac surgical patients, the median (IQR) times for cardiopulmonary bypass and aortic cross 
clamp were 80 (53 to 105) and 53 (35 to 74), respectively.  
 
  
   
 240 
Table E3 Mechanical ventilatory variables 
 
Respiratory Variable Units Value 
   
FIO2 % 38 (12.4) 
Peak Inspiratory Pressure cm H2O 19.9 (3.1) 
Positive End Expiratory Pressure cm H2O 5.2 (1.5) 
Mean Airway Pressure cm H2O 8.9 (1.9) 
SIMV rate resp / min 18.5 (2.2) 
Measured Patient Rate  resp / min 18.4 (2.8) 
Expiratory Tidal Volume  ml /kg 11.9 (3.6) 
Oxygen saturations % 97.8 (4.8) 
   
Data are presented as mean (SD), and refer to values taken before paired  
measurement episodes (n = 142).
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Table E4 Baseline hemodynamic variables according to fluid responsiveness, with Fontan (single 
ventricle) patients excluded 
 
Hemodynamic Variable Units Response 
(N = 52) 
Non-
response 
(N = 52) 
P AUC 
(95% CI) 
Basic      
Heart Rate (bpm) bpm 142 (25) 135 (24) 0.13 _ 
Central venous pressure mmHg 7.8 (2.8) 8.2 (2.9) 0.54 0.54 
 (0.43 to 0.64) 
Systolic Blood Pressure mmHg 94 (22) 87 (19) 0.08 _ 
Diastolic Blood pressure mmHg 52 (12) 50 (10) 0.41 _ 
Advanced: Routine      
Stroke Volume Index  ml / m2.6 28 (8) 33 (12) 0.008 _ 




cm5 / m2.6 
1338 (654) 1128 (466) 0.05 _ 
Effective Arterial 
Elastance 
mmHg / ml / 
m2.6 
2.71 (1.1) 2.17 (0.90) 0.005 _ 
Advanced: Static      
Total End Diastolic 
Volume Index 
ml / m2.6 256 (76) 308 (84) <0.001 0.69 
(0.59 to 0.79) 
Central Blood Volume 
Index 
ml / kg 16.3 (3.6) 17.9 (5.1) 0.06 0.58 
(0.47 to 0.68) 
Active Circulating 
Volume Index 
ml / kg 47.3 (12.5) 55.3 (15.7) 0.004 0.65 
(0.55 to 0.76) 
Maximum rate of systolic 
arterial pressure rise 
mmHg / sec 1111 (408) 861 (274) <0.001 0.68 
(0.58 to 0.78) 
Advanced: Dynamic      
Systolic Pressure 
Variation 
% 12.1 (9.4) 10.3 (7.4) 0.25 0.58 
(0.47 to 0.68) 
Pulse Pressure Variation % 21.4 (9.8) 21.9 (9.8) 0.79 0.51 
(0.40 to 0.61) 
Stroke Volume Variation % 22.0 (6.6) 23.2 (8.3) 0.39 0.55 
(0.45 to 0.66) 
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Data are presented as mean (SD), and refer to paired measurement episodes (n = 114). Abbreviations: 
AUC, area under receiver operating characteristic curve; bpm, beats per minute. 
  





Figure E1. Pairwise scatter plots showing relationships between selected baseline haemodynamic variables 
and change (delta) in total end diastolic volume after volume administration.  
Abbreviations: TEDVI = total end diastolic volume index; dp/dt =  maximum rate of systolic arterial pressure 
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Chapter 7 Accuracy of transpulmonary ultrasound dilution 
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To investigate the qualitative and quantitative accuracy of transpulmonary ultrasound dilution 




Prospective, observational study in a multi-disciplinary paediatric intensive care unit. Seventy 
three critically ill children (67 post cardiac surgery), with a median (IQR) age of 10 (3-50.3) 
months and a median (IQR) weight of 8 (3.43-13) kg were enrolled.  
Measurements: Ultrasound dilution (TPUD) measurements were performed on patients within 
one hour of undergoing two-dimensional echocardiography, which was used as the comparator 
technique. Shunt was diagnosed by characteristic changes on the TPUD curve shape, and was 
considered “test-positive” only if two or more measurements suggested the presence of the 





12/73 (16.4%) patients had a shunt identified by both TPUD and echocardiography. The overall 
accuracy (95% Conf. intv.) was 86.1% (75.6 to 96.6%), with a sensitivity of 85.7% (57.2 to 
98.2%) and specificity of 86.4% (75.0 to 94.0%). The estimated Qp:Qs ranged from 0.7 to 1.4, 
which was consistent qualitatively with the echocardiographic findings on colour flow Doppler. 
Shunt was detected by TPUD alone in 8 children; 6 of these had clinical conditions known to 
compromise dilution curve analysis (valve regurgitation, asymmetric pulmonary blood flow). 














Ultrasound dilution, Echocardiography, Shunt detection. 
  




Critically ill children admitted to the paediatric intensive care unit (PICU) may have undiagnosed 
anatomic shunts, both cardiac and extra cardiac in origin. This phenomenon has been 
investigated predominantly following corrective cardiac surgery for congenital heart disease, 
where the incidence of echocardiographically diagnosed residual shunt may be in the range of 
33 – 38% for certain lesions.1-4 However, the accuracy of shunt identification may vary 
according to the timing of imaging (relative to surgery), and the echocardiographic modality 
used.3 Anatomic shunting may also be common among patients without known cardiac disease, 
who are admitted to the general intensive care unit for other reasons.  For example, patent 
foramen ovale is a common lesion in the general population, occurring in approximately 30% of 
adults.5 The potential for this to result in hypoxemia from right to left shunting increases in the 
PICU setting, where elevated right sided pressures may occur secondary to pulmonary disease. 
Accurate and prompt diagnosis of anatomic shunts may be further hampered by lack of an on-
site cardiology service, which may lead to increased morbidity and prolonged length of stay. 
Thus, an accurate alternative method for diagnosing anatomic shunts would be beneficial. 
 
Transpulmonary ultrasound dilution (TPUD) (COstatus® Transonic systems, Ithaca, NY, USA) is 
a novel, invasive technology 6 capable of accurately measuring cardiac output and blood 
volumes in small children 7, paediatric animal models 8,9 and adults.10,11 In addition to 
hemodynamic volumetric assessment, TPUD technology can detect the presence of anatomical 
shunts based upon the shape of the dilution curves. This method utilizes pre-existing central 
venous and arterial lines, and does not require special skills apart from the correct indicator 
injection technique. Catheter laboratory studies in children 12 and an animal model 13 showed 
high sensitivity and specificity of this technology for the identification of large shunts. Recently, 
Lindberg et al 14 reported TPUD to be an accurate tool for shunt detection when compared with 
transoesophageal echocardiography in the immediate post operative cardiac surgery period in 
21 children. In addition, they demonstrated no significant difference between the TPUD 
technology and transit time ultrasound flow probes (considered as gold standard for flow 
measurements) for the measurement of Qp:QS (ratio between pulmonary to systemic blood 
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flow) preoperatively in the same cohort of patients. However, both the paediatric studies 
mentioned above 12,14 typically investigated subjects with left to right shunts only. 
 
We carried out our study with the aim to evaluate the TPUD  method  for (a) the accuracy of 
detection of small anatomic shunts and (b) the assessment of right to left and bidirectional 
shunts in addition to the left to right shunts (Qp:Qs estimation) in a cohort of critically ill children.  
 
 
7.3 Material and Methods 
 
This was a prospective, single centre, observational study conducted within a 20 bed multi-
disciplinary PICU between September 2010 to August 2012. The study was approved by the 
regional ethics committee (South East London REC2, 10/H0802/62). Written informed consent 
was obtained from all the parents or the legal guardians. 
 
 
7.3.1 Study subjects 
 
The children included in this study were part of a larger 100 patient cohort of critically ill children 
enrolled for studying their hemodynamic profiles.15 Seventy-three children (45 males) with the 
median (IQR) age and weight of 10 (3 - 50.3) months and 8 (3.43 - 13) kg respectively, were 
included into this study. Sixty seven (91.8%) were post cardiovascular surgery, 5 (6.8%) had an 
admission diagnosis of sepsis and 1 child (1.4%) had primary respiratory pathology The 
remaining twenty seven children were excluded from the analysis as they fell into one of the 
categories of the exclusion criteria (see below). All 73 subjects had pre-existing central venous 
and arterial catheters (see inclusion criteria below). Sixty eight (93.2%) patients had central 
venous catheter in the superior vena cava, placed percutaneously via the internal jugular 
approach, with the remainder sited in the inferior vena cava, via the femoral vein. Catheter 
position was confirmed radiographically.  
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7.3.2 Inclusion and exclusion criteria  
 
Children admitted to the PICU with pre-existing arterial line, central venous access and a clinical 
indication for echocardiography were considered for study inclusion. Clinical indications for 
echocardiography included (a) routine post cardiac surgery imaging, or (b) requirement for 
significant haemodynamic support (>60ml/kg fluid resuscitation in the previous 24 hours, or the 
need for dopamine infusion > 5mcg/kg/min) or (c) presence of a murmur. 
 
 Exclusion criteria included children with: (a) extreme hemodynamic instability, (b) previously 
recognized valvular regurgitation, (c) known unrepaired anatomical shunts and (d) single 
ventricle physiology. Extreme haemodynamic instability was defined as either of the following 
occurring in the 30 minute period before transpulmonary ultrasound dilution measurement and 
echocardiography: (a) ongoing fluctuations in the bedside haemodynamic variables of heart rate 
and/or blood pressure and/or central venous pressure greater than approximately 20% of 
baseline, or (b) requirement for an increase in inotropic or vasopressor support, greater than an 
increment of 5 mcg/kg/min for dopamine or 0.05 mcg/kg min for adrenaline or noradrenaline.  
 
 
7.3.3 Data collection 
 
The following data were collected within the first 24 hours following admission to the PICU: (a) 




7.3.4 Transpulmonary Ultrasound Dilution measurements 
 
The transpulmonary TPUD technique utilizes an extra-corporeal arterio-venous (AV) loop and 
two reusable ultrasound sensors - one on each side of the loop [6]. A roller pump provides a 
constant blood flow rate 9-12 ml/min in the AV loop. Normal saline (0.5 – 1 ml/kg, maximum 
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30ml) at body temperature is used as an indicator, and injected via the venous limb. The 
velocity of an ultrasound beam directed through a column of isotonic saline at body temperature 
is 1533 m/sec which is different from that of blood (ranging typically between 1570 – 1585 
m/sec). Thus, saline injected into the venous limb will produce a transient change in ultrasound 
velocity in both the venous and arterial limbs, in proportion to the degree of dilution. This is 
expressed graphically on the monitor as an arterial dilution curve (marked ‘b’ in Fig.3-2), with 
the y axis representing percent saline concentration in the arterial blood, and the x axis being 
time). The venous curve (marked as ‘a’ in Fig.3-2) on the screen only shows the shape of 
injection (flow) and is not normalized to percent dilution. The arterial dilution curve can be used 
to calculate cardiac output. 
                
Dilution curves representing right to left shunts (see Fig. 3-4) exhibit a short appearance time 
(arrow ‘a’ on figure 3-4) and an abnormal upslope (arrow b) or an extra hump (arrow c). This is 
due to a part of the indicator bypassing the lungs through the shunt and reaching the arterial 
sensor earlier followed by the rest of the indicator.16 Dilution curves representing left to right 
shunts (see Fig. 3-5) have a normal appearance time but there is more asymmetry of the 
downslope versus upslope than in normal curves, due to recirculation of the indicator (shown as 
‘d’ in Fig.3-5). Bi-directional shunts demonstrated characteristic properties of both types of shunt 
i.e. short appearance times and asymmetry of the downslope. 
 
Major dispersion of the dilution curve happens in the heart mixing chambers. The difference in 
the appearance time between femoral and radial artery locations is of the order of 2 cardio 
cycles. Location of the injection and the recording site is taken into account by the TPUD 
dilution software.  The operator is required to enter these details before the measurement. 
In addition to qualitative shunt detection, the software also provides a quantitative estimate of 
the ratio between the pulmonary to systemic blood flow (Qp/Qs). This is derived via algorithms 
based upon the observed changes in the shape of the dilution curve due to the presence of 
anatomical shunts.16-18 Here, Qp/Qs is derived by comparing the predicted area under a normal 
dilution curve with the area of the observed dilution curve. In right to left shunts the observed 
area of the ‘hump’ represents part of the indicator that bypasses lungs. Thus, the ratio of the 
rest of the area (from indicator that passed the lungs) to the total area (including the ‘hump’) that 
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was recorded in the arterial site gives a Qp/Qs ratio less than one. In the case of left to right 
shunt, the observed area under the curve is larger than the area of the predicted normal dilution 
curve due to the presence of saline recirculation, resulting in an abnormally extended 
downslope. Thus the ratio of observed area under dilution curve to predicted area gives Qp/Qs 
ratio greater than one.  
 
7.3.5  Procedure for validating shunt detection 
 
Echocardiography was considered as the reference method for shunt detection. A single, 
detailed 2D echocardiographic scan was performed when clinically indicated. Transthoracic 
ultrasound examinations were performed using the Philips IE33 Ultrasound system (Philips 
Medical Systems, Andover, MASS, USA) using S12-4, S8-3 or S5-1 probe as appropriate for 
the patient size.  Conventional echocardiographic methods were employed to detect residual 
shunts including cross-sectional echocardiography coupled with pulsed wave, continuous wave 
and colour flow Doppler assessment of any residual shunts. These techniques allow 
determination of whether the residual shunt is right to left, left to right or bidirectional but they 
cannot reliably quantify Qp:Qs in this setting. The operators commented on the direction of any 
residual shunt.  
 
Shunt size was described as: 
 
“tiny” if there was only a narrow jet of flow on colour flow Doppler which was not visualized on 
cross-sectional imaging alone,  
 
“small” if the shunt jet appeared wider than 2mm and if a residual shunt could be visualized 
without colour flow Doppler. 
 
 “moderate to large”, where a shunt was not pressure restrictive and which appeared 
hemodynamically significant by volume loading of cardiac chambers.  
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Postoperative transthoracic echocardiographic imaging is often difficult due to the absence of 
good acoustic windows. If there were very small shunts detected by colour flow Doppler then 
occasionally the angle of insonation did not permit reliable measurement of jet direction, which 
typically occurs with very small colour flow Doppler jets. The final echocardiographic findings 
were agreed by two experienced observers (KN, JMS) who were blind to the TPUD results.  
 
All TPUD measurements taken within one hour on either side of the echocardiogram were 
considered as eligible for shunt detection (fig 4-2). Ultrasound measurements were made for a 
variety of reasons. A minimum of one “set” of TPUD measurements was required as part of the 
study protocol; however we also performed additional sets of TPUD measurements when 
therapeutic manoeuvres were made for clinical indications within the time window (for example, 
administration of a fluid bolus or addition of a vasoactive agent). Each “set” of TPUD 
measurements required a minimum of two, sequential injections (each generating their own 
dilution curve). Significant abnormality in either the injection or dilution curves was detected by 
the CO Status® software. Measurements that had error messages such as: ‘repeat: noisy base 
line’, or ‘make smooth short injection’ lacked sufficient quality to be analysed for shunt by the 
software, and were excluded from the analysis. In such cases, injection was repeated until at 
least two analysable curves were produced. Ultrasound dilution was considered to have 
identified a shunt only if two or more measurements within a set suggested presence of the 
shunt. In all cases, operators performing both echocardiography  and TPUD  were blinded to the 
results from the other technique. 
 
 
7.3.6 Statistical analysis 
 
Diagnostic accuracy of the TPUD technique for shunt was quantified via calculation of 
sensitivity, specificity, accuracy and likelihood ratios (all were reported with 95% confidence 
intervals) using Stata v 12.1 (StataCorp, Texas, USA) incorporating the ado file “diagti” 
(courtesy of Aurelio Tobias and Paul Seed, downloaded from Stata Journal 4-4, sbe36_2) 
 





Paired TPUD and echocardiographic assessments were carried out in 73 children. Overall, 
4.7% of TPUD measurements were not analysed by the software due to technical issues 
outlined above (see methods). We did not encounter thrombosis of the AV loop in any patient. 
Haemodynamic data at time of echocardiography and TPUD measurement, expressed as mean 
(SD), included: heart rate 137 (27) beats per minute, systolic blood pressure 92 (20) mmHg, 
diastolic blood pressure 51 (11) mmHg, and central venous pressure of 8.7 (3.7) mmHg. All 
patients were mechanically ventilated, and 65 (89%) required at least one agent for inotropic 
and/or pressor support. These included: milrinone (n = 64), dopamine (n = 20), adrenaline (n = 
3), noradrenaline (n = 4) and levosimendan (n = 2). A set of TPUD dilution measurements was 
repeated for five children because of a therapeutic manoeuvre occurring within the time window 
between initial TPUD and echocardiography: four required fluid boluses (10 ml/kg) and two 
addition of an inotropic agent (one child requiring both). This did not affect shunt detection via 
TPUD, neither quantitatively nor qualitatively. 
 
The prevalence of shunt by echocardiography was 19.2% (14/73). The qualitative diagnostic 
accuracy of TPUD for shunt detection is shown in the table. This gives a sensitivity (95% Conf. 
intv.) of 85.7% (57.2 to 98.2%), specificity of 86.4% (75.0 to 94.0%), accuracy of 86.1% (75.6 to 
96.6%), positive likelihood ratio of 6.32 (3.21 to 12.5) ,and negative likelihood ratio of 0.17 (0.05 
to 0.60). The positive and negative predictive values were 60% (36.1 to 80.9%) and 96.2% 
(87.0 to 99.5%) respectively. 
 
Shunt was detected in 12 children by both TPUD and echocardiography (table). For 7 of these 
children, the direction of shunt flow by TPUD concurred with the echocardiographic assessment. 
In the remaining 5 children, the direction of the shunt by echocardiography was indeterminate 
due to the very small size of the shunt. However, TPUD designated a shunt direction in all 5 
children (two each were left to right and right to left and one was bi-directional). In all five cases, 
the direction of shunt designated by TPUD was consistent with the anatomic lesion: both of the 
left to right shunts were seen following ventricular septal defect repair, the two right to left 
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shunts were seen following repair of tetralogy of Fallot and total anomalous pulmonary venous 
drainage (one each), and the bidirectional shunt occurred following atrioventricular septal defect 
repair with a small right ventricle. 
 
Shunt was positive in eight children by TPUD only (seven of these were left to right and one was 
right to left), while 2 children had shunt detected by the echocardiography alone. Both shunts 
characterized by echocardiography alone were very small or tiny (see methods). Fifty one 
children had no shunt detected by either of the techniques. 
 







TPUD positive 12 (16.4%) 8 (11.0%) 20 
 
TPUD negative 2 (2.7%) 51 (69.9%) 53 
Total 14 59 73 
 
 
The size of the TPUD-derived Qp:Qs ratio for those with left to right shunts was less than 1.4 in 
all cases. Similarly, the TPUD-derived Qp:Qs ratio for patients with right to left shunts was 
always greater than or equal to 0.8 (see Fig.7-1). All of these agreed with echocardiographic 
estimates, and constituted small or tiny shunts not requiring further surgical intervention. There 
was no difference in the mean (SD) values for TPUD-estimated Qp:Qs between shunts detected 
by both TPUD and echocardiography and those detected by TPUD alone: 1.13 (0.02) versus 
1.15 (0.02) respectively, p = 0.77. 
  





 Figure 7-1 Distribution of pulmonary to systemic flow ratio estimated by TPUD. The size of the TPUD-
derived Qp:Qs ratio for left to right shunts was less than 1.4 and for right to left shunts was always greater 





We have demonstrated broad agreement between TPUD and echocardiography in terms of 
both anatomical shunt detection (sensitivity 85.7%, specificity 86.4%) and quantification in a 
group of critically ill children with small residual shunts (Qp:Qs 0.83 to 1.34).  
 
Utilization of dilution curves for the recognition and quantification of anatomic shunts   is not 
new; studies using dye as the indicator first appeared in the mid 20th century.19-22 To our 
knowledge, the largest study describing shunt detection via dye dilution was published by 
Morrow et al in 1966.23 Dilution curves were recorded intra-operatively and postoperatively in 
260 patients with pre-operative intra-cardiac shunts . Criteria for the shunt detection based upon 
dilution curves characteristics were analogous to ours. Their study demonstrated that, in 96 
percent of the cases, the presence or absence of a shunt determined from the intraoperative 
curves was confirmed by the findings at the postoperative study, providing a reliable, objective 
assessment of the effectiveness of the surgical procedure via a minimally invasive approach. In 
the last decade, use of transpulmonary thermodilution for this purpose has been described, 
although only as isolated case reports.24,25 
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Boehne et al 12 compared TPUD with oximetry during routine cardiac catheterization in 20 
children and adolescents with large shunts. They found a sensitivity of 100% and specificity of 
92.8% for TPUD for identification of cardiac shunts as compared to the data from the cardiac 
catheterization. Shih et al 13 reported a success rate of greater than 95% for right to left shunt 
detection with a false positive rate of 3% and a false negative rate of 5.2% in an animal model 
using TPUD. However, subjects in both of these studies  had  large anatomical shunts which 
may have contributed to the high specificities and sensitivities. 
 
Developments in TPUD indicator technology and curve analysis have provided two new 
potential advantages: (i) the ability to detect smaller shunts, and (ii) accurate quantification of 
the shunt direction and relative flow which has recently been substantiated by Lindberg et al.14 
They demonstrated no significant difference between  the TPUD and the transit time ultrasound 
flow probes for the estimation of Qp/Qs in the pre-operative paediatric cardiac surgical children 
.This is potentially important for several reasons. First, shunt flow may be significant, even in 
relatively small shunts, and also out of proportion to pressure gradients across chambers 
connected by the shunt.26,27 Second, intra- and extra-cardiac shunts are not always apparent on 
echocardiography2,3,28,29 and may need confirmation and quantification via alternative 
investigational modalities such as MRI or cardiac catheterization, which carry different risk 
profiles for the patient. Thus, TPUD may be a useful screening tool to evaluate patients who 
may need more detailed investigation. 
 
With this in mind, we have evaluated the performance of TPUD technology for detection and 
quantification of small shunts in a cohort of critically ill children. The sensitivity and specificity 
reported by us is slightly less than that reported in the above studies.12,13 This may be due to 
four main reasons:  
 
(a) Lack of a true gold standard for the reference method 
 
The limitations of transthoracic echocardiography in the immediate post-operative period are 
well documented, where intra-cardiac shunt detection can be influenced by many factors 
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including the quality of windows post thoracotomy, type of operative repair and rapidly changing 
hemodynamics.1-4 In addition, we did not investigate the false positive cases (shunt detected by 
TPUD only) for the presence of extra cardiac shunts, which are common with some cardiac 
lesions.28,29 Overall, the net effect may be to inflate the apparent false positive rate. 
 
(b) Timing of measurements 
 
Our study design allowed for a two-hour window where TPUD measurements could be made 
(up to one hour either side of the echocardiogram), and included manoeuvres that could change 
shunt dynamics. However we chose this study design to reflect real world conditions, i.e. to 
mimic how TPUD may be used in everyday clinical practice. 
 
(c) Size of the shunts 
 
Shunt identification via an indicator dilution technique is influenced by the amount of indicator 
flow through the shunt, which is proportional to shunt size; hence larger shunts are generally 
associated with more abnormal curves. All the residual shunts identified by echocardiography in 
our cohort of children were very small or tiny as compared to those in the above studies, which 
may increase our false negative rate.  
 
(d) Factors specific to left to right shunts 
 
As previously discussed, asymmetry of the dilution curves produced from left to right shunting is 
proportional to the flow of indicator through the shunt, with most hemodynamically significant left 
to right shunts having a Qp/Qs ratio greater than or equal to 1.5. Asymmetry of the dilution 
curves may also occur in several clinical scenarios without shunting, as highlighted in the 
literature 16-22 and by the manufacturer. These include moderate or large valvular regurgitation, 
and substantial asymmetry of lung perfusion as seen after surgery for correction of total/partial 
anomalous pulmonary venous return or transposition of the great vessels. However, in these 
scenarios, the estimated Qp/Qs typically range between 1.1 and 1.4. Such conditions may have 
contributed to six of the eight false positive TPUD results in our study. Five of these children had 
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at least moderate valvular regurgitation and one child was post partial anomalous pulmonary 
venous return surgery. In all these cases the Qp/Qs values were between 1.1 and 1.4, well 
within the specification and thus not misleading the operator for presence of a large 
hemodynamically significant shunt. 
  
Our results yielding a sensitivity and specificity of 85.7% and 86.4% respectively, demonstrate 
that TPUD represents an acceptable bedside tool for anatomical shunt detection. Given the 
potential confounding factors outlined above, it is possible that the accuracy is even higher. This 
compares favourably with intra operative transoesophageal echocardiography (an established 
method for detection of residual shunts), where a study of 573 post cardiac surgical patients 
yielded a sensitivity and specificity of 58% and 57% respectively versus transthoracic 
echocardiography.1 
 
Furthermore, shunt quantification produced Qp:Qs estimates that were consistent with 
echocardiographic findings, in cases where a shunt was detected with both techniques.  
 
A key limitation of our study (in addition to those outlined above) was a lack of larger shunts in 
our patient population. Although it is highly likely that TPUD will be accurate at detecting larger 
shunts, we do not yet know whether the quantitative estimates of QpQs in this setting are 
accurate; thus further studies using an accurate, quantitative comparator (for example, MRI) are 
required. 
 
In addition to the above there are  few limitations of the TPUD technology per se: 
 
1) Use of an extra corporeal AV loop required heparinisation of the AV loop. However, the total 
amount of heparin required to flush the system was very small [Heparin concentration 1unit/ml; 
priming volume of  the extra corporeal loop was 5.3 ml (2.7ml for the neonates)]. This was 
unlikely to have any significant effect on the coagulation profile of the patient. There was an 
option to redirect all the heparin solution into the injection syringe at the start of the 
measurement but this was not performed in our patients  due to the small volume of heparin 
infused. 
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2) TPUD measurement required simultaneous use of both central venous catheter and arterial 
line. Invasive blood pressure monitoring was unavailable for the duration  of the measurement 
(3-5min) . However, blood pressure was measured non invasively during the measurement 
period in these patients. 
 
3) As the TPUD utilized normal saline (1ml/kg, maximum of 30 ml ) as an indicator, recurring 






The transpulmonary ultrasound dilution technique accurately diagnoses the presence of small 
anatomical cardiac shunts. The estimates of Qp/Qs agreed qualitatively with the 
echocardiographic assessment of observed shunts as tiny or small.  The ability to provide 
Qp/Qs estimations may be beneficial in identifying the small shunt flow increasing to clinical 
significance. 
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Chapter 8 Summary, Conclusion  and Future direction 
 
Advanced haemodynamic monitoring can prove beneficial for the  management of critically ill 
children. This includes cardiac output monitoring and estimation of different markers for 
predicting fluid responsiveness in critically ill patients. CO monitoring could help physicians to 
differentiate between various causes of low blood pressure (such as low CO, low systemic 
vascular resistance index or both) . This could be useful in guiding and monitoring therapies 
intended for augmentation of CO (fluid bolus or inotrope administration). Previous studies have 
demonstrated inaccurate clinical estimation of CO hence, a range of devices is in use to 
measure CO. However, majority of them are intended and validated for use in adult patients. 
Their use in paediatric practice has been limited by technical challenges such as wide age and 
weight range, age variable vascular properties and rapidly changing haemodynamics with 
disease pathology. 
 
We studied two different types of CO monitoring in children. TPUD is an indicator dilution based 
tool (normal saline is used as an indicator) requiring the use of an extra corporeal loop with 
each end connected to an existing arterial and central venous catheter. PRAM is a pulse 
contour based monitoring device, which is easily connected to an arterial catheter already 
present in many critically ill children. 
 
Chapter 1 is a review of various commercially available methods for measuring cardiac output. 
There is a description of each method together with its advantages and limitations. The 
methods are also referenced to current literature review focussing on paediatric application and 
literature wherever possible. Though transpulmonary thermodilution technique is considered a 
gold standard for practical purposes but it is far from an ideal CO monitoring device. The current 
choice of any particular device is predominantly based upon clinician experience or preference, 
availability and patient factors. The chapter also introduces newer less invasive monitoring such 
as Nexfin and NICOM devices currently been investigated for clinical application. 
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Chapter 2 is a review of literature of the various static and dynamic markers, commonly 
employed in clinical practise for predicting fluid responsiveness. It discusses the physiological 
basis of origin of these markers including limitations of their use. Special emphasis is given to 
the static and dynamic markers measured by TPUD and PRAM respectively, along with the 
relevant literature review. We conclude (from literature review) that dynamic markers outperform 
static markers for prediction of fluid responsiveness in adult patients. Changes in the aortic 
blood flow peak velocity and passive leg raising showed consistent results. However, further 
studies are required to confirm their accuracy in paediatric practise.  
 
Chapter 3 focuses on the physics and principles behind TPUD and PRAM. TPUD makes use of 
indicator dilution curves for calculation of CO based upon Stewart-Hamilton equation. In 
addition, it also measures three novel static markers - TEDVI, CBVI and  ACVI. We investigated 
these markers for their utility in prediction of fluid responsiveness after fluid bolus administration 
or inotrope therapy. TPUD also provides qualitative and quantitative estimate for anatomic 
shunts based upon characteristics of dilution curves. PRAM on the other hand, is based upon 
pulse contour technology used with peripheral arterial catheters. It utilises arterial waveform 
characteristics to measure CO. In addition, it also measures dynamic markers - SPV, PPV and 
SVV, which were investigated for prediction of fluid responsiveness in our study. PRAM also 
gives an estimate of dP/dt max - a marker for systemic ventricular contractility. This enabled us 
to study the role of myocardial contractility in response to fluid bolus administration. We have 
also discussed the various limitations of these two methods. 
 
Chapter 4 is a description of research methodology for different aspects of the study. The three 
main research questions investigated were (i) Validation of PRAM against TPUD (ii) Prediction 
of fluid responsiveness using static and dynamic markers including the effect of baseline 
contractility and (iii) Accuracy of TPUD for identification of small anatomic shunts.  
 
Chapter 5 is a validation study for PRAM. PRAM is based upon pulse contour methodology but 
has not been validated for measuring CO in critically ill children. TPUD has recently been 
validated for the same cohort of children. This study investigated the accuracy of PRAM against 
TPUD technique. Our hypothesis for assessing the accuracy of PRAM for measuring absolute 
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values and tracking changes in CO after therapeutic interventions in children was not true. We 
concluded that there was an unacceptable lack of agreement between the two technologies for 
measurement of CO in critically ill children. In addition, PRAM was also not able to track 
changes in CO accurately as compared to the TPUD method. The results were demonstrated 
by use of Bland-Altman and polar plot analysis. The study led to the revision of the PRAM 
algorithm, which requires further validation.  
(Br J Anaesth. 2013 Mar;110(3):425-31).  
 
Chapter 6 is a study of static and dynamic markers measured by TPUD and PRAM respectively 
for prediction of fluid responsiveness in the paediatric age group. Fluid overload is shown to be 
an independent risk factor for poor outcomes in critically ill patients. Only 50% of the ITU 
patients are known to be responders to fluid bolus administration leading to unnecessary fluid 
overload in the non-responders. Hence, administration of fluid boluses to likely responders will 
prevent fluid overload in predicted non-responder population. Our hypothesis regarding the 
predictive ability of novel static and dynamic markers measured by TPUD and PRAM 
respectively was false. The overall predictive ability for all the markers was poor . Volumetric 
(static) markers (ACVI, TEDVI and CBVI) measured by TPUD performed slightly better than the 
dynamic markers measured by PRAM (SVV, PV and SPV). TEDVI was the best predictor in our 
study.  
However, baseline myocardial contractility had a significant influence on the stroke volume 
response after fluid bolus administration (true hypothesis). In addition, predictive ability 
improved slightly when baseline contractility was taken into account.  
Search for newer, accurate markers and on going testing of accuracy of the established 
markers in different clinical settings for prediction of fluid responsiveness should continue. Effect 
of various elements of venous properties such as venous capacitance or resistance on stroke 
volume response to fluid bolus administration needs further investigation in children. 
 
Chapter 7 is an observational, double blind study investigating the accuracy of TPUD for 
detection of small anatomic shunts. The accuracy was assessed against trans-thoracic 
echocardiography performed by experienced cardiologists as a reference method. The overall 
accuracy was 86.1% with a sensitivity of 85.7% and a specificity of 86.4%. The quantitative 
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estimation of ratio between pulmonary to systemic flow was also consistent with the 
echocardiographic findings on colour flow Doppler. We concluded that TPUD was qualitatively 
and quantitatively accurate method for detection of small anatomical shunts proving our 
hypothesis true. 
(J Clin Monit Comput. 2015; 29(3):407-414)  
 
  










Children/Young People  INFORMATION SHEET  
Advanced haemodynamic monitoring in critically ill children 
 
 
We are asking if you would like to join in our research project. This sheet explains the research. 
We have given another sheet to your mum or dad, and we will be asking their permission, as 
well as yours.  
 
What is research?  
 
Research is how doctors and nurses find out the best way to look after children (and adults) 
when they get sick. For example, if we have a new medicine, we will compare the new medicine 
to an older one, to see which works best. 
 
What is this research project about?  
 
As you know, you will soon be having a heart operation. After the operation, you will be looked 
after in the PICU (this stands for: Paediatric Intensive Care Unit). You will have a chance to visit 
the PICU before your operation, and the nurses will explain how everything works. 
 
After your operation, we will use special heart monitors to measure how fast your heart is 
beating and also what your blood pressure is.  
 
Here’s the research bit. We have two new types of heart monitor that we would like to use, as 
well as the ordinary monitors. We think that they may give us extra information that may be 
useful for children in the future who need heart operations.  
 
What do I have to do? 
 
You won’t need to do anything. If you take part, we will use the two extra monitors, as well as 
the usual ones. The extra monitors connect to the usual ones, so you won’t notice them.  
 
Is it painful? Is it risky? 
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No. We won’t need to do anything painful (like extra blood tests). The way we look after you will 
be exactly the same whether you take part in the research project or not. 
 
Do I have to take part? 
 
No, it’s up to you and your mum or dad. If you want to take part, we will ask mum or dad to sign 
a form, giving us their permission.  
 
Can I change my mind? 
 
Yes, that’s no problem if you do. 
 
What happens after that? 
 
If the monitors are useful, we will tell other doctors around the world. 
 
What if I have some more questions? 
 
Tell you mum or dad. They will get in contact with us (we are the doctors who are running the 
research project), and one of us can come and talk to you. 
 
Our names are: Shane, Rohit and Naga. 
 
 
Thanks for reading this! 
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      Parent/Guardian  INFORMATION SHEET  : Emergency Admissions 
Advanced haemodynamic monitoring in critically ill children 
   
 
We would like to invite you to allow your child to take part in a research study. Before you 
decide it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully. One of our research team 
members will be available to answer any questions you may have.  
 
 
The study will look at   Advanced haemodynamic monitoring in critically ill children 
 
 
What is the purpose of the study?  
 
When a child is admitted to the intensive care unit, they require very close monitoring. We 
routinely monitor heart rate and blood pressure, to allow us to assess how the heart and blood 
vessels (cardiovascular system) are functioning. In addition, depending upon the severity of the 
illness of your child, we may place additional lines into one of each type of the large blood 
vessels, called arteries and veins (arteries take blood out from heart to the different parts of the 
body, veins take blood from the rest of the body towards the heart). This allows us to monitor 
the cardiovascular system accurately and continuously.  
 
In adults, it is possible to make a more detailed assessment of the cardiovascular system using 
extra monitoring equipment (for example, we can measure how much blood is being pumped 
around the body each minute). Up until now, these extra measurements have been very difficult 
to perform in children; one of the main limiting factors has been size. However, recent advances 
in technology means that monitors are now available which may be suitable for children. 
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In this study, we wish to evaluate two new cardiovascular monitors in ill children admitted to 
intensive care unit. We plan to use these monitors in addition to the routine measurements and 
monitoring. We will compare the information from the new monitors to that provided by our 
standard ones; however the new monitors will not be used to alter the type of care we give. 
 
If these monitors provide useful new information, they may be used in the future to guide clinical 
care. For example, we may be able to better judge when a child needs fluid therapy, or to adjust 
the dose of medications used to support the heart and circulation. 
 
 
Why have I been invited? 
 
Your child has been invited because he/she has been admitted to intensive care and requires 
detailed monitoring using the lines described above. We aim to assess the new monitors in 100 
children requiring intensive care. 
 
 
Do I have to take part? 
 
It is up to you to decide to join the study. If you do decide to enter your child into the study, you 
will be given this information sheet and a consent form to sign (for which you will receive a 
copy). Should you decide not to take part, the treatment of your child will not be affected. You 
are free to withdraw at any time, without giving a reason. However, if you do withdraw, we would 
ask that we can use the information that has already been collected. 
 
 
What is involved in taking part? 
 
Your child will be monitored in the intensive care unit with two extra monitors for up to 48 hours 
after admission. 
 
   
 273 
One of the monitors, called PRAM (Pressure Related Analytical Method) does not actually 
attach onto your child directly, but uses information continuously taken from the routine blood 
pressure (arterial) line, which will have been placed earlier for standard care. The monitor is 
approximately 15” by 8”, and will be placed behind the bed space. 
 
The second monitor, is called ‘COstatusTM’ (9” by 6” in size), and is used to measure blood flow 
with ultrasound technology. Here, we will make use of the two pressure monitoring lines that are 
already in place (one is arterial, for measuring blood pressure; the other is venous for 
measuring pressure in the veins). We will make a maximum of eight measurements over the 48 
hours after admission. Each measurement takes approximately 5 minutes, and involves two 
steps. First, we will divert a small amount of blood (one teaspoon) from the blood pressure 
(arterial) line into the venous line. Second, we will inject a small amount of salt solution (saline) 
into the diversion, and the machine will then measure how the ultrasound signal changes during 
this process. The saline solution is exactly the same as that which we use as our intravenous 
fluids (in other words, your child will already be receiving saline as part of routine care). During 
measurement, we aim to recycle all of the blood back into your child’s veins; very occasionally 
up to half a teaspoon may remain in the lines after the a set of measurement. 
 
 
Are there any risks or side effects involved in taking part? 
 
We do not foresee any risk with the PRAM monitor. 
 
The second monitor (COstatusTM) poses two potential risks: 
 
First, as stated above, measurements may mean that a small amount of blood is withdrawn 
from your child. In majority of the cases, all of this blood is recycled back into your child’s vein. 
However, very infrequently a small amount of this blood may be unsuitable for recycling .We 
anticipate that this may be up to a maximum of            half a teaspoon per set of measurement, 
or a maximum of 2 teaspoons over 48 hours. This is extremely unlikely to have any 
consequence; for example this will not result in your child requiring a blood transfusion. 
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Second, when we make the measurements, we will be unable to use the arterial line to measure 
blood pressure for a period of approximately 10 seconds. If necessary, we can measure blood 
pressure during this time by other means. In addition, all other monitors will continue (heart rate, 
oxygen levels, breathing rate). 
 
Your child will not experience any pain, as no needles are involved 
 
 
Is there any benefit from being in the study? 
 
No, there is no benefit to your child from taking part in this study. However, if we find an 
unexpectedly abnormal result, we will tell the clinical team looking after your child, who may 




Who is performing the study? 
 
The research is being led by Dr Shane Tibby who is a consultant in Paediatric intensive care. 
The research project is being undertaken as part of a higher degree (MD) for Dr Rohit Saxena 
(research fellow working in the intensive care unit).  
 
 
Who has reviewed the study? 
 
All research in the NHS is looked at by independent group of people, called a Research Ethics 
Committee. This study has been reviewed and given favourable opinion by the South East 
London (2) Research Ethics Committee. 
 
 
What happens with the results of the study? 
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Once we have collected all the information, we will analyse the data and then aim to publish 
these results within the following year in a medical journal. All information collected will be 
confidential, and no information will appear in any medical publication that will allow your child 
to be identified. 
 
We can arrange to send you an electronic copy of the publication.  Please mention your interest 




Is any payment involved? 
 
The doctors involved will receive no payment for recruiting patients or performing the study. You 
or your child will not receive any payment if you decide to take part. 
 
 
Who can I contact for further information? 
 
If you have any concerns or questions about the study please contact: 
 
i) Dr Shane Tibby, Consultant PICU, Evelina Children’s Hospital 
Contactable during weekdays on 020 7188 4572  
 
ii) Dr Rohit Saxena, Clinical Research fellow, PICU, Evelina Children’s Hospital. Tel 
07940039078 
 
iii) Dr Naga Kishore Puppala, Clinical Research fellow, PICU, Evelina Children’s Hospital. Tel 
07725056466 
 
For out of hours queries, please contact a member of the medical team, who will relay this to the 
Consultant on call. 
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Thank you for considering your child taking part in the study. If you decide to take part, you will 
receive a copy of this information sheet and a copy of the signed consent form. 
 
  







Title of Project: Advanced haemodynamic monitoring in critically ill children 
 
 
Name of Principal Researcher: Dr Shane Tibby 
 
Patient Identification Number for this trial: 
 
 
Please initial box 
 
 
1. I confirm that I have read and understand the information sheet dated ……………  
(version…….) for the above study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
2. I understand that my child’s participation is voluntary and that I am free to withdraw 
him/her at any time, without giving any reason, without affecting his/her medical care or 
legal rights. 
 
3. I understand that relevant sections of my child’s medical notes and data collected during 
the study may be looked at by responsible individuals from the research group where it is 
relevant to my child taking part in this research. I give permission for these individuals to 
have access to these records. 
 




























When completed, make three copies. Please retain the original and insert in the medical 
notes, give one copy to the patient’s parent/guardian, and the final copy to the research 
team. 
 
Thank You 
 
